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collections of Li-Fraumeni Syndrome cases. The second paper identifies couples’ coping 
and communication processes regarding cancer stressors, using semi-structured 
qualitative interviews of individuals with Li-Fraumeni Syndrome and their partners. The 
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cancer-specific worry. Couples cope with this worry by balancing multiple roles, 
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 This dissertation is dedicated to couples and families who shared their 
vulnerabilities, strengths, and incredible life stories with me. I am honored to have been a 
part of these intimate conversations. My husband found this quote and it perfectly 
embodies the spirit of love, balance, and support that I observed in these couples, a 
phenomenon that I tried to represent in this work.   
 
 
“A Marriage” by Michael Blumenthal 
 
You are holding up a ceiling 
with both arms. It is very heavy, 
but you must hold it up, or else 
it will fall down on you. Your arms 
are tired, terribly tired, 
and, as the day goes on, it feels 
as if either your arms or the ceiling 




something wonderful happens: 
Someone, 
a man or a woman, 
walks into the room 
and holds their arms up 
to the ceiling beside you. 
 
So you finally get 
to take down your arms. 
You feel the relief of respite, 
the blood flowing back 
to your fingers and arms. 
And when your partner's arms tire, 
you hold up your own 
to relieve him again. 
 
And it can go on like this 
for many years 
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CHAPTER 1: INTRODUCTION 
 
Statement of the Problem 
 Cancer genetics and inherited risk of developing cancer have significant health 
and psychological implications for individuals and their families. Inherited (germline) 
genetic mutations underlie 5-10% of all cancers, and researchers have identified more 
than 50 hereditary cancer syndromes that may predispose carriers to certain types of 
cancer (Berger, 2011; Lindor, McMaster, Lindor, & Greene, 2008). Within the field of 
heritable cancer syndromes, research has focused on the process of genetic testing, early 
screening, cancer prevention, and risk-reduction. A growing body of work regarding the 
psychological, relational, and emotional effects of genetically heritable cancer exists 
alongside this corpus of medical prevention and intervention research.  
 The nature of heritable cancer syndromes inherently lends itself to family studies. 
Not only are multiple family members across generations and genders at elevated risk of 
cancer; the family unit as a whole must cope with each new cancer diagnosis, genetic 
testing results, cancer treatment, and cancer prevention strategies. Family relationships 
among siblings, parents and children, cousins, spouses, etc. can all be affected, based on 
the course of the cancer diagnosis, treatment, and prevention strategies. However, 
research regarding the implications of cancer syndromes for family relationships is still in 
the formative stages. The limited research literature has shown that social support is very 
important in helping family members cope with cancer syndromes, and this includes 
support within families in terms of tangible assistance and emotional connections (Peters 





To best capture the complex nature and effects of genetically heritable cancer 
syndromes in the family context, this dissertation employed multiple research methods, 
including a quantitative study based on psychological assessment questionnaires, a 
qualitative study derived from semi-structured interviews with couples, and a social 
network analysis of quantitative data derived from interviews with individual partners 
about their social support networks. These three empirical studies and associated papers 
focused on one specific hereditary cancer susceptibility disorder, the Li-Fraumeni 
Syndrome (LFS), to best illustrate its effects on family relationships and the couples 
coping strategies associated with this challenging syndrome.  
LFS is an autosomal dominant cancer predisposition syndrome, typically 
characterized by early age at cancer diagnosis and a high lifetime cancer risk. The overall 
cancer risk associated with LFS is estimated to be 50% by age 40 and as high as 90% by 
age 60 (Mai et al., 2016), with the most common cancers being early-onset breast cancer, 
osteosarcoma, soft tissue sarcoma, brain tumors, leukemia, and adenoid cystic carcinoma 
(more details about LFS can be found in the following chapter). Women with LFS have 
higher aggregate risks of all cancers combined due to the very high risk of female breast 
cancer. Individuals with LFS also have a substantial risk of multiple primary cancers, 
starting in childhood. Given the complexity of the syndrome and the stressors it creates 
for family members, to date there has been little research on its psychosocial effects on 
individuals and their families. The present dissertation was designed to help fill that gap 





Figure 1. Illustrative Pedigree of an LFS Family 
 
Considering the limited amount of existing psychosocial research regarding LFS, 
the following review of literature focuses more broadly on couples’ psychological and 
emotional coping with a member’s cancer status in the context of newly diagnosed 
sporadic cancers, and other heritable cancer syndromes such as Lynch Syndrome, Von 
Hippel-Lindau (VHL), and Heritable Breast and Ovarian Cancer (HBOC). By broadening 
our attention to studies on family relationships and family functioning in other cancer 
syndromes, we may identify the unique aspects of individual and partner coping in LFS. 
In addition, HBOC is more common and more intensively studied, having a larger body 
of literature investigating dyadic processes. The goals of this literature review are twofold. 
The first is to identify specific gaps in existing couples research regarding heritable 
cancer syndromes and provide suggestions for future directions of study. The second goal 
is to synthesize the existing literature to propose clinical implications and provider 





involves dramatically elevated risks of cancer. This type of cancer syndrome requires 
life-long coping skills and social support. Many of the current psychological 
interventions focus on acute treatment once a patient has been diagnosed with a cancer. 
These skills are useful for people with a heritable cancer syndrome, but they do not 
address the more long-term complications and anticipatory emotional distress that can 
cause strain and burdens on a relationship. The literature review elaborates on the 
nuanced framework that is required for professional teams to develop adequate forms of 
care for people with heritable cancer syndromes and their families.  
 Since LFS is a rare syndrome, and related psychosocial research is limited, this 
investigator applied multiple research methods to investigate the dyadic experience of 
coping with an LFS diagnosis within couples. Quantitative research methods using 
relatively precise standardized measures with established reliability and validity have the 
most potential to produce findings that can be generalized, whereas qualitative studies 
can provide more in-depth understanding of individuals’ life experiences, and generate 
novel hypotheses that warrant further investigation. Mixing qualitative and quantitative 
research methods may also provide deeper exploration of causal pathways, interpretation 
of meanings that individuals attach to their experiences, and contextual factors that may 
mediate or moderate the topic of study. Consequently, findings from this multi-method 
investigation of how stresses of heritable LFS influence couple relationships and how 
partners cope with cancer risk can broaden current knowledge and lead to evidence-based 
recommendations for clinicians working with couples affected by such syndromes. This 
set of studies emphasizes that cancer genetics is neither solely an individual nor 
biomedical matter, but rather a familial and psychosocial issue, and clinical practice and 





Theoretical Framework: Family Stress and Resilience 
The family stress and resilience framework guided this investigation into the 
stressors (the threat of cancer, as well that associated with cancer screening and treatment 
procedures) and coping processes of couples facing LFS and how couple relationships are 
influenced by their ability to cope with such a significant set of stressors. According to 
Allen and Henderson (2017), family stress and resilience theory combines two important 
family theories: family stress theory and risk and resilience theory.  Family stress theory 
(the ABCX model) focuses on how individuals experience and respond to life stressors 
that challenge their ability to cope, depending on their resources (versus vulnerabilities) 
and perceptions (Boss, 1987). According the ABCX model, A is the stressful event, B 
equals family resources or strengths, and C is the family’s perception of the stressor event, 
or how they define or attribute meaning to the event (Hill, 1958). Stressor events can vary 
along a number of dimensions, such as acute versus chronic, and normative versus non-
normative. Thus, an LFS diagnosis is a chronic stressor that is relatively non-normative 
or unusual. 
In the ABCX model, if a couple or family lacks adequate resources for coping 
with a stressor and has negative perceptions of the stressor (e.g., as overwhelming), this 
can lead to a crisis state of disequilibrium and deterioration in functioning (e.g., 
debilitating individual anxiety and intra-couple conflict), the X component of the model. 
However, in the presence of effective resources (e.g., good couple communication) and 
constructive perceptions (e.g., “We will face this cancer threat together as a couple, and 
make wise decisions about the best medical procedures to use to stay healthy.”), a couple 
is more likely to weather the stressors, both as individuals and as a dyad. Individuals in a 





resources as a group (e.g., cohesiveness and mutual emotional support) that can help the 
members stay healthy and moving forward, even in the face of adversity (Patterson, 
2002). 
In response to a stressor, families develop specific strategies and roles for coping 
with the current challenges associated with that stressor. Coping in the context of an new 
cancer diagnosis involves the family’s ability to adapt functionally to both the immediate 
distress of the diagnosis and treatment, and to make long-term adjustment to life changes 
(Burke, 2009). Family coping may involve shifts or changes in roles and responsibilities, 
communication, and how family members deal with conflict. Some family stressors that 
may interfere with successful coping could include loss of daily routine, physical 
symptoms, loss of confidence, feelings of isolation, loss of financial security, and feelings 
of guilt or resentment. A weakness with the ABCX model is its focus on specific, isolated 
stressors that require a family response. Given the long-term nature of life with LFS, it is 
important to consider how multiple coping styles may be employed at different time 
points in response to different stressors. Additionally, if families are carrying a low level 
of stress constantly (i.e., cancer worry), they may need to develop regular or daily 
strategies for creating positive meaning in their lives. Some families may avoid the 
stressor developing into a crisis state of disequilibrium and deterioration by using coping 
resources that help them tolerate the stress and/or hold the degree of stress to a low level. 
However, in the stress and coping model, it is unclear how a family would cope with 
simultaneous acute (cancer diagnosis) and chronic stressors (constant vigilance and 
prevention actions). This dissertation aims to address this ongoing process of coping and 
family adaptation, utilizing aspects of family resilience theory, which extends theory and 





The second component of the framework utilized in the present set of dissertation 
studies is the risk and resilience perspective (Demo, Aquilino, & Fine, 2005), which 
explores how families react to experiences in ways that can either produce negative 
outcomes (risks), as well as their ability to overcome life challenges and grow stronger 
(resilience). If families are able to cope and adapt in a dynamic manner, they can rebound 
positively within the context of adversity. Resilience is not simply innate in humans, but 
involves a complex interplay of multiple risk and protective processes that are influenced 
by individual, interpersonal, socioeconomic, and cultural factors (Walsh, 2012). Using 
this frame of reference, families that have genetic or social vulnerabilities, can 
counterbalance these risks with positive influences at multiple levels.  
On the family level, supportive relationships can nurture individuals through 
attachment, support, and encouragement. Walsh (2007) discusses how the family 
resilience perspective moves away from the deficit-based lens of viewing families, to 
seeing families as having the potential to heal and grow from the challenges and 
adversities that they face. Over time, families transition and develop, and variable coping 
strategies must be employed for short-term crises or long-term chronic needs. This view 
of multiple, complex changes to the family system maps well onto families living with 
LFS. This dissertation will address how some families thrive by making meaning out of 
their adversity, maintaining flexibility and connectedness, and utilizing their social and 
economic resources (i.e., mobilizing social networks, building financial security, and 
integrating into larger health systems). The processes for building and maintaining family 






Cancer experiences profoundly affect patients’ and their relatives’ lives. Much of 
the psychosocial literature has focused on the negative consequences of living with 
cancer; however, our study of resilience may enable providers to promote more positive 
psychosocial outcomes before, during, and after the cancer experience (Molina et al., 
2014). For all phases of the cancer continuum, resilience descriptions in the literature 
have included preexisting or baseline characteristics of patients and their family members, 
such as demographics and personal attributes (e.g., optimism, social support), 
mechanisms of adaptation such as coping and constructive interactions with medical 
personnel (e.g., positive provider-family communication), as well as positive 
psychosocial outcomes including growth and improved quality of life after “bouncing 
back” from the initial negative impact of a cancer diagnosis. Families can provide their 
members a sense of stability and understanding that enables healing, particularly through 
the use of shared rituals, spirituality, and cultural or ethnic traditions (Walsh, 2007). For 
health services providers, promoting resilience is a critical element of patient 
psychosocial care. 
Walsh (2012) posits that stressors and challenges are inherent in the human 
condition. Her concept of family resilience involves the potential for recovery, repair, and 
growth in families facing serious life challenges. Although some families are shattered by 
major stressors, disruptive transitions, or persistent hardship that develop into destructive 
crises, other families are, remarkably, able to emerge strengthened, more resourceful and 
better prepared to move forward with their lives.  
Taken together, family stress and resilience theory addresses how families are 
prepared for, deal with, and learn from stress and risk (Allen & Henderson, 2017). This 





theory to understand how couples living with LFS cope with the unique stressors of 
genetic testing, high cancer risk, intense cancer screening and the need to consider risk-
reducing surgery.  
The research questions and hypotheses of the present three studies were informed 
by tenets of family stress and coping theory and resilience theory. The first study 
examined the general distress, cancer-specific distress, and coping styles of individuals 
with LFS and their partners. From a family stress and coping perspective, the various 
types of stressors associated with an LFS diagnosis are likely to be associated with an 
increase in couples’ levels of emotional distress and the risk of individual and relational 
problems in functioning. The ABCX model also suggests that the members of the couple 
will respond to the stressors with various specific coping strategies, so our study 
examined the degree to which both partners’ coping styles may affect the LFS-diagnosed 
individual’s functioning. 
The second study investigated how couples cope with the challenges of LFS, 
paying particular attention to the shared strength or resilience that is built between two 
partners. This study explored some of the key processes in family resilience such as 
communication, problem-solving, and meaning-making (Walsh, 2007). This exploratory 
study considered whether there were any patterns of coping across couples, especially in 
the face of ambiguous danger related to cancer risk of family members. Family stress, 
coping, and resilience concepts emphasize the family preparation and response to life 
challenges. These constructs draw attention to how families learn from stressful events 
and how life lessons are communicated among family members. In the context of LFS, 
families may be faced with multiple stressors (genetic testing results, multiple acute 





these stressors affected the quality of the couple relationship. Given the importance of 
multiple independent primary cancers in LFS, the study focused how couples coped and 
created shared belief systems across extended periods of time and multiple stressors.   
The third study focused on family psychosocial distress and communal coping 
from a social networks perspective, exploring the shared supports and mutual exchanges 
of resources within couple dyads. The social network perspective is a social science 
which focuses on the joint activities and exchanges between participants in a social 
system (families in this study). Wasserman & Faust (1994) define a social network as a 
group of individuals and the relation or relations that define them. The core concepts of 
the social network perspective are: 1) “actors” are the main social unit and the core of 
social network analysis; in this study the actors are the two partners that are married to 
each other; and 2) “ties” capture how actors are connected to one another (behavioral 
interaction, physical connection) by marriage. Utilizing the “dual ego-centric” approach 
(Faust, 2007), a social network analysis tool commonly used to count directly the 
frequencies of relationship configurations in the data, we can visualize and quantify the 
actors and their ties to each other and the people around them.  
A variety of protective factors may interact with risk factors to buffer couples 
from the negative effects of cancer(s), and the social network perspective focuses on the 
role of the partners’ social support resources. The aim of this study was to explore how 
much couples relied on their partners for various forms of support and how much their 
family and friend networks overlapped. It is not well understood whether or how mutual 
support between members of a couple, or the size of their shared networks, may 
contribute to the effectiveness of social support in reducing the level of distress of these 





support in LFS couple relationships were associated with lower levels of distress. The 
utilization of these shared social resources may provide insight for organizational patterns 






CHAPTER 2: LITERATURE REVIEW 
 
 There multiple varieties of hereditary cancer syndromes, varying by age-at-onset, 
specific cancers implicated, mode of inheritance, etc. This chapter focuses on Hereditary 
Breast/Ovarian Cancer (HBOC) and LFS, summarizing the prevalence and penetrance of 
each syndrome, the unique psychosocial implications of each syndrome for individuals 
with the syndrome and their partner, as well as recommendations to health professionals 
for providing patient- and couple-centered care. The published literature regarding 
psychosocial functioning of couples affected by heritable cancer syndromes is sorely 
lacking, and consequently there exists a significant limitation in healthcare professionals’ 
abilities to provide evidence-based care to these individuals and their partners. To address 
this gap in knowledge, and to help develop guidelines for the design of appropriate 
medical and psychological support structures, this review draws on the psychosocial 
literature on couples coping with cancer, research on cancer caregiver burden, and the 
specific research regarding functioning of couples with HBOC and LFS. I present an 
argument for conceptualizing and treating genetic cancer syndromes as conditions that 
are chronic, relapsing, or intermittent in nature, and as such it is crucial that on-going 
support structures be developed for people and families affected by them.  
The field of heritable genetic cancer syndromes and psychosocial research has 
focused on the functioning of individuals with the germline genetic mutation that causes 
each disorder. Findings regarding the individuals’ coping, stress levels, perceived ability 
to manage symptoms, and care have provided useful insights into how the medical 
community can best support them when they receive their genetic testing results. 





diagnosis can have on the relationship dynamics between individuals with an elevated 
risk of cancer and their romantic partners. Long-term partners have been consistently 
identified in medical research as playing major influential roles in lives of individuals 
who have cancer or are recovering from cancer. The partner’s own health behaviors, 
support for the individual with cancer, and the couple’s relationship quality all play 
significant roles in the individual’s emotional, social, and physical outcomes. 
This review first considers the importance of a couple-specific contextual 
approach in heritable cancer syndrome research. Second, the existing literature on couple 
functioning in these two prototypic heritable cancer syndromes is described. Finally, 
recommendations are proposed for health care practitioners, mental health clinicians, and 
genetic counselors who work with these families, to facilitate their employing a more 
family-forward model of support and treatment. In this way, future research and 
interventions increasingly can be extended beyond the patient to their partner and family.  
 
Couples and Cancer 
Traditionally, the focus of cancer care and its research has been on the individual 
experiences of patients or their spousal caregivers, but there has been a shift toward 
looking more closely at caregiver-patient dyads (Q. Li & Loke, 2014). This attention to 
the transactions between caregivers and patients as care partners can provide useful 
insights regarding the reciprocal nature of stress and support in these close relationships 
(Fletcher, Miaskowski, Given, & Schumacher, 2012). Several conceptual models have 
been identified that specifically target caregiver-patient dyads in the cancer population. 
The relationship intimacy model addresses the psychosocial adaptation of couples to 





and their engagement in communication styles that sustain and/or enhance the 
relationship during times of stress. Communication is defined as a transactional process 
in which individuals create, share, and regulate meaning; it is an essential part of the 
support that patients and caregivers provide for each other. Research suggests that this 
population has a desire for increased communication and openness.  
In the other conceptual model, proposed by Fletcher et al. (2012), caregiver-
cancer patient dyads are conceptualized as a functional unit, with their mutuality 
involving three dyad-level concepts: “communication,” “reciprocal influence,” and 
“caregiver-patient congruence.” Reciprocal influence refers to the effects that two 
members of a dyad have on each other. The concept of reciprocal influence has expanded 
previous literature that simply focused on the influence of the patient’s illness and need 
for assistance on caregivers. More recent findings illustrate how the stress process is 
reciprocal on multiple dimensions, and aspects such as caregiver and patient well-being, 
role adjustment, mental health, psychological distress, physical health, and quality of life 
appear to be interrelated (Bambauer et al., 2006; Chen, Chu, & Chen, 2004; Kim et al., 
2008).  
A third model, proposed by Sullivan (Sullivan, 2012), is the Communal Coping 
Model, which has previously been applied to pain communication. Communal coping 
refers to couple members holding a shared assessment of a health threat and vision of 
shared action about how to manage the event (Lyons, Mickelson, Sullivan, & Coyne, 
1998). This model involves: a) one or both members of the couple holding the belief that 
a join effort is advantageous, needed, or useful; b) partners communicating about the 





Caregiver-patient congruence emphasizes the synthesis of data from individual 
members of a relationship into a dyadic variable. For example, related terms such as 
agreement, concordance, or disparity address the level of congruence between a patient’s 
and caregiver’s experiences. One study used a promising conceptual approach, the Actor-
Partner Interdependence Model, and structural equation modeling to explore the effect of 
partners’ dissimilarity in distress on the caregiver’s quality of life (Kim et al., 2008). 
Results from the latter study revealed that, although each person's psychological distress 
was the strongest predictor of their own quality of life, partner's distress and 
(dis)similarities in couple-related distress also played significant roles in one's quality of 
life. The present research also utilizes a version of the Actor Partner Interdependence 
Model that integrates the responses of individuals in a dyadic romantic relationship.  
These models suggest that research into the caregiving experiences of families 
with cancer should go beyond just the caregiver or the cancer patient’s experiences to 
look at the caregiver-patient dyad as a unit (Fletcher et al., 2012). Although these models 
help illuminate the cancer experience itself, genetically heritable cancer syndromes carry 
a lifelong burden of cancer risk beyond the single, acute occurrence. Therefore, research 
on these families must expand these models to incorporate dyadic coping during non-
active cancer periods (during which cancer treatment is not a major activity) as well.  
Relationship satisfaction is an important factor that modifies how successfully 
couples cope with cancer. One study found that relationship quality had a moderating 
effect on the secondary trauma stress symptoms that were exhibited by partners of cancer 
patients (Brosseau, McDonald, & Stephen, 2011). The researchers found that 23% of 
partners of cancer patients exhibited clinically significant levels of secondary traumatic 





that relationship quality exhibited buffering effects only for the couples that reported 
higher levels of relationship quality, and this moderation was found for both the cancer 
patient and their partner.   
There are several ways in which partners can show their support for an individual 
with cancer. Studies have examined the effects of three specific types of support (active 
engagement, protective buffering, and overprotection) on a variety of outcomes such as 
the marital satisfaction of both partners and whether these types of support were actually 
perceived as helpful by the cancer patient (Hagedoorn, Kuijer, et al., 2000), as well as the 
self-efficacy, physical health, and mental health of patients with a chronic illness (de 
Ridder, Schreurs, & Kuijer, 2005). Active engagement by partners means involving the 
patient in discussions and using constructive problem-solving methods; protective 
buffering by partners means hiding one’s concerns to protect their spouse; and 
overprotection rests on an underestimation of the patient’s capabilities, resulting in 
unnecessary help and excessive praise for accomplishments. Overall, partner protective 
buffering and overprotection behaviors have not been shown to improve the self-efficacy 
and marital satisfaction of the patient. Conversely, one study found a positive association 
between active engagement and the patient’s marital satisfaction, especially for patients 
with high levels of psychological distress and more physical limitations (Hagedoorn, 
Kuijer, et al., 2000). These findings demonstrate the important process in which both 
partners should be actively engaged in care and utilize open communication.  
Relationship satisfaction in couples confronted with colorectal cancer (Hagedoorn 
et al., 2011) was described in a sample of 29 female patients and 59 male patients and 
their partners, who participated in a study measuring the association between past and 





in the short-term, spousal active engagement was positively associated with relationship 
satisfaction in patients and their partners, but this observed only occurred when past 
spousal support had been low. Spousal protective buffering was found to be negatively 
associated with relationship satisfaction in patients, again only when past spousal support 
was low. If past spousal support was high, participants reported their current relationship 
quality as high, regardless of partner’s current support behaviors (Hagedoorn et al., 2011). 
These results demonstrate the buffering effect that high spousal support that existed 
before a cancer had on the marital relationship, as well as the positive impact of active 
engagement on the part of the spouse during colorectal cancer.  
These studies illustrate both the effects of cancer on partners and the methods that 
partners use to support their sick spouse. The burden of cancer on both partners is well 
established; however, what is less well-known is how couples function when there is a 
constant risk of cancer in the future, or how couples cope with multiple separate primary 
cancers across the trajectory of their relationship. The next sections describe literature 
regarding the unique dyadic interactions that occur between people who carry mutations 
that increase their risk of cancer and their partners.  
 
Hereditary Breast and Ovarian Cancer Syndromes 
Genetic Origin, Prevalence, and Penetrance 
Hereditary Breast and Ovarian Cancer Syndrome (HBOC) is an inherited genetic 
condition in which in which an elevated risk of breast and ovarian cancer is passed from 
generation to generation in a family. Two genes are associated with the majority of 
HBOC families: BRCA1 and BRCA2, an acronym in which BRCA stands for BReast 





developing breast and other cancers, such as mutations in the TP53, PTEN, CDH1, ATM, 
CHEK2 or PALB2 tumor suppression genes and many others. Blood tests now include 
many of these genes in a single, multiple-gene panel test. A mutation (alteration) in either 
BRCA1 or BRCA2 gives a woman a markedly increased lifetime risk of developing breast 
and ovarian cancer. Men with these gene mutations also have an increased risk of breast 
cancer and prostate cancer. There is a slight increase in the risk of other cancers, 
including pancreatic cancer and melanoma, among carriers of BRCA1 or BRCA2 
mutations. Not all families with multiple cases of breast and ovarian cancer have 
mutations in BRCA1 or BRCA2. Prevalence estimates of BRCA1/2 among U.S. women 
range from 1:400 to 1:500 (excluding Ashkenazi Jewish populations) and it occurs in all 
ethnic and racial populations (NCI, 2018). The penetrance of the breast and ovarian 
cancer for women with a BRCA1/2 pathogenic variant can be as high as 87%, and 20% 
for men, but varies for BRCA1 and BRCA2. Risk of breast cancer within the general 
population is relatively low (risk of malignancy = 12%), compared with individuals 
carrying BRCA1 (46-87%) or BRCA2 (38-84%) mutations. The same applies to ovarian 
cancer, which is rare in the general population (1-2%) but which occurs at a much higher 
rate than for those with BRCA1 (39-63%) or BRCA2 (16.5%-27%).   
 
Partnerships in the Context of HBOC 
The available literature on the psychological impact of being a partner of an 
individual diagnosed with a hereditary cancer syndrome has focused primarily on 
partners of women who carry (or are at high risk of carrying) the BRCA1/2 gene mutation. 





than, the distress levels of their mutation affected partners. There is very limited literature 
on men with the BRCA1/2 gene mutation and their romantic relationships.  
One study measured the specific needs of the spouses of who received genetic 
counseling for a positive BRCA1/2 result (Metcalfe, Liede, Trinkaus, Hanna, & Narod, 
2002). The researchers surveyed 59 spouses of female mutation carriers. The mean 
relationship duration was 26 years (range: 2.5-50 years). All participants were supportive 
of their spouses' decision to undergo genetic testing and counseling. Four respondents 
stated that they wished that they had received additional support at the time of test 
disclosure, and 20% felt that their wives had received inadequate support. One-quarter of 
the spouses believed that their relationship had changed because of genetic testing; most 
felt that they had become closer to their wives. Husbands were most concerned about the 
risk of their wife dying of cancer (43%), followed by the risk of their spouse developing 
cancer (19%) and the risk that their children would test positive for the BRCA mutation 
(14%). Distress levels, measured by the Impact of Event scale, suggest that few spouses 
were experiencing clinical levels of distress.  
The role of the partner without the mutation or who is not at elevated risk of 
cancer can be complicated. These partners must share their concerns with their partner 
regarding genetic testing and cancer screening for their children; however, they will 
never experience the testing or screening themselves. To evaluate how involved non-
mutation carrying spouses are and how their level of involvement affects their mutation-
positive partners and relationships, one study surveyed male partners of BRCA1/2-
muation positive women with children (DeMarco et al., 2010). Only 27% of fathers 
attended pretest cancer genetic counseling with mothers. Compared with fathers who did 





alliances with mothers, were more likely to have sought out information about BRCA1/2 
testing, and felt more informed about testing. The conclusion that the researchers drew 
was that fathers who attend genetic counseling sessions may be better equipped to 
support mothers about making key decisions later on, including medical and family 
communication decisions. Additionally, helping fathers became more involved in the 
genetic counseling process, encouraging a stronger alliance between partners.  
In conclusion, partners of women with a BRCA1/2 mutation often request 
additional support for themselves and their partners. These partners are involved in the 
genetic testing process to varying degrees, which in turn affects the couple/parenting 
dyad. The literature on BRCA1/2 mutation-positive women still lacks thorough research 
on the dyadic family planning processes and decision-making conversations that occur 
between partners. Hoskins (2008) conducted in-depth interviews with young BRCA1/2 
mutation-positive women regarding their romantic relationships and found that disclosure 
to a partner resulted in increased feelings of closeness and trust. This points to the 
importance of open communication and supportive partnerships; however, there is a need 
for research that can describe the full experience of the partner without the mutation, as 
well as interviews that systematically inquire about both partners’ experiences.   
 
Li-Fraumeni Syndrome 
Genetic Origin, Classification, Prevalence, and Penetrance 
LFS is an autosomal dominant cancer predisposition syndrome that can result in 
multiple cancer diagnoses across the course of an individual’s life. Many individuals with 
LFS receive a cancer diagnosis in childhood or adolescence. LFS is a highly penetrant 





cancer among mutation carriers is very high within LFS families (Becze, 2011). The risk 
of developing cancer by age 40 is estimated to be 50%, and is 90% at age 60 (Mai et al., 
2016), meaning that 9 out of 10 TP53 mutation-positive LFS patients will develop cancer 
at some point in their life. Germline mutations in the TP53 tumor suppressor gene are the 
cause of LFS in about 70% of families (Schneider, Zelley, Nichols, & Garber, 1993). 
These mutations result in aberrant function of the TP53 protein, and lead to inappropriate 
and abnormal cell growth. The most common cancer types in patients with LFS are 
female pre-menopausal breast cancer, bone cancer (osteosarcoma), soft tissue sarcomas, 
brain tumors, and cancer of the adrenal gland (adrenocortical carcinoma) (Mai et al., 
2016).  
There are diagnostic criteria through which an individual is clinically classified as 
having LFS. Classic LFS is defined by meeting all the following criteria: a proband with 
a sarcoma diagnosed before age 45, a first-degree relative with any cancer before age 45, 
and a first or second-degree relative with any cancer before age 45 or a sarcoma at any 
age (F. P. Li et al., 1988) According to the alternative Chompret criteria people can be 
classified clinically as having LFS if (1) the proband has a tumor belonging to the LFS 
tumor spectrum before age 46, and ≥one first- or second-degree relative with an LFS 
tumor before age 56 years; (2) probands have multiple independent tumors, two of which 
belong to the LFS tumor spectrum and the first of which occurred before the age of 46; (3) 
a proband has an adrenocortical carcinoma or choroid plexus tumor, regardless of family 
history. Studies have shown that 92-95% of people who tested positive for the TP53 





Although LFS has been considered to be a rare hereditary cancer syndrome, 
recent data suggest that the frequency of a germline TP53 mutation may be as high as 
1:500 (Andrade et al., 2017). 
Although LFS outcomes can be dire, cancer screening and early detection of 
cancers have shown promise in reducing cancer-related morbidity and mortality (Villani 
et al., 2016). Since women with LFS have been shown to have a 93% lifetime risk of 
developing breast cancer, medical practitioners recommend commencing breast MRIs, 
ultrasounds, and mammography starting at an earlier age than people at average risk of 
breast cancer. In order to screen for other cancers for both men and women, screening 
protocols are being developed that employ an annual full body MRI, blood tests, 
ultrasounds, colonoscopies, brain MRI, and physical exam (Kamihara, Rana, & Garber, 
2014). 
Genetic testing in families at risk is the first step in early cancer detection. When a 
family knows which specific TP53 mutation they are carrying, testing previously untested 
family members is much cheaper and simpler, since it targets only the family-specific 
mutation), and they are equipped with knowledge that better prepares them to work with 
healthcare providers to establish a routine of cancer screening.   
 
Partners in the Context of LFS.  
Couples with LFS face unique decision-making challenges regarding medical and 
genetic testing decisions, screening and prevention behaviors, and familial disclosure. 
This section describes strategies reported by patients as they handle those situations, and 
findings regarding the experiences of non-LFS partners and current gaps in the literature.  





correlated with cancer-specific distress that individuals experienced before receiving their 
genetic testing results for TP53 mutations. Specifically, a higher number of cancer 
diagnoses and deaths in first-degree relatives were associated with greater cancer-specific 
distress in individuals from LFS families before they had their testing.   
Overall, studies have shown that even after genetic education and counseling, 
patients with suspected TP53 mutations are less likely to elect genetic testing than 
patients at risk of other genetically heritable cancer syndromes such as BRCA1/2, which 
is associated with increased risks of breast and ovarian cancer. This difference has been 
attributed to the fact that BRCA1/2 mutation-carriers have specific surgical options 
available to decrease their risk of breast or ovarian cancer, whereas patients with TP53 
mutations have less specific options because the types of cancers they are at risk of are so 
varied (Parsons, 2011). These results demonstrate the conflict that individuals are faced 
with regarding genetic testing. Lower perceived self-efficacy regarding coping with the 
possibility of future cancer may prevent individuals from pursuing testing (Peterson et al., 
2008). However, there are likely other variables in play that must be investigated. Other 
family members’ beliefs regarding genetic testing have a large influence on the 
individual’s behavior, but this relationship has not been studied previously in LFS 
patients.  
One study in the Netherlands looked at distress in partners of individuals with 
LFS and Von Hippel-Lindau disease (VHL; another rare autosomal dominant cancer 
syndrome that results in higher risk of a broad range of tumors developing in early 
childhood or adulthood) (Lammens et al., 2011). In a study of 50 LFS or VHL affected 
individuals and their partners, the researchers found that 28% of the partners reported 





worry reported by the partner were significantly correlated with the distress levels of the 
high-risk spouse. The researchers also found that younger partners as well as partners 
with less social support in their lives reported higher levels of distress. Importantly, 76% 
of the partners who participated in the study believed that they, and not just their at-risk 
spouses, should be offered routine professional psychosocial support.  
Since inheritance of a TP53 gene mutation results in a nearly 100% lifetime risk 
of cancer, a prominent concern for young families is whether the mutation will be passed 
on to younger generations. There are a variety of options outside of natural conception 
that can be considered, such as adoption, surrogacy, or even pre-implantation genetic 
diagnosis (PGD), in which genetic testing for the family’s TP53 mutation is conducted on 
the embryo before it is implanted into the uterus. There are important ethical 
considerations that accompany each of these options, and it is recommended that pre-
natal testing only be done after thorough consultation with a team of clinicians that 
includes a pediatric oncologist, geneticist, psychosocial worker, prenatal care provider, 
and ethical representative. The major potential psychological benefit to the family of pre-
natal testing would be to reduce uncertainty in high-risk families.  
Oftentimes adults learn that they are mutation-positive after they have already had 
children. In such cases, the next question they face is whether to test a child, and if so, at 
what age. (Alderfer et al., 2015) conducted a qualitative study to explore the decision-
making process that parents undergo when deciding whether or not to test their child 
(who may or may not have already had cancer) for the TP53 mutation. All of the families 
in the sample had at least one relative who had tested positive for the mutation and were 
involved in decision-making about whether to put their child through the process. Three 





consideration, with the family members citing the immediate benefits of knowing; 
considered decisions involved parents taking time to weigh the risks and benefits, but 
then reaching a conclusion easily; deliberated decisions, which were difficult and focused 
on psychosocial concerns such as not wanting to burden the child, adding unnecessary 
stress if the child never actually does have cancer, discrimination, and insurance issues. 
Across the board, TP53 mutation testing interest was high (92%), with the vast majority 
of parents focused on the benefits of testing (Alderfer et al., 2015). 
In summary, the themes that arose in the literature on LFS individuals and their 
partners focused on cancer-related distress, genetic testing for children, and patients’ self-
efficacy in the context of larger family history. Both individuals with LFS and their 
partners reported a need for increased mental health support, but tailored interventions for 
families coping with heritable cancer syndromes are still in beginning testing stages. The 
next section describes family interventions that may be adapted for this unique group. 
  
Interventions 
 Interventions vary in their goals and treatment style. Literature on chronic illness 
points to couple interventions that focus on couple relationship quality and functioning. 
Typically, such interventions focus on various methods to foster emotional 
expressiveness, reduce social isolation, prevent the disease from dominating couple and 
family life, help the individuals deal with loss of a loved one, promote collaboration 
among family members, improve empathy for all sides, deal with stigma, and resolve 
intra-family conflict (Medicine, 2001). Psychoeducation is often combined with couple 





especially as it relates to secondary prevention (encouraging regular exams and screening 
tests to detect disease in its earliest stages; e.g., mammograms to detect breast cancer).  
 A review of 10 different intervention studies targeted at female breast cancer 
patients and their partners found overwhelming benefits for both partners in some 
dimensions such as quality of life, psychological distress, relationship functioning and 
physical symptoms associated with cancer (Brandao, Schulz, & Matos, 2014). Although 
there was significant diversity in many of the characteristics and theoretical orientations 
underlying the interventions, all of the interventions included training in specific coping 
strategies, problem-solving, and communication skills. Other common elements included 
a significant psychoeducation component, promotion of emotional expression and social 
support, promotion of sexual and body adaptation, and promotion of benefit finding, 
post-traumatic growth, and a focus on sources of meaning in one’s life. These results are 
in line with research findings for psychological interventions that have been found 
beneficial for couples dealing with other types of cancer (H. Badr & Krebs, 2013; Baik & 
Adams, 2011; Hopkinson, Brown, Okamoto, & Addington-Hall, 2012).  
Relational coping and skills building are the foci of many studies looking at 
effects of psychosocial interventions with couples dealing with a current or recent cancer. 
However, couple interventions related to cancer can also be designed with a preventive 
goal in mind. An intervention study by Manne (2013) aimed to involve spouses in the 
colorectal cancer screening behaviors of their non-adherent spouse. The results indicated 
that using a couple-tailored print brochure resulted in higher intentions to engage in 
colorectal cancer screening as well as an increase in husbands’ support for their wives’ 
engagement in colorectal screening (Manne et al., 2013). Although there was no 





intervention groups, there was an increased tendency for the couples who received the 
couples-tailored brochure to view colorectal cancer screening as having benefits for their 
marital relationship. Examples of these benefits included both partners having increased 
relational perspectives regarding cancer, support for spouse screening, and more 
discussions with one’s partner about colorectal cancer screening. This type of prevention 
and screening study has direct relevance for couples in which one partner has a heritable 
cancer syndrome and is recommended to have regular cancer screenings starting at an 
early age. The challenge is that these couple-focused interventions have been developed 
for newly diagnosed sporadic cancer patients and their partners, and not much is known 




The importance of psychosocial and family issues in genetically heritable cancer 
syndromes has been widely recognized but under-researched. After an exhaustive search 
of relevant literature on this topic, only a handful of publications were found that dealt 
directly with couple relationships and/or the psychological effects of these syndromes on 
individuals and their partners. Because these syndromes are heritable, research on family 
communication and family functioning is very relevant. Despite the inclusion of family 
members as participants in many medical studies of heritable cancer syndromes, few 
researchers have looked at changes in family processes over time, and adaptation of 
family relationships under the stress of past, current, or future cancer. This static or short-
term viewpoint on cancer does not lend itself to understanding the experiences of couples 





 Psychological interventions designed to help couples dealing with cancer have 
been shown to have immediate benefits for both partners. Relational psychoeducation and 
communication skills building are psychological interventions that offer a framework for 
clinicians working with heritable cancer syndromes and the families with whom they 
work. Medical Family Therapy is a growing field that utilizes many of the traditional 
theories and techniques from different types of family therapy, but it also draws attention 
to the biopsychosocial nature of the human experience (Ruddy & McDaniel, 2016). 
Medical family therapists must be familiar with illnesses and their effects on individuals 
and families, understand the medical evaluation and treatment system and how to work 
collaboratively with medical providers, and be familiar with techniques that assist 
families in coping with the unique stressors that hereditary illness places on them. 
Increased numbers of trained medical family therapists working in conjunction with 
genetic counselors, oncologists, and clinical researchers who are familiar with the 
syndromes touched on in this review are desperately needed. These interdisciplinary 
teams can work together to increase the amount of targeted research on intervention and 





CHAPTER 3: STUDY 1 
 
Dyadic Coping Styles and Cancer Worry in Li-Fraumeni Syndrome Couples 
Background 
 After heart disease, cancer is the most common cause of death in the United 
States (CDC, 2015). According to the National Cancer Institute (2014), one’s lifetime 
risk of developing any type of cancer is 40.37%. This risk probability varies based on a 
range of factors such as gender, age, and race. In addition, certain inherited genetic 
characteristics can put some people at a higher risk of cancer than the general population. 
More than 80 hereditary cancer syndromes have been described in the professional 
literature, with 5-10% of all cancers diagnosed in the United States developing from a 
hereditary genetic mutation (Lindor et al., 2008). The majority of these are genetic 
mutations that are inherited in an autosomal dominant fashion from parent to child and 
significantly increase a person’s risk of developing cancer.  
 
Li-Fraumeni Syndrome  
 Li-Fraumeni Syndrome (LFS) is an autosomal dominant cancer predisposition 
syndrome that can result in elevated risk of multiple cancers across the course of an 
individuals’ life. Commonly, individuals with LFS receive a cancer diagnosis early in life, 
such as childhood or adolescence. The most common cancer types in patients with LFS 
are breast cancer, bone cancer, soft tissue sarcomas, brain tumors, and cancer of the 
adrenal gland (Mai et al., 2016). The number of cancer occurrences as well as deaths 
from cancer is very high within LFS families, and they face the possibility of a second or 





40 years is estimated to be 50%, and 90% at 60 years (Mai et al., 2016), meaning that 9 
out of 10 people with LFS will develop cancer at some point in their life. Germline 
mutations in the TP53 tumor suppressor gene cause LFS in about 70% of clinically-
defined families (Schneider et al., 1993). The elevated risk of cancer can cause distress 
and elevated worry about cancer among individuals with LFS as well as their families. 
Fortunately, regular cancer screening and early detection of cancers have shown promise 
in reducing cancer-related morbidity and mortality (Villani et al., 2016).   
 
Cancer Worry 
For individuals facing a high cancer risk due to a genetic diagnosis, the worry and 
anxiety related to future cancers can be overwhelming. Research on individuals 
diagnosed with LFS has shown that they experience psychological distress beyond the 
stress of daily functioning (Lammens et al., 2010). A study of 18 LFS families found that 
23% of participants reported clinically relevant levels of LFS-related distress. This 
finding reflects a larger trend in the literature regarding cancer-specific distress in 
individuals who are at risk of hereditary cancers. For example, women with BRCA1/2 
mutations face higher chances of breast and ovarian cancer at younger ages than the 
general population, and research has found that these women typically have higher than 
average levels of emotional distress, especially in the months following genetic testing 
(Butow, Lobb, Meiser, Barratt, & Tucker, 2003; Ringwald et al., 2016).  
To distinguish between general distress (such as general anxiety and depression) 
and cancer-specific distress, many studies have explored the concept of “cancer worry” in 
terms of how distressed a person is regarding risk of future cancers, and how much this 





functioning in a variety of areas such as job performance, enactment of family roles, and 
personal health maintenance (Wellisch, Ormseth, Hartoonian, & Owen, 2012). One study 
of women with a high risk of breast cancer showed that two-thirds reported that their 
worries about breast cancer interfered with their life functioning in multiple domains 
(Trask et al., 2001). In that study, the high-risk women who reported more cancer worry 
also reported greater anxiety and confusion, diminished mental health, and difficulty in 
performing their usual roles in and outside the home.  
 
Contributing factors to cancer worry, cancer worry’s interference in 
functioning. Some interventions such as genetic counseling can reduce worry about 
developing cancer, as shown in a group of women whose breast and ovarian cancer worry 
was measured before and after receiving genetic counseling (Bish et al., 2002). 
Unfortunately, beyond Lammens (2010) research on psychological distress, very little 
literature exists exploring cancer worry in this population, and there is even less research 
regarding how these individuals and their partners can cope with the future risk of cancer. 
 
Partners’ Cancer Worry 
Heritable cancer susceptibility disorders involve a cycle of intense psychological 
experiences not only for the at-risk individuals but also for their life partners. The 
relational implications of genetic risk may be examined within family systems theory 
(Peterson, 2005), in which events that affect an individual are predicted to also affect the 
whole family system. A genetic diagnosis and its implications, as in the case of hereditary 
tumors, are viewed not as a single event, but rather as an on-going dynamic process that 





on relatives, whether the results of each family member’s genetic testing are positive 
(mutation-carrier) or negative (non-carrier); even those who are not at risk personally 
may experience significant worry about the results of genetic testing (Bowles Biesecker 
& Marteau, 1999).  
Several studies have shown that the partners of people with rare hereditary cancer 
syndromes also exhibit high levels of psychological distress and worry (Hagedoorn, 
Buunk, et al., 2000; Lammens et al., 2011). However, the findings of studies on distress 
in cancer patients and their partners have been inconsistent. In several studies, intimate 
partners were found to be just as distressed as patients (Baider, Cooper, & Kaplan De-
Nour, 1996; Baider & Kaplan De-Nour, 1997; Northouse & Swain, 1987; Oberst & Scott, 
1988). In a study by Given and Given (1992), husbands of women with recurrent breast 
cancer reported even more depressive symptoms than their wives. Other studies of 
couples dealing with heritable breast cancer showed lower levels of distress for the 
husbands than for the patients (C. Hoskins et al., 1996; Northouse, Templin, Mood, & 
Oberst, 1998).  
Lammens (2011) found that TP53 mutation carriers were not significantly more 
distressed than non-carriers or those at risk but who did not undergo genetic testing. 
Additionally, those participants with a lack of social support were more prone to report 
clinically relevant levels of distress (Lammens et al., 2011). This study of LFS spouses 
also pointed out that many of the partners reported a desire for additional mental health or 
support services to help them cope with their TP53 mutation-positive partner’s risk of 
cancer. These studies demonstrate that spouses of individuals with LFS are also in need 
of psychosocial support from clinicians and may not receive adequate attention from 





account for interdependence between two partners’ responses must be used to determine 
the pattern of cancer worry between partners.  
 
Dyadic Coping 
To provide the most effective care, patients and their partners must develop 
effective coping skills together. Coping is defined by Folkman and Moskowitz (2004) as 
the thoughts and behaviors used to manage the internal and external demands of 
situations that are appraised as threatening. Coping with cancer is considered to be a 
dyadic process, with patients’ adjustment and behaviors being affected by their partners’ 
adjustments and behaviors, and vice versa (Berg & Upchurch, 2007). Partners of 
individuals with LFS are in a unique position, due to the nature of the syndrome. They 
may have been caretakers for their partners for past cancers, but they also have the 
potential to become a future caretaker for their partner, or potentially their children.  
A study by Hagedoorn (2011) found that active spousal engagement in coping 
was positively associated with relationship satisfaction in patients with colorectal cancer, 
as well as in the partners. Spousal protective buffering, which involves hiding one’s 
worries and fears and avoiding talking about the disease, was associated with lower 
relationship satisfaction in the patients. This relationship was only significant, however, 
when past spousal support (before cancer) was reported to be low. When past spousal 
support was high, then the participants rated the quality of their relationship relatively 
high, regardless of the partner’s current types of support behaviors.  
Breast cancer is an example of a dyadic stressor; i.e., a stressor that affects both 
members of a couple. The two primary objectives of dyadic coping are the reduction of 





triggered when one partner communicates stress to the other either verbally or 
nonverbally. The other partner receives and interprets the stress signals and responds with 
some type of dyadic coping that is aimed at assisting the other person. Bodenmann (2005) 
broadly differentiates between positive and negative dyadic coping. The former includes 
supportive, delegated, and common dyadic coping. In supportive dyadic coping, one 
partner assists the other in his or her coping efforts, for example, by empathic 
understanding, practical advice, or expressing solidarity with the partner. In delegated 
dyadic coping, one partner takes over responsibilities and tasks to reduce the other’s 
stress. Common dyadic coping occurs when both partners are similarly concerned about 
the stressor and participate more or less symmetrically in the coping process; for example, 
by joint problem-solving, joint information seeking, or relaxing together. In contrast, 
negative dyadic coping includes hostile, ambivalent, and superficial responses; that is, 
support that is accompanied by the partner distancing and showing disinterest, or support 
that is insincere or unwillingly provided. 
Dyadic coping appears to have different effects for patient versus their partners. A 
longitudinal study of metastatic breast cancer patients and their spouses found the effects 
of common positive dyadic coping on cancer-related distress significantly differed for 
patients and their partners (Hoda Badr, Carmack, Kashy, Cristofanilli, & Revenson, 
2010). Partners experienced lower levels of distress compared with the slightly higher 
levels of distress in patients. Although all participants who used more negative coping 
experienced significantly greater distress at all times, the association was stronger for 
patients than for their partners. Lastly, the study found that use of more common positive 






In the present study, each partner’s individual coping styles were measured, and 
the strengths of both partners’ coping styles were examined in relation to the degree of 
cancer worry reported by the spouse with LFS. This comparison allowed our model to 
integrate both members’ styles of coping and their influences on the distress of the 
individual with regard to cancer.   
 
Gender Differences in Response to Cancer 
The findings from studies on distress in cancer patients and their partners have 
been inconsistent. In several studies, intimate partners were found to be as distressed as 
patients (Baider et al., 1996; Northouse & Swain, 1987; Oberst & Scott, 1988). In one 
study, husbands of patients with recurrent breast cancer reported even more depressive 
symptoms than their wives (Given & Given, 1992). However, other studies among 
couples dealing with breast cancer showed lower levels of distress for the husbands than 
for the patients (C. Hoskins et al., 1996; Northouse et al., 1998). 
In one study of 150 cancer patients and their romantic partners, the researchers 
explored whether the cancer patients and their partners differed on their levels of 
psychological distress and reported quality of life as a function of their gender-role 
identities (Pikler & Brown, 2010). Results from this study showed that individuals who 
ascribed to a masculine gender-role identity, regardless of whether they were a patient or 
a partner, were more at risk of developing depressive symptoms compared with those 
who ascribed to a feminine gender-role identity. Also, partners of cancer patients were 
more at risk of developing anxiety symptoms as compared with the cancer patients 
themselves, regardless of gender-role identity. The researchers found no significant 





& Brown, 2010). Building on that study, the present study included measures of general 
psychological distress such as anxiety, depression, and somatization as a possible 
contextual factor that influences cancer worry. We also anticipated higher amounts of 
psychological distress symptoms in our female participants, especially if they were the 
partner of an individual with LFS.  
 
Objectives 
The goals of the current study were two-fold. First, it compared the psychosocial 
outcomes of spousal pairs to determine if there is a significant difference in the level of 
emotional functioning between LFS and non-LFS partners. Second, cancer-specific 
coping styles and psychological distress of the non-LFS partner were tested as predictors 
of the cancer worry of the LFS partner.  
 
Hypotheses 
1. The general distress scores of non-LFS partners will be higher than LFS partners, 
with females having the highest levels of distress.  
2. The cancer worry scores of LFS partners will be higher than non-LFS partners, 
with females having more cancer worry.  
3. Mediation: For the LFS partner group, frequency of cancer worry will have a 
direct effect on how cancer worry impacts daily functioning; this direct effect will 
be mediated by how cancer worry impacts mood.  
4. Moderation: The more adaptive coping the non-LFS partner reports, the less that 






The current study analyzed data from the ongoing LFS study at the National 
Cancer Institute, National Institutes of Health (NCI Protocol #11-C-0255; NCT 
00004007). The main goal of the larger LFS study is to investigate the clinical, 
epidemiologic, and genetic etiology of LFS, as well as to establish a national and 
international standard for cancer screening for individuals with or at risk of LFS. At its 
inception in 2011, the LFS study investigators conducted extensive recruitment by 
establishing a study website and disseminating information to a network of oncologists, 
genetic counselors, and the members of relevant specialty medical professional societies 
(the most common mode of referral to the study). The main recruitment strategy for the 
study has been through referrals from NIH clinicians, healthcare practitioners outside of 
the NIH, the NCI Cancer Information Service, interested laypersons, and other family 
members. Many of the participants had a high prevalence of cancer in the family medical 
history (cancer pattern reminiscent of LFS) and had either already received genetic 
counseling and genetic testing or were interested in starting the process. Previous 
publications on this research sample have shown that they are well-educated and 
predominantly white (Peters et al., 2016). 
After contacting the research team and enrolling on the study, participants 
completed a rigorous consent process and the Individual Information Questionnaire (IIQ), 
which included baseline medical and psychosocial assessments. The psychosocial portion 
of the IIQ baseline assessment utilized multiple standardized psychometric instruments to 
capture the challenges that arise in navigating the wide range of individual and family 
issues related to this highly penetrant cancer disorder. I requested baseline data from the 





identifiers were removed from this dataset and replaced with coded participant ID 
numbers. The data file was stored on a secure NIH computer that was password-protected, 
and the Excel program document itself was also password protected.  
Sample 
106 couple pairs were identified among study enrollees as having completed a 
baseline assessment. 30 of 106 couples included data from one or both partners who were 
deceased (other family members completed the assessment for them) and did not 
complete the psychosocial portion of the baseline assessment; data from both partners 
were removed from the analytic file. Two couples had one partner who did not complete 
the psychosocial portion of the IIQ, one couple disagreed on their marital status, and in 9 
couples both partners were untested and it was unclear which partner had LFS. After 
these couples and the couples that included one or more deceased partners were removed, 
there were data from 64 couples (128 individuals) available for analysis. Among these 64 
couples, 49 pairs included a female partner with a genetic test result that indicated that 
they were TP53 mutation-positive or related by blood to the LFS mutation (at risk of the 
mutation). Fifteen couples were comprised of a male partner who was TP53 mutation-
positive at the time the survey was completed.  
The participants’ ages ranged from 22-80, with mean ages for women and men 
with LFS being 42.6 and 48.2, respectively, and for non-LFS women and men being 47.5 
and 45.3, respectively (see Table 1, which summarizes demographic characteristics of the 
sample). Participants were well educated (70% had a college degree or higher) and had 
high levels of income (63% of participants reported annual household income over 





Four women with LFS, one man with LFS, and four non-LFS men identified as 
Ashkenazi Jews.  
The majority of participants had at least one child; only nine couples had no 
children. Forty-four couples reported having a child with cancer, and 28 couples reported 
having a child with LFS.  
Table 2 summarizes the cancer histories of the participants, as well as the cancer 
histories of first- and second-degree relatives of LFS partners. Sixty percent of LFS men 
and 88% of LFS women had a personal history of cancer, and the types of cancer that the 
participants had are described in Figure 2. Overall, breast cancer incidence in the women 
with LFS was very high, with 46 reported cases of breast cancer in the LFS cancer group. 
There were three cases of soft-tissue sarcomas in LFS men and seven in women. Four 
men also reported a history of prostate cancer. 
The LFS participants also had many first-degree relatives with a cancer history 
(see Table 3). Thirty-six LFS participants reported a mother with cancer, and 17 of whom 
died from cancer. Thirty-four LFS participants reported a father with a cancer history, 21 
of whom fathers died from cancer. Sixty-one of the participants’ siblings had a cancer 
history, 31 of whom died from cancer. Finally, eighteen of the participants’ children had 
















Figure 2. Total Number of Participant Cancers by Cancer Site 
 
* Indicates cancers most commonly associated with LFS.  
Measures 
Several questions included in the original study’s Individual Information 
Questionnaire (IIQ) were intended to assess the psychological and social functioning of 
adult participants at the time of enrollment.  These four measures were standardized, 
validated scales used widely in cancer genetics research and in other NCI studies to 
characterize the baseline functioning of adult participants and for the purposes of 
comparison across conditions. This study employed the Brief Symptom Inventory, 





depression and anxiety symptoms, cancer worry, stress, and coping strategies of 
participants. 
Psychological Distress: The Brief Symptom Inventory (BSI-18) is an 18-item short form 
of a psychometrically validated self-report instrument that is used to measure 
psychological distress within the past 7 days in the domains of depression, anxiety and 
somatization (Derogatis, 2001). This assessment has been successfully and broadly used 
in medical and clinical research. Global distress and 3 sub-scale scores are calculated and 
compared with appropriate norms in the general population. The BSI-18 is sensitive to 
relatively recent changes (1 week) in mood that may accompany difficult recent events in 
self or relatives. In a study of men and women who received genetic testing for BRCA1/2 
mutations, the BSI-18 was used to measure general distress, and was found to have a 
reliability coefficient between .89 and .91 at different longitudinal time points (Graves et 
al., 2011). The BSI-18 was found to be highly reliable for the LFS sample (α = .88) and 
the non-LFS sample (α = .88). Normative T-scores derived from general population 
norms were computed for each BSI-18 subscale. According to the BSI-18 manual, 
respondents who have a t-score ≥ 63 on any two symptom scales or on the summary GSI 
scale should be classified as having clinically significant distress. For a copy of the BSI-
18 with instructions and questions, please see Appendix A.  
 
Perceived Stress: The Perceived Stress Scale (PSS) is a widely used, 10-item, self-report 
instrument for measuring individual perception of stress, i.e., the degree to which 
situations in one’s life are appraised as stressful (Cohen, Janicki-Deverts, & Miller, 2007). 
Previous studies have shown strong reliability and validity, and in a study of breast 





time points (Golden-Kreutz, Browne, Frierson, & Andersen, 2004). The questions in the 
PSS ask about feelings and thoughts during the last month, including a number of direct 
queries about current levels of experienced stress. Items assess how unpredictable, 
uncontrollable, and/or overloaded the respondents found their lives, especially important 
in LFS syndrome with so many unanswered questions about medical assessment and 
management. For the full PSS with instructions and questions, please see Appendix B.  
 
Cancer Worry: We used a modified Lerman Breast Cancer Worry Scale to assess 
cancer-related worry (Lerman, Daly, Masny, & Balshem, 1994). The breast cancer 
version has high internal consistency and is widely utilized in the field of cancer research 
(Caruso, Vigna, & Gremigni, 2017; Custers et al., 2014). Higher worry scores have been 
associated with poor adherence to screening in at risk women (Brain et al., 2002; Lerman 
et al., 1994; Lerman et al., 1995). The questions were modified to focus on general cancer 
worry on a 4-point scale (1 = “not at all or rarely” to 4 = “a lot”) regarding the frequency 
with which cancer worry affects one’s thoughts, feelings and ability to perform daily 
activities. Lammens et al. (2011) adapted the same tool to assess cancer worry in families 
with LFS and Van Hippel Disease (VHL). They found high reliability for TP53-positive 
spouses (.90) and in the current study, we also found high reliability for participants with 
LFS (α = .78) The Cancer Worry Scale can be found in Appendix C.  
 
Brief COPE: To measure the type of coping employed by each partner, the Brief COPE 
scale was used (Carver, 1997). The Brief COPE is a 28-item measure of coping strategies 
that was created to measure the coping reaction to a stressful situation, in this case, 





the full COPE scale (Carver, Scheier, & Weintraub, 1989), which included 60 items, and 
15 coping strategies (4 items per coping strategy). The Brief COPE has two items for 
each of 14 strategies (active coping, planning, positive reframing, acceptance, humor, 
religion, using emotional support, using instrumental support, self-distraction, denial, 
venting, substance, behavioral disengagement, and self-blame). Participants rated how 
often they had been using each type of coping on a scale of 1-4, with 1 = I haven’t been 
doing it at all, 2 = I have been doing it a little bit, 3 = I have been doing this a medium 
amount, and 4 = I have been doing this a lot. There is no “overall” composite coping 
score for all scores combined; it was designed evaluate each coping strategy separately. A 
study of cancer survivors ranged in reliability from .50 to .90 for each subscale (Schmidt, 
Blank, Bellizzi, & Park, 2012). In our study, the reliability for LFS partners ranged 
from .49 to .97 for each subscale. The reliability for non-LFS partners ranged from .45 
to .91 for each subscale. The Brief COPE can be found in Appendix D.  
 
Analyses 
 Analyses were conducted using statistical software SPSS version 21 (IBM Corp, 
2012) and Mplus version 8 (Muthen & Muthen, 1998-2017). Un-weighted descriptive 
statistics were obtained for categorical and continuous variables, including socio-
demographics, BSI global distress, anxiety, depression, somatization, perceived stress, 
cancer risk perception, cancer worry, and coping styles. Bivariate analysis was conducted 
using independent t-tests to compare baseline demographic characteristics. Pearson 
correlation coefficients were used to estimate linear correlations in post-hoc analyses. 
Correlation coefficients of 0.10, 0.30 and 0.50 indicated small, moderate and large effect 





run in SPSS to reduce the Brief COPE, and then a Confirmatory Factor Analysis (CFA) 
was run in Mplus to test the structure of the factors. Lastly, we ran two path analysis 
models. To test hypothesis 3, we ran a mediation path analysis with bootstrapping in 
Mplus, and to test hypothesis 4, we ran a moderated mediation analysis with 
bootstrapping in Mplus. Mediation effects can be completely, partially, or inconsistently 
mediated (Ledermann, Macho, & Kenny, 2011). Complete mediation occurs when the 
direct effect (c) is zero and the indirect effect is nonzero.  
 
Results 
First, descriptive statistics for the sample were calculated and are reported in 
Tables 1-3. The results for all for groups on the BSI, PSS, and Cancer Worry Scale for 
four groups are reported in Tables 4, 5, and 6. The four categories include male and 
female LFS participants, and male and female non-LFS participants. Independent t-tests 
were run to compare male and female participants within the LFS and the non-LFS 
participants to determine if there were significant differences in their scores on these 
measures. Additional tests were run to compare members of the same gender across LFS 
groups. The results of the t-tests for the BSI and PSS showed that we did not have the 
statistical power to detect significant differences across LFS groups or gender. This did 
not support the hypothesis that general distress would be higher for the non-LFS group, 
and specifically in women.  
The results of independent t-tests showed that men with LFS reported higher 
mean perceived cancer risk than men without LFS (t(60) = -3.80, p < .001, d = .70), male 
with LFS: M = 7.53, SD = 2.75; male no LFS: M = 5.00, SD = 2.08,), and women with 





< .001, ,d = 2.65, female with LFS: M = 8.98, SD = 1.28; female no LFS: M = 4.80, SD = 
1.66). These high mean scores indicate that men and women with LFS report perceiving 
that they will almost definitely get cancer in the future. Within the LFS group, female 
participants reported higher perceived cancer risk than men (t(61) = -2.82, p < .01, d 
= .84), female with LFS: M = 8.98, SD = 1.28; male with LFS: M = 7.53, SD = 2.75) 
(Tables 5 and 6).  
Similarly, there was also a significant difference in cancer worry based on 
whether participants had LFS or not (Table 5). Men with LFS had significantly more 
frequent thoughts of cancer than people of the same gender without LFS (t(60) = -3.71, p 
< .001, d = .58, male with LFS: M = 1.73, SD = .79; male no LFS: M = 1.15, SD = .42,), 
and these thoughts of cancer more frequently affected their mood (t(60) = -4.77, p < .001, 
d = .56, male with LFS: M = 1.33, SD = .49; male no LFS: M = 1.00, SD = .00,). Women 
with LFS had significantly more frequent thoughts of cancer than people of the same 
gender without LFS (t(60) = -5.14, p < .001, d = 1.52, female with LFS: M = 2.42, SD = 
2.42; female no LFS: M = 1.13, SD = .35,), and thoughts of cancer more frequently 
affected their mood (t(60) = -3.11, p < .001, d = .92, female with LFS: M = 1.66, SD 
= .82; female no LFS: M = 1.00, SD = .00,), and these thoughts of cancer more frequently 
affect their daily functioning (t(60) = -3.86, p < .001, d = .63, female with LFS: M = 1.35, 
SD = .635; female no LFS: M = 1.00, SD = .00).  
There was also a gender difference for cancer worry within the LFS group. 
Women with LFS had significantly more frequent thoughts of cancer than men with LFS 
(t(61) = -2.54, p < .01, d = .82, female with LFS: M = 2.42, SD = .942; male with M = 
1.73, SD = .799), and thoughts of cancer more frequently affected their daily functioning 





male with LFS: M = 1.00, SD = .00). (see Figures 3, 4, and 5, which illustrate the 
differences in cancer worry across groups). 
These findings did support the hypothesis that the cancer worry scores of LFS 
partners would be higher than non-LFS partners, with females having higher frequency of 
cancer worry. These mean levels of cancer worry demonstrate that some women with 
LFS have thoughts of cancer several times a day, with the majority of men and women 
with LFS thinking about cancer on a weekly or daily basis.   
Post-hoc analyses demonstrated that for participants with LFS, the number of 
total cancers they had personally developed was positively correlated with the perception 
of cancer risk (r(63) = .24, p < .05), but was not significantly correlated with cancer 
worry frequency. These results indicated that the stronger their prior cancer history, the 
higher they believed their chances were of getting another cancer. Additionally, age of 
the participants with LFS were significantly negatively correlated with their reported 
comparative cancer risk (r(63) = -.40, p < .01), perceived cancer risk (r(63) = -.26, p 
< .05), frequency of cancer worry (r(63) = -.38, p < .01), and frequency that mood was 
affected by cancer worry (r(62) = -.31, p < .05). These results indicated that older 
participants worried less about cancer, and their own perception of their risk was lower 
















Figure 3. Frequency of Thoughts of Getting Cancer 
 






Figure 5. Frequency of Cancer Thoughts Affecting Daily Functioning 
 
Partners’ Coping Styles  
First, we ran a comparison of female and male use of the 14 coping styles through 
independent t-tests. Within the LFS group, women reported using emotional support, 
venting, positive reframing, and planning significantly more than men (see Table 7). In 
the non-LFS group, women reported higher levels of coping using emotional support, 
instrumental support, religion and self-blame. I then reduced the number of coping style 
variables to use in the path analysis model with cancer worry.  
 
Data Reduction and Analysis of Coping Styles. The Brief COPE data were 
screened for univariate outliers; no out-of-range values were identified. LFS group and 





analysis was low, with a final sample size of 64 (using listwise deletion) for each group, 
providing a ratio of >4 cases per variable.  
Initially, the factorability of the 14 Brief COPE items was examined. It was 
observed that for both groups all 14 items correlated at least .3 with at least one other 
item, suggesting reasonable factorability. Additionally, the communalities for 12 items 
were all above .3, confirming that each of those items shared some common variance 
with other items. However, two items “substance use” and “religion” had communalities 
under .3 for both LFS and non-LFS partners, and these two items were dropped. Given 
these indicators, factor analysis was deemed suitable with 12 items.  
An oblimin form of oblique rotation using a Principle Analysis Factoring 
extraction was selected to identify and compute composite scores for the factors 
underlying the short version of the COPE scale. For the LFS group, initial eigenvalues 
indicated that the first two factors explained 36% and 15% of the variance, respectively. 
The two-factor theoretical model, which explained 51% of the variance for the LFS group, 
was supported empirically by the data for the LFS group. Similarly, initial eigenvalues 
indicated that the first two factors for the non-LFS group explained 34% and 20% of the 
variance, respectively. Thus, the two-factor solution, which explained 54% of the 
variance was also selected for the non-LFS group. 
Composite scores were created for each of the two factors for the two groups, 
based on the mean of the items that had their primary loadings on each factor. Higher 
scores indicated greater use of the coping strategy.  
For the LFS group, the first factor (8 items, eg. “self-distraction, venting, planning, 





behavioral disengagement, self-blame”) “Maladaptive Coping”. Adaptive Coping was the 
factor that participants reported using the most.  
For the non-LFS group, the first factor (6 items, eg. “active coping, use of 
instrumental support, use of emotional support”) was similarly named “Adaptive Coping”, 
however two items (self-distraction and humor) were dropped from the final factor 
solution due to low factor loading scores. The second factor was comprised of the same 
three items as the bloodline group and similarly named “Maladaptive Coping”.  
Table 7 presents the loadings of each item on the rotated two-factor solution. The 
“Adaptive Coping” factor was finally comprised of the six items that were shared across 
LFS and non-LFS groups: active coping, use of emotional support, use of instrumental 
support, venting, positive reframing, and planning. The “Maladaptive Coping” factor was 
comprised of three items: denial, behavioral disengagement, and self-blame.    
 A Confirmatory Factor Analysis (CFA) was conducted in Mplus to verify the 
factor structure of the observed variables. This analysis was run to test the hypothesis that 
the latent constructs of adaptive and maladaptive coping were related to the specified 





Figure 6. Latent Variable Factor Structure 
 
For the LFS group, the reliability coefficient for adaptive coping was ω = .84, and 
for maladaptive coping it was ω = .57. For the non-LFS group the reliability coefficient 
for adaptive coping was ω = .82, and for maladaptive coping it was ω = .78.1 
The maladaptive coping scales were dropped due to very low variance scores for 
both partners. The data indicate that very few participants (29% of the sample) reported 
any use of the maladaptive coping styles, leading to the low variance. In addition, the two 
latent variables were not significantly correlated with one another indicating an issue with 
fit. The model was then reduced to one latent variable: adaptive coping for LFS and non-
LFS participants.  
                                                 
1 McDonald’s ω was used to calculate the reliability of the latent variables developed in this study because 
McDonald’s ω addresses the relation between question items and latent variables. In the “Methods” section 






The next step in the analysis was to run a mediation model for cancer worry for 
the LFS spouse. To do so, we estimated a path model using maximum likelihood within 
Mplus. This was done to test the hypothesis that the frequency of LFS partner’s worries 
about cancer (X) affected their ability to perform daily activities (Y), which is mediated 
by the how often their cancer worry affects their mood (M). A path analysis model in 
Mplus was used to test this mediation model in which cancer worry’s effect on daily 
functioning (Y) and cancer worry’s effect on mood (M) were endogenous variables, and 
cancer worry frequency (X) is an exogenous variable. The estimated path model is shown 
in Figure 7. All three of these variables were observed, so rectangles rather than circles 
were used to represent the variables.  
Results indicated that worry frequency (X) was found to be a significant predictor 
of worry’s effect on mood (M), b = .49, SE = .09, p < .001, and that effect on mood (M) 
was found to be a significant predictor of worry’s effect on daily functioning (Y), b = .55, 
SE = .08, p < .001. These results support the mediational hypothesis. When controlling 
for the mediator, cancer worry frequency (X) was no longer a significant predictor of 
worry’s effect on daily functioning (Y), b = .57, SE = .09, ns (p = .59), consistent with 
full mediation. The indirect effect was tested using a bootstrap estimation approach with 
10,000 samples. These results indicated the indirect coefficient was significant (b = .28, 
SE = .07, CI = .14, .42) indicating a significant mediation effect.  
These results did support the study’s mediation hypothesis, i.e., that for the LFS 
group the frequency of cancer worry would have a direct effect on the degree to which 
cancer worry affected daily functioning, and that this direct effect was mediated by how 





thoughts of cancer, the more their daily functioning is affected adversely, but this is a 
function of cancer worry affecting moods. 
Figure 7. Cancer Worry Mediation Model 
 
Moderated Mediation Model 
 The final step in model testing was to assess whether the coping styles of the LFS 
partner themselves and the coping style of their partners moderated the relationship 
between cancer worry and cancer worry affecting daily functioning. This part of the 
analysis plan employed a path analysis model to test for partner effects of coping style on 
cancer worry. Other studies have stressed the importance of analytic strategies that 
recognize that data from members of couples are non-independent (they are linked and 
correlated) (Brandao et al., 2014). Path analysis captures both the direct and indirect 
effects between partners while simultaneously accounting for partner interdependencies 
in the data (Cook & Kenny, 2005).  
Using Mplus software, we analyzed each partner’s scores on each of the coping 
styles as predicting the LFS partner’s level of cancer worry affecting their daily 





frequency of cancer worry affecting one’s mood were created. The moderators (adaptive 
coping for LFS and non-LFS) were calculated as measured variables for the final model 
because of the small sample size. 
Gender 
The moderated mediation model was run separately for gender, with one analysis 
specific to the model for female LFS partners and another analysis for the model for male 
LFS partners. There was a variance of zero in the male LFS score for the outcome 
variable and therefore that model would not run. We continued the analysis with data 
from only female LFS participants and their male non-LFS partners.  
Figure 8. Moderated Mediation Model Women with LFS and Partners 
 
The full moderated mediation model for LFS women is presented in Figure 8. 
Interaction terms were created by multiplying the mediator with each of the moderators. 
If the interaction term were significant, that would indicate a joint effect of MW or MZ, 
and a significant moderation effect. In this study, no significant interaction terms were 
observed, indicating that adaptive coping for the non-LFS spouse did not significantly 





their cancer worry affected daily performance, as shown by nonsignificant interactions b 
= .038, SE = .09, ns (p = .68). These findings do not support the hypothesis that the more 
adaptive coping the non-LFS partner reports, the less that the LFS partner’s cancer worry 
affected mood would affect their daily functioning. Additionally, the LFS partner’s own 
adaptive coping did not moderate the relationship between cancer worry affected mood 
and daily functioning, b = -.12, SE = .074, ns (p = .11). 
 
Discussion 
The purpose of the current cross-sectional study was to examine the relationship 
between general distress, coping, and cancer-specific distress for couples in which one 
partner had LFS. We used baseline data from participants with LFS and their spouses in 
the NCI’s LFS Cancer Screening Study to compare each partner’s general distress level, 
cancer-specific distress, and coping styles. One of the goals of this study was to test for 
significant differences between partners in general distress and cancer-specific distress in 
couples coping with LFS. The second goal of this study was to identify coping strategies 
of both partners that can alleviate the cancer-specific distress of a LFS partner. This 
dyadic-level goal specifically examined the relationship between cancer worry and mood 
and daily functioning among individuals with LFS, and also identified potential 
protective coping styles that partners employ that may be associated with reducing cancer 
worry’s impact on daily functioning.  
 We hypothesized that (1) general distress (depression, anxiety, somatization, and 
perceived stress) would be higher for the non-LFS group, and specifically in women. The 
data did not support that hypothesis, and we did not find significant differences across 





partners would be higher than non-LFS partners, with females having more cancer worry. 
Our data supported this second hypothesis, with LFS females having the most cancer 
worry and highest perception of cancer risk, followed by LFS men, and lastly by non-
LFS men and women. These results are what one would expect from a high-risk cancer 
sample, and the gender difference also appropriately parallels the higher cancer 
penetrance in women with LFS.  
 The present study also found a significant cancer worry mediation model for 
women with LFS only. For these LFS women, the frequency of cancer worry had a direct 
effect on how frequency of cancer worry affected their daily functioning, and this direct 
effect was mediated by how cancer worry affects individuals’ mood. These results 
partially supported the hypothesis for LFS partners, but the outcome variable, cancer 
worry affecting daily functioning, had very little variation for male LFS participants and 
therefore was dropped from the model. Using just the female LFS partners, we tested the 
final hypothesis that the more adaptive coping the non-LFS partner reported, the less that 
the LFS partner’s mood will affect their daily functioning. The data did not support this 
moderated mediation hypothesis, with neither the LFS partner’s own adaptive coping nor 
their non-LFS partner’s adaptive coping moderating the relationship between cancer 
worry affected mood and daily functioning. The methodological limitations of the data 
set may have contributed to the ambiguity of the findings for the moderator variables. 
The following section of this paper discusses some potential explanations for the lack of a 






Strengths and Limitations 
 This sample size of 67 couples was both a study strength and limitation. Although 
the sample size is small, this study represents the largest sample of couples with LFS in 
the world. The only other study of couples with LFS had 17 couples in their sample 
(Lammens, 2011). Our small sample size was due to the rarity of LFS, as well as to the 
small number of spouses who enrolled and participated in the LFS screening study. There 
were also significantly fewer LFS men with female partners enrolled in the study (15 
couples). This small male LFS sample is representative of the disproportionately high 
number of women with LFS enrolled (about two-thirds female participants) in the LFS 
Screening Study. The reasons for oversampling of women with LFS may be due to the 
fact that breast cancer is the most commonly occurring cancer in LFS, and consequently 
cancer occurrence/risk is higher for women. Additionally, women in general are likely to 
seek health care services (Thompson et al., 2017), health information (Stefan, 2015), and 
to engage in cancer screening (Davis, Buchanan, Katz, & Green, 2011). Future follow-up 
data collection and recruitment efforts will focus on enrolling more men with LFS and 
their female partners in the LFS Study cohort.  
 This study was subject to several other limitations that deserve consideration. 
First, the sample was limited in terms of racial, educational, and economic diversity. All 
participants were white, highly-educated, and wealthy, and thus do not represent the 
social and economic makeup of the United States. The participants’ mental health and 
coping skills were sound, and these individuals were highly motivated to engage in 
research. Our participants were highly motivated and able to participate in a rigorous 
research study protocol that included hours of paperwork, visits to local doctors, regular 





requires taking off time from work and/or finding childcare, although travel costs were 
underwritten by the study. They must also have been sufficiently savvy about the US 
health care system to successfully navigate genetic testing, insurance coverage for a rare 
syndrome, taking out a life insurance policy, and compiling medical records from all of 
the relevant procedures or screenings. This unique sample clearly is subject to significant 
selection bias; our results cannot be reliably generalized to the US population at large.  
Future research must include community-based recruitment and focus on oversampling, 
non-white, lower education and lower SES-status families. This can be accomplished by 
collaborating with health institutions that provide community-level care for a more 
diverse range of people seeking genetic testing, genetic counseling, and cancer screening. 
My/our data document that these study participants comprise a high-functioning group, 
with excellent coping skills. The maladaptive coping factor dropping out of the model 
may be due to this aspect of their positive coping.  
Our data rely on self-reports, potentially subject to implicit or explicit biases. 
Social desirability may have played a role in under reporting distress or maladaptive 
coping styles. This may be due to the nature of LFS, in which families go through periods 
of relative normality while the partner with LFS is cancer-free; but when a cancer is 
diagnosed, there is a large adjustment and shift in the family that occurs. When the 
participants enrolled in the study and completed the questionnaires, they were not 
actively being treated for a cancer at that time (a requirement of the study). This 
limitation can be addressed in future analyses that combine both the quantitative results 
with some of the descriptive coping styles identified in Study Two of this dissertation. 





 A second limitation was the poor fit of the Brief Cope confirmatory factor 
analysis. This may be due in part to cross loadings of specific items on the two factors, 
adaptive and maladaptive coping. Contrary to our expectation, coping styles of members 
of married couples were only weakly correlated, which may illustrate the collaborative 
nature of couple coping, in which each partner specializes in different coping behaviors 
that are complementary, rather than mirroring the same coping behaviors. This measure 
simply asks respondents about frequencies of use of coping styles, but does not establish 
the processes that contribute to each partner’s use of particular coping styles (e.g., an 
intent to protect one’s partner from emotional distress regarding LFS). Thus, responses to 
the coping measure shed limited light on the dyadic interaction of partners’ coping styles. 
We did not test the interaction of two partners’ coping styles as a potential moderator, an 
approach that may be a valuable next step in research on couple coping with LFS.  
Future research in this area might benefit from using different measures of 
coping, for example, moving away from measures of individual coping styles to using 
dyadic coping measures such as the Dyadic Coping Inventory (DCI) (Burri, Blank Gebre, 
Bodenmann, 2008: Dyadic Coping Inventory Test Manual). This measure has been used 
in studies of couples coping with chronic pain and other health conditions, but may also 
be applied to cancer and heritable cancer risk. The DCI may also address the lack of 
moderation effects on LFS partner’s cancer worry. It is possible that an individual-level 
coping assessment may not be an accurate method for capturing the complex and 
interpersonal nature of dyadic coping. Additionally, the use of qualitative research 
methods has the potential to explore the unique coping styles that these couples employ 
in the face of cancer risk. The next paper in this dissertation explores dyadic coping from 





in this study. Social network analysis, used in Study 3, also helps broaden understanding 
of social support in this population. The Brief Cope only includes two indices of support: 
emotional and instrumental, and many participants reported high levels of these types of 
support. 
 A third limitation is the phrasing of the Cancer Worry scale for non-LFS spouses, 
which asked them to report the frequency with which they thought about their own risk of 
cancer (even though they are assumed to be at a lower risk of cancer than their LFS 
spouse). Therefore, future questionnaires could utilize a cancer worry scale that captures 
the degree or frequency of worry that non-LFS spouses report about their partner’s 
cancer risk, rather than their own cancer worry.  
 Lastly, this study was cross-sectional, with the Individualized Information 
Questionnaires administered at baseline rather than longitudinally at various time points. 
Thus, results need to be interpreted with caution, especially given the small sample size. 
Future studies could either employ longitudinal data collection or utilize information 
gained from the qualitative paper of this dissertation regarding the unique coping styles 
of this population and their ongoing, low-level stress. The qualitative findings could be 
used to construct more appropriate measures of coping and distress, that then could be 
validated using a similar process of exploratory and confirmatory factor analysis.  
 In spite of these limitations, the present study makes several important 
contributions to the literature on couples coping with LFS. Most valuable, this is the first 
study that compared married partners’ responses on multiple measures of distress, cancer 
worry, and coping in an LFS population. We obtained detailed medical and family 
histories, and used standardized and study-specific psychosocial measures. Second, the 





experiencing clinically-indicated levels of depression, anxiety, or somatization at the time 
of study enrollment. This is significant because the questionnaire was administered 
during the time when many families recently discovered the presence of TP53 mutation 
in their family or they are about to receive genetic testing results. The results of the 
current study do not address how levels of distress or cancer worry vary once the 
participants enroll in the study and begin intensive screening. Study Two of this 
dissertation addressed this evolution of emotional experiences, since interviews occurred 
after enrollment and during their visits to the clinical center.  
 
Clinical Implications 
Clinicians working with this population of LFS-affected families can utilize the 
information from this study in several ways. First, it may be helpful to consider that 
although there are gender differences in the level of perceived cancer risk, cancer worry, 
and cancer worry impacting mood and daily functioning, men and women with LFS both 
have frequent thoughts about their risk for cancer. More importantly, these thoughts 
occur on a daily or weekly basis and can influence the mood and daily functioning of 
patients.  
People with LFS and their partners have multiple strategies for coping with this 
worry that are adaptive or maladaptive. Clinicians may want to make note of family 
members that are engaging in maladaptive behaviors such as behavioral disengagement, 
denial, or self-blame. Specifically, women married to men with LFS are more likely to 
engage in self-blame than men. Clinicians or mental health experts can remind both 
partners that they are similarly stressed and that it may be helpful to participate in joint 





of their lives for the long-term, couples may do well do recognize that coping styles may 
change over time and should seek professional help to them manage stress and health 
care concerns.  
 
Conclusion 
In conclusion, although we had speculated that our participants might be very 
distressed and withdrawn due to the many physicial, emotional and social challenges 
associated with LFS, this study generally found the opposite. Specifically, most 
participants reported few pyschosocial symptoms, indicating low general distress, with 
only five participants meeting the criteria for clinically significant distress. The results of 
the present study indicate that LFS partners with LFS experience significantly more 
cancer-specific worry than non-LFS partners. Some women with LFS had thoughts of 
cancer multiple times a day, and most men and women with LFS were thinking about 
cancer with a daily/weekly frequency, which then affects their mood and daily 
functioning, especially for women with LFS. Although these couples employed multiple 
methods for coping with the stress related to finding out that they or a family member 
were at increased risk of cancer, these coping styles do not necessarily protect against the 
impact of cancer worry on mood and on daily functioning of people with LFS. Our 
findings show that although people with LFS are worried about cancer, this worry does 
not translate to significant levels of distress for themselves nor their partners. These 
subjects demonstrated remarkable resilience despite being challenged by one of the most 








Table 1. Descriptive Statistics of Analytic Sample 
 
 LFS Partner Non-LFS Partner 
 Men 
(N = 15) 
Women 
(N = 49) 
Men 
(N = 49) 
Women 
(N = 15) 
Average age (years) 48.2 42.6 45.3 47.5 
Age range (years) 27-84 22-65 27-71 27-80 
Educational level n (%) 
   Less than high school 1 (6.7%) 0 (0%) 0 (0%) 1 (6.7%) 
   HS grad or GED 1 (6.7%) 2 (4.1%) 3 (6.1%) 1 (6.7%) 
   Vocational/trade     
       school 
2 (13.3%) 2 (4.1%) 3 (6.1%) 0 (0%) 
   Some college 2 (13.3%) 6 (12.2%) 7 (4.3%) 1 (6.7%) 
   College graduate 2 (13.3%) 21 (42.9%) 13 (26.5%) 7 (46.7%) 
   Some graduate school 3 (20%) 2 (4.1%) 6 (12.2%) 1 (6.7%) 
   Masters or doctoral 
degree 
4 (26.7%) 13 (26.5%) 14 (28.6%) 4 (26.7%) 
Income (>$50,000) 80% 80% 77% 93% 
Children  
# Children     
0 1 (6.7%) 8 (16.3%) 8 (16.3%) 1 (6.7%) 
1 3 (20%) 7 (14.3%) 8 (16.3%) 2 (13.3%) 
2 4 (26.7%) 25 (51%) 25 (51%) 5 (33.3%) 
≥3 7 (46.7%) 9 (18.3%) 8 (16.3%) 7 (46.7%) 
Child average age 15.4 15.4 15.4 15.4 
Child with LFS 9 19 19 9 
Note: n = the number of participants, % = the percent of each LFS status and gender 






Table 2. Personal Cancer History (all cancers combined) 
 
 LFS Partner Non-LFS Partner 
 
# of cancers 
Men 
(N = 15) 
Women 
(N = 49) 
Men 
(N = 49) 
Women 
(N = 15) 
0 6 (40%) 6 (12.2%) 43 (87.8%) 12 (80%) 
1 5 (33.3%) 23 (46.9%) 5 (10.2%) 3 (20%) 
2 2 (13.3%) 12 (24.5%) 1 (2%) 0 












Table 3. Cancer History in First-Degree Relatives of Participants with LFS 
 
 Male LFS Female LFS 
Family members had cancer (n) 
Mother 5 31 
Father 5 29 
Sibling 24 37 
Child 11 9 
 
Family died of cancer (n) 
Mother 5 12 
Father 3 18 
Sibling 9 22 








Table 4. Participants’ General Distress Scores 
 
 LFS Partners Non-LFS Partners 
 Men 
(N = 15) 
Women 
(N = 49) 
Men 
(N = 49) 
Women 
(N = 15) 
Brief Symptom Inventory - Mean (SD) 
       Global Distress 46.87 (9.93) 46.13 (9.47) 44.79 (9.10) 45.27 (10.35) 
       Anxiety  49.07 (8.46) 46.85 (9.39) 47.29 (7.83) 45.60 (8.71) 
       Depression 49.07 (9.57) 48.52 (8.38) 47.23 (7.25) 49.20 (9.73) 
       Somatization 44.87 (5.38) 45.92 (7.83) 44.15 (5.79) 45.73 (8.36) 
 
Perceived Stress Scale Global Score 
Mean (SD) 12.60 (5.01) 14.57 (7.25) 12.29 (5.79) 15.53 (7.17) 






Table 5: Participants’ Cancer-Specific Distress (perceived cancer risk and worry) 
 LFS Partners Non-LFS Partners 
 Men 
(N = 15) 
Women 
(N = 48) 
Men 
(N = 47) 
Women 
(N = 15) 
 
1) Compared with other people your age, what are your chances of getting cancer 
(or another cancer) in your lifetime? 
 
 M = 4.20a 
SD = 1.207 
M = 4.88b 
SD = .334 
M = 2.64c 
SD = 1.131 
M = 3.00c 
SD = .655 
 
2) Compared with other people your age, what are your chances of getting cancer 
(or another cancer) in your lifetime? 
0 = no chance that I’ll get cancer; 5 = I may or may not get cancer; 
10 = I will almost certainly get cancer in my lifetime 
 
 M = 7.53 a 
SD = 2.748 
M = 8.98 b 
SD = 1.28 
M = 5.00 c 
SD = 2.075 
M = 4.80 c 
SD = 1.656 
 
3) How often have you thought about your own chances of getting cancer (or 
another cancer)?  
 M = 1.73 a 
SD = .799 
M = 2.42 b 
SD = .942 
M = 1.15 c 
SD = .416 
M = 1.13 c 
SD = .352 
 
4) How often have thoughts about your chances of getting cancer (or another 
cancer) affected your mood? 
 M = 1.33 
SD = .488 
M = 1.66 
SD = .815 
Missing = 1 
M = 1.00 
SD = .0 
Missing = 2 
M = 1.00 
SD = .000 
 
 
5) How often have thoughts about cancer affected your ability to perform your daily 
activities? 
 M = 1.00 a 
SD = .000 
M = 1.35 b 
SD = .635 
Missing = 1 
M = 1.04 
SD = .204 
Missing = 2 
M = 1.00 
SD = .000 
 
Note: Means for cancer risk perception (questions 1 & 2) and cancer worry (questions 3, 
4, & 5) were compared with non-independent t-tests. Means that have different 






Table 6. Detailed Responses of Perceived Cancer Risk and Worry  
 LFS Partners Non-LFS Partners 
 Men 
(N = 15) 
Women 
(N = 48) 
Men 
(N = 47) 
Women 
(N = 15) 
1) Compared with other people your age, what are your chances of getting cancer (or 
another cancer) in your lifetime? 
Much less (1) 1 (6.7%) 0 (0%) 9 (18.4%) 0 (0%) 
A little less (2) 0 (0%) 0 (0%) 10 (20.4%) 3 (20%) 
About the same 
(3) 
3 (20%) 0 (0%) 21 (42.9%) 9 (60%) 
A little more (4) 2 (13.3%) 6 (12.2%) 3 (6.1%) 3 (20%) 
Much more (5) 9 (60%) 42 (85.7%) 4 (8.2%) 0 (0%) 
     
3) How often have you thought about your own chances of getting cancer (or another 
cancer)?  
Not at all or rarely 7 (46.7%) 9 (18.4%) 41 (83.7%) 13 (86.7%) 
Weekly 5 (33.3%) 16 (32.7%) 5 (10.2%) 2 (13.3%) 
Daily 3 (20%) 17 (34.7%) 1 (2%) 0 (0%) 
Several times a day 0 (0%) 6 (12.2%) 0 (0%) 0 (0%) 
     
4) How often have thoughts about your chances of getting cancer (or another cancer) 
affected your mood? 
Not at all or rarely 10 (66.7%) 24 (49%) 47 (100%) 15 (100%) 
Weekly 5 (33.3%) 17 (34.7%) 0 (0%) 0 (0%) 
Daily 0 (0%) 4 (8.2%) 0 (0%) 0 (0%) 
Several times a day 0 (0%) 2 (4.1%) 0 (0%) 0 (0%) 
     
5) How often have thoughts about cancer affected your ability to perform your daily 
activities? 
Not at all or rarely 15 (100%) 35 (72.9%) 45 (95.7%) 15 (100%) 
Weekly 0 (0%) 9 (18.8%) 2 (4.3%) 0 (0%) 
Daily 0 (0%) 4 (8.3%) 0 (0%) 0 (0%) 







Table 7. Participants’ Coping Styles 
 
 LFS Partners Non-LFS Partners 
Coping Styles  
    M (SD) 
Men 
(N = 15) 
Women 
(N = 49) 
Men 
(N = 49) 
Women 
(N = 15) 
1. Self-Distraction 4.87 (2.03) 5.10 (1.77) 3.88 (1.55) 4.27 (1.22) 
2. Active Coping 4.47 (2.10) 5.45 (1.84) 4.88 (1.86) 4.93 (1.79) 
3. Denial 2.52 (1.13) 2.16 (0.55) 2.18 (0.67) 2.60 (1.24) 
4. Substance Use 2.07 (0.26) 2.69 (1.34) 2.73 (1.50) 2.53 (0.83) 
5. Use of Emotional Support 3.87 (1.64)a 5.37 (1.74)b 3.63 (1.83)c 4.93 (2.02)d 
6. Use of Instrumental Support 3.47 (1.30) 4.43 (1.90) 3.18 (1.58)a 4.53 (1.81)b 
7. Behavioral Disengagement 2.13 (0.83) 2.33 (0.90) 2.24 (0.72) 2.47 (1.19) 
8. Venting 3.00 (1.20)a 3.65 (1.20)b 2.82 (1.25) 3.27 (1.28) 
9. Positive Reframing 4.53 (2.03)a 5.73 (1.95)b 4.39 (1.82) 4.93 (2.12) 
10. Planning 4.20 (1.97)a 5.49 (1.86)b 4.59 (1.89) 5.07 (1.83) 
11. Humor 3.93 (2.37) 4.22 (1.90) 2.73 (1.20) 3.27 (1.34) 
12. Acceptance 6.40 (2.41) 6.86 (1.44) 6.22 (1.84) 6.47 (1.41) 
13. Religion 3.87 (2.64) 4.84 (2.55) 3.35 (1.94)a 4.87 (2.33)b 
14. Self Blame 2.73 (1.58) 2.69 (1.25) 2.49 (0.98)a 3.27 (1.34)b 
Note: Means were compared with non-independent t-tests. Means that have different 






Table 8. Rotated Factor Analysis Pattern Matrices   
 
LFS Partners  Factor 1 Factor 2 
Self-distraction .369 .112 
Active coping .691 .008 
Denial .110 .728 
Use of emotional support .560 -.040 
Use of instrumental support .609 -.016 
Behavioral disengagement -.364 .421 
Venting .616 .226 
Positive reframing .688 -.106 
Planning .822 .011 
Humor .417 .133 
Acceptance .562 -.516 
Self-blame .234 .404 
   
Non-LFS Partners Factor 1 Factor 2 
Self-distraction .404 .360 
Active coping .616 -.019 
Denial -.084 .769 
Use of emotional support .784 -.017 
Use of instrumental support .675 -.025 
Behavioral disengagement -.136 .819 
Venting .649 .356 
Positive reframing .602 -.061 
Planning .660 .000 
Humor .428 .335 
Acceptance .365 -.237 
Self-blame .162 .733 
 






CHAPTER 4: STUDY 2 
 
In-depth Interviews with Couples Affected by Li-Fraumeni Syndrome 
Background 
Li-Fraumeni Syndrome (LFS) is a rare hereditary genetic condition, and is most 
often caused by a deleterious mutation on the TP53 gene (a tumor suppressing gene) 
(Lindor et al., 2008). A mutation in the gene results in an almost 100% lifetime risk of 
developing one cancer, and a 45% possibility of a second cancer developing later in life 
(Mai et al., 2016). Nearly half of affected individuals have a cancer diagnosis before the 
age of 40, and many individuals develop multiple cancers over the course of their life 
(Kratz et al. 2017). The TP53 mutation is autosomal dominantly inherited, so parents 
have a 50-50 chance of passing the gene mutation on to their children. In many cases, 
cancers associated with Li-Fraumeni syndrome develop in children or young adults, but 
they can occur during any stage of life. People with Li-Fraumeni syndrome are typically 
younger when they develop cancer compared with healthy individuals in the general 
population. Thus, when a family member is tested and determined to be positive for LFS, 
lifelong cancer screenings are recommended to prevent and catch cancer early enough to 
avoid death.  
 
Psychosocial Impact of LFS Diagnosis on Families 
There are several routes to the identification of LFS and proof that the diagnosis is 
correct. One possibility is when a family member is diagnosed with cancer, the diagnosed 
individual’s doctor or oncologist notices a strong prevalence of cancer in the family 





the cancers which characterize this syndrome. The combination of early-onset breast 
cancer and sarcoma in family members was the original finding that triggered the 
investigation of this disorder. Certain very rare cancers, such as adrenal cortical 
carcinoma and choroid plexus tumors represent a very strong clinical clue to the presence 
of LFS. the patient’s doctor then recommends genetic testing. A family member who 
tests positive for deleterious germline mutations in the TP53 gene confirms the diagnosis, 
but about 30% of patients with a clinical picture suggestive of LFS do NOT have 
detectable mutations in this gene. Presumably, there are other undiscovered genes which 
account for that minority of cases. 
A mutation-positive family member with LFS may decide to spread the word to 
parents, siblings, cousins, aunts, and uncles, who are definable risks of themselves being 
carriers of the family’s mutation, i.e., 50% probability among first-degree relatives, 25% 
probability among second-degree relatives. From there, some families engage in cascade 
testing for the specific mutations in other family members begins, and multiple 
generations of TP53 mutation-positive individuals are identified (McBride et al., 2017).  
The degree of open communication about genetic testing differs from family to 
family. Given the nature of modern family relationships and the complexity of genetic 
information itself, communication of testing results can be difficult or even impossible in 
some circumstances (Patenaude, 2006). Patients bear primary responsibility for sharing 
their information with relatives, but various factors (i.e., infrequent communication, poor 
relationship quality, or fear of the other relative’s reaction) may prevent a patient from 
sharing the genetic testing information with potentially affected relatives.  
Another complexity to the LFS story is the fact that approximately 14% of people 





a person will not carry this mutation, nor will they have a strong family history of cancer. 
However, the descendants of a de novo carrier can transmit the mutation to their own 
children (Renaux-Petel et al., 2018). Regardless of whether a person inherits a mutation 
or the mutation occurs for the first time in a person, that person has a 50% chance of 
passing on either their own normal copy of the TP53 gene and a 50% chance of passing 
on their mutated copy of the gene to his/her child. 
The TP53 test, unsurprisingly, often contributes to psychological distress for the 
person undergoing the testing. Peterson et al. (2008) examined the psychosocial 
functioning of individuals undergoing genetic testing for LFS. They found that greater 
cancer-specific distress for TP53 mutation carriers was associated with factors such as a 
lower quality of life and a higher number of first-degree relatives with cancer. 
Additionally, even without a personal cancer diagnosis, individuals who reported a higher 
perceived risk of having the TP53 mutation reported significantly more cancer-specific 
distress. A case study examined the experiences of an individual female with multiple 
independent primary malignancies and explored the benefits and burdens of ongoing 
cancer screening (Jhaveri et al., 2015). The researchers used this case to point out that 
although aggressive cancer screening can provide temporary relief when no cancers are 
found, the emotional trade-off is the anxiety of a possible cancer diagnosis that exists 
leading up to the screening, as well as any “false positive” scan results that have to be 
followed up with a biopsy or additional scans. 
The cancer-related implications of TP53 mutations have been studied for the past 
two decades, and medical protocols for close monitoring and full body cancer screening 
have been developed (McBride et al., 2014).(McBride et al., 2014). The screening 





individuals with LFS (Villani et al., 2011). One example of a comprehensive screening 
protocol is the Toronto Protocol (Kratz et al., 2017), which combines annual brain 
magnetic resonance imaging (MRI), annual rapid whole-body MRI, annual breast MRI 
for female patients, physical exams every 6 months (including blood and urinalysis), and 
colonoscopies every 2-5 years.  
Although the main goal of screening is to increase survival for patients with LFS 
by detecting cancers at an earlier stage in their natural history, at point in time when the 
cancer may still be curable. These screening protocols require significant investments of 
time and resources, and can be emotionally exhausting for the patients and their families. 
A meta-analysis of 578 participants with LFS from 13 cohorts in 6 countries found that at 
first baseline MRI-based cancer screen, the overall detection rate of new cancers was 7% 
(Ballinger et al., 2017). An LFS screening program at MD Anderson Cancer Center 
evaluated the benefits and drawbacks of intense early detection cancer screening (Ross et 
al., 2017). They found that participants reported the perceived drawbacks (logistical 
issues, difficulty navigating the system, screening being draining, negative emotional 
reactions) did not outweigh the benefits (peace of mind, centralized screening, knowledge 
as power, screening making LFS more livable). The study found that despite significant 
benefits of screening, there are still notable drawbacks that may limit engagement in 
screening protocols. Many of the participants in the study also mentioned that the 
screening protocol had a large impact on their families and that family emotional and 
pragmatic supports were important to comply with the screening process. Yet, the precise 
impact of screening on multiple family members, with or without LFS, is not yet well 
understood, largely because these protocols are relatively early in their development. The 





and screening utility are important in understanding their decisions for making shifts in 
family resources in response to a perceived threat. The family members’ joint 
perspectives and influence on a patient’s screening behaviors have not been explored. 
This indicates a need for further research on the family implications of LFS cancer 
screening that includes the viewpoints of multiple family members.  
The medical community’s focus on the patient or individual with LFS ignores the 
risk of LFS for family members, caregiving burden, shared anticipation of a diagnosis, 
and the psychological impact that LFS can have on family members. Having a heritable 
form of cancer risk can strain the resources of individuals and families because of the 
nature of cancer (van Oostrom et al., 2007). Families with heritable cancer often deal 
with multiple aspects of cancer treatment and prevention for several family members over 
time, often simultaneously. Cancer diagnosis and treatment, recovery from cancer, and 
continued anticipation of cancer can all have significant mental health effects on the 
individual with LFS as well as his or her family members and other loved ones (Harris et 
al., 2010).  
This study applied tenets of a family systems framework to the context of couple 
experiences with LFS, consistent with prior research demonstrating the significant role 
that spousal relationships play in cancer experiences and high cancer risk syndromes. 
Using Family Systems and Family Resilience frameworks, we applied qualitative 
research methods of data collection, coding, and validation to identify themes from 
interviews of couples affected by LFS, with an emphasis on how couples’ relationships 






Family Experiences with Li-Fraumeni Syndrome 
In the general medical oncology community, the term “affected” refers to an 
individual who has had cancer. In the cancer genetics community, individuals with a 
germline mutation in a known cancer susceptibility gene are at varying degrees of cancer 
risk, although they may not (yet) have developed a cancer themselves. In a genetic sense, 
such a person could be described as “affected” as well. 
In this paper we expand this definition. We assume that cancer and the not yet 
manifest cancer susceptibility affects the individual with cancer, the person’s 
spouse/partner, the rest of their family, and potentially their social, networks; i.e., the 
whole family system is affected. Family systems theory suggests that individuals cannot 
be understood in isolation from one another, but rather as a part of their family, as the 
family is a socio-emotional unit (Bowen, 1978). As a result, we use the term “affected” to 
indicate any person or relationship that has been touched by the increased risk of cancer 
or a cancer experience. Research shows that the family system can greatly influence the 
members’ degrees of distress and worry regarding each cancer occurrence, because these 
emotional experiences are interrelated (Hagedoorn, Buunk, et al., 2000). The literature 
has shown mixed results regarding the psychological and emotional functioning of these 
families. Participants with LFS in (Peters et al., 2016) study of emotional, tangible, and 
spiritual forms of social support did not report a lack of support or confidants in their 
lives. In contrast, another study of distress in people with LFS found that both LFS 
partners and non-LFS partners had clinically significant levels of distress (depression, 
anxiety, somatization) and reported a desire for increased mental health support for 





contradictory findings to better address the emotional, social support, and mental health 
needs of families faced with a high burden of cancer risk. 
The psychosocial research related to genetically heritable forms of cancer has not 
been expanded beyond the study of individuals with heritable diseases, and studies 
looking at multiple family members with LFS are still needed. Currently, the majority of 
the qualitative research in this area focuses on the individual family member with the 
diagnosis, but this overly simplifies a complex family process over a lifetime. Family 
dynamics and systemic reactions to stress are important parts of the LFS experience. The 
analysis of this phenomenon must be expanded beyond the individual level to the family 
level. Specifically, research that integrates assessments of how multiple family members 
are affected by LFS and how they deal with this diagnosis together would more 
accurately capture their collective experience and could better serve clinicians working to 
support these families. 
Cancer and Couple Relationships  
One of the most important relationships in a family is the spousal dyad, which 
serves as the foundation for family formation in traditional family structures. Studies 
have shown that intimate partner relationships are the single largest source of happiness 
in a person’s life, as well as the largest source of distress and violence (Rakovec-Felser, 
2014). The quality of couple relationships has a large impact physical and mental health 
and well-being (Berkman, 2000). The daily transactions of social support between 
intimate partners affect psychological functioning of each individual partner, their health 
behaviors, as well as their health outcomes (Sarma et al., 2018).  
The present study is the first to our knowledge to qualitatively study couples 





relationships between heterosexual individuals with LFS and their married partners. 
Focusing our attention on married couples is a starting point for understanding the 
development of the entire family. The rarity of psychosocial studies on people with LFS 
and their families presents a unique opportunity to apply a family systems lens to the 
challenges faced by couples and move beyond individual-level data.   
Couples who learn of an LFS diagnosis for one of the partners must learn how to 
negotiate new roles, create new meaning in their lives in the context of LFS, and cope 
together with the diagnosis. Partners of individuals with LFS may be unsure how to best 
support their partner and the rest of the family. As the non-LFS partner, they may 
struggle with finding appropriate ways to be involved in medical treatment, prevention, 
and advocacy of their LFS-positive partner. They also may underreport the impact that 
the LFS diagnosis and the risk of cancer have on their partner, as well as on their own 
psychological and emotional well-being, because a common style of coping by spouses 
of cancer patients is protective buffering, in which a spouse hides his or her concern and 
emotional distress from the patient in an effort to protect them from further worry 
(Hagedoorn, Kuijer, et al., 2000). The individual covers up their own distress as an 
attempt to protect the sick partner, but this does not mean that the non-LFS partner is 
unaffected by the diagnosis. As a result, the couple may no longer engage in the open 
communication required for them to share their innermost thoughts and feelings without 
fear of hurting the other. Consequently, it is important to explore factors that influence a 
couple’s tendency to engage in protective buffering, especially when they are living with 
a major stressor such as LFS for the rest of their life.  
One study of individuals with LFS and their partners (Lammens et al., 2011) 





services for their non-LFS spouses and partners. The researchers examined distress in 50 
partners of individuals with LFS and Von Hippel-Lindau disease (VHL)2 and found that 
28% of the partners reported clinically relevant levels of distress related to the cancer 
syndrome (Lammens et al., 2011). Levels of distress and worry reported by the partner 
were significantly correlated with the distress level of the high-risk spouse. The 
researchers also found that younger partners as well as partners with less social support 
reported greater distress. 76% of the partners who participated in the study believed that 
they, and not only their at-risk spouses, should be offered routine professional 
psychosocial support. From this research, we can conclude that the distress and support 
systems of non-LFS spouses are important to consider both for their own well-being and 
the well-being of the spouse with LFS. However, this prior research did not evaluate 
dyadic models in which the distress levels of two partners interact and, due to the small 
sample sizes that are unavoidable in rare diseases, the results solely consisted of 
correlations and linear regression analyses, rather than multilevel modeling. 
To build a conceptual model for the present inquiry into dyadic effects of LFS, we 
extrapolated from results of studies regarding the variety of roles that non-bloodline 
partners may inhabit when their partner is experiencing a newly-diagnosed sporadic 
cancer; i.e., support person, co-parent, decision-maker, health proxy, and caregiver (Q. P. 
Li, Mak, & Loke, 2013). Data on the cancer experiences of couples coping with sporadic 
cancers can shed light on the range of psychosocial challenges that LFS couples might 
face. One study by (Manne et al., 2004) examined associations among couple 
communication regarding cancer, psychological distress, and relationship satisfaction of 
                                                 
2 Von Hippel-Lindau disease is another rare autosomal dominant cancer syndrome that results in higher 





women diagnosed with early stage breast cancer. A sample of 148 couples completed a 
videotaped discussion of a cancer-related issue and a general issue in their relations, as 
well as measures of psychological distress and relationship satisfaction. Videotapes were 
coded with the Rapid Marital Interaction Coding System (Heyman et al., 2001). The 
researchers’ analysis focused on partner responses to patient self-disclosures. During the 
cancer-specific discussions, patients reported less distress when partners responded to 
disclosures with reciprocal self-disclosure and humor and when partners did not 
immediately propose solutions for the other’s problem. The researchers found that when 
couples were discussing a general issue, the link between partner responses to patient 
self-disclosures and patient distress was weaker than when they were discussing cancer. 
The results suggested that male partner openness in their responses played a role in 
helping women adapt to breast cancer, specifically increasing reciprocal self-disclosure, 
using humor appropriately, and reducing problem-solving attempts, which may improve 
adaptation and relationship intimacy during and after this stressful life event (Manne et 
al., 2004). Overall, these findings on bi-directional communication and humor suggest 
that couples dealing with a stressful illness experience find support in open discussions 
regarding the breast cancer of the female partner. Yet, these studies do not address the 
ways in which communication styles vary over time for couples who face multiple 
cancers, and the experience of men with a cancer diagnosis and their unaffected female 
partners.  
Studies of other heritable cancer syndromes, such as Hereditary breast and 
Ovarian Cancer associated with mutations in the BRCA1/2 genes, provide insight into 
how couples cope with high risk of cancer. A study by Metcalfe et al. (2002)(Metcalfe et 





counseling for a positive BRCA1/2 result. The researchers surveyed 59 spouses of female 
mutation carriers. The mean length of relationships was 26 years (range: 2.5-50 years). 
All participants were supportive of their spouses' decision to undergo genetic testing and 
counseling. Four respondents stated that they wished that they had received additional 
support at the time of test disclosure, and 20% felt that their wives had received 
inadequate support. One-quarter of the spouses believed that their relationship had 
changed because of genetic testing; most felt that they had become closer to their wives. 
Husbands were most concerned about the risk of their wife dying of cancer (43%), 
followed by the risk of their spouse developing cancer (19%) and the risk that their 
children would test positive for the BRCA mutation (14%). Distress levels, measured by 
the Impact of Event scale, suggested that few spouses were experiencing clinically 
elevated levels of distress, compared with the general population at the time of data 
collection. Specifically, distress was measured by the level of intrusion that genetic 
testing results had on their lives, as well as how much the partners avoided the event. 
Men with a high school education or less displayed significantly higher levels of distress 
than more educated men, but age and cancer status of their female partners was not 
associated with varying distress levels. The researchers suggested that the gender 
discrepancies regarding reported distress may be due to male partners minimizing their 
distress in order avoid worrying their partners or a general gender difference regarding 
reports of clinical distress, with women more likely to admit distress than men due to 
socialization into culturally-specific gender roles. The impact of genetic testing varies by 
couple, but these findings indicate important gender differences, and encouraging results 
about the increased closeness of couples after a genetic test. Regarding limitations of the 





male partners. In addition, the study only assessed one time point in the experiences of 
one partner. When applied to the experiences of couples with heritable cancer syndromes, 
the study only utilized individual-level analysis at the beginning of living with the cancer 
syndrome and did not include dyadic-level analyses.  
Prior studies that have examined participants’ perceptions of relationships in 
heritable cancer syndromes have focused on heterosexual, mostly male partners of 
mutation-positive individuals. Hoskins et al. (2008) conducted in-depth interviews with 
11 young women who learned before marriage that they had a high risk of early-onset 
breast and ovarian cancer due to their BRCA1/2 mutation status. The narratives that were 
collected through the interviews illustrated the complexity that the women faced in 
forming a relationship with a new partner, with regard to sharing information about their 
mutation. An opportunity for relationship-building was highlighted when they shared 
their experiences of disclosing their BRCA mutation status to partners. Although the 
disclosure was often preceded by feelings of fear and anxiety, many participants reported 
that doing so had positive effects on their relationships. If the partner was able to respond 
with interest, empathy, and affection, the participants reported increased future intimacy 
and increased attachment (L. M. Hoskins, Roy, Peters, Loud, & Greene, 2008).(L. M. 
Hoskins et al., 2008). Thus, interviews represent a more comprehensive and potentially 
beneficial approach to gaining information about relationships of couples affected by 
LFS.  
The complexity of couple dynamics in the context of heritable syndromes has yet 
to be captured in a study that involves both partners in an in-depth discussion about the 
syndrome and their relationship patterns and changes in relation to the syndrome. Prior 





perceptions of each individual partner, but very rarely were both partners included in the 
discussion, and dyadic processes of coping were not the focus of those studies. The 
present study paper takes a family systems and strengths perspective to investigating the 
multifaceted dyadic process of living with LFS.  
 
Theoretical Framework 
 The Family Resilience Framework (Walsh, 2012) guided this study of couples’ 
processes of coping processes with LFS. This framework is part of a movement in recent 
decades to shift away from an overemphasis on pathology and family deficits to more 
attention on family strengths. Family resilience, in this model, is defined as how a family 
adapts, works through, and learns from stressful situations, developing personal resources 
as a result of being challenged. One of the basic premises guiding this framework is that 
stressful events and persistent challenges influence the whole family, and in turn, specific 
family processes mediate the level of recovery and development of resilience of each 
family member and the entire family as a whole. Interventions that employ this 
framework are aimed at building family strengths when addressing problems, thereby 
reducing vulnerability to future stressors. Hopefully, as families become increasingly 
resourceful, their ability to meet future challenges will be improved. Family resilience is 
not the same for every family, but there are some common characteristics that have been 
found to distinguish families that can successfully cope from families that are unable to 
regroup after a major stressful event such as an LFS diagnosis. One of the common 
strengths is the ability to seek out emotional support and tangible practical support from 
each other as well as from the family’s external support network when under duress from 





stressors associated with diagnosed cancer risk, those stressors may have a detrimental 
impact on the emotional quality of their relationships, their communication, and family 
cohesiveness.  
The Family Resilience Framework has been used to explore family challenges 
such as a mental illness diagnosis, divorce, and deployment in military families (Walsh, 
2002). In the context of LFS, people do not always define their situation as presently 
severe, unless they are currently being treated for a cancer. However, the challenges of 
living with LFS may not always be so immediately and clearly observable; rather, they 
may manifest as chronic, ongoing, and changing over time, such as the anticipation and 
stress of possible future cancer diagnosis or loss of a family member to cancer. These 
types of anticipated losses fall into the category of what Riskind (1998) has described as 
“looming vulnerability” in which individuals and other family members are experiencing 
the anticipatory danger of significant losses and grief over the ambiguous expectancy that 
sometime in the future the diagnosed person may die from cancer. Thus, since resilience 
does not mitigate a family’s risk of cancer, resilience must be applied to the family’s 
preparation for future events that may threaten their family functioning. Rolland (2006) 
has emphasized the utility of using the concept of anticipatory loss, defined as “the 
experience of living with possible, probably, or inevitable loss,” (p.140) as a framework 
for investigating the emotional experiences and meaning-making processes of families 
dealing with LFS.  
 
Objectives 
Research Question: How do couples in which one partner has LFS cope with their 





This study involved in-depth qualitative interviews with couples in which one 
partner had TP53 mutation-positive LFS, to identify the challenges unique to couples 
coping with LFS, to explore what coping strategies and resources couples use to manage 
the emotional, pragmatic challenges, and to assess the natural history of resilience. For 
this purpose, couple resilience was defined as role flexibility, dyadic adaptation, and 
balancing of responsibilities. Specifically, this study focused on couple dynamics, as well 
as the ways in which married partners discuss LFS as a shared burden, the extent to 
which couples approach cancer treatment and prevention together, and how the couples 
handle cancer-risk related issues regarding their children (genetic testing, discussing 
cancer with them, etc.). The goal of the study was to contribute to an ongoing effort to 
help families affected by LFS navigate changes to their daily life and outlook on the 
future.  
Living with heightened vigilance regarding cancer can have a range of 
psychological and emotional effects on families with LFS. Using a Family Resilience 
framework, this study was designed to identify the strategies that couples describe using 
in response to ongoing challenges that couples face, either as the person with LFS or 
married to a person with LFS. Specifically, this study explored specific processes of joint 
coping that couples have used, as well as the values, attitudes, and beliefs that they hold 
regarding how to best cope with the ongoing threat of cancer.  
 
Methods 
This study was part of the Li-Fraumeni Syndrome Cancer Screening Study (11-C-
0255, ClinicalTrials.gov; Identifier NCT01443468; www.lfs.cancer.gov) conducted at the 





Board. The main goal was to investigate the clinical, epidemiologic, and genetic etiology 
of LFS, as well as to establish a national and international standard for cancer screening 
for individuals with or at risk of LFS. To establish a standard routine physical screening 
for people with LFS, a cohort of participants has been invited to the National Institutes of 
Health (NIH) Clinical Center to do full body, brain, and breast MRIs (for female 
participants who still have intact breasts), complete physical exams, and psychosocial 
interviews. The psychosocial interviews are conducted with each member of the family 
individually and with all presenting members together.  
Data collection 
From its inception in 2011, the LFS study conducted extensive recruitment by 
establishing a study website and disseminating information to a network of oncologists 
and genetic counselors, and the membership of relevant medical professional societies 
(the most common mode of referral to the study). Prospective patients and their families 
were referred to the Clinical Genetics Branch (CGB) by NIH clinicians and other 
healthcare professionals from outside NIH, the NCI Cancer Information Service, 
interested laypersons, and family members themselves. Interested individuals contact the 
CGB. A CGB Referral Team research nurse then conducts a telephone interview with the 
patient or another member of the family to collect cancer history information on the 
individual and family. Such information includes enumeration of extended family 
members, type of tumors, ages at diagnosis, number of multiple primary tumors, vital 
status, number of affected and unaffected individuals, etc. Once it is established that the 
person has met the clinical criteria for LFS and does not have an active cancer at the time 
of enrollment, they are enrolled and provided with consent information. Additionally, 





in the study, though if they were not at high risk for cancer, they did not participate in the 
cancer-screening portion. For more detailed information regarding the inclusion and 
exclusion criteria, please see Mai et al. (2016). Participants who enrolled in the study 
underwent a rigorous baseline evaluation, which included both medical and mental health 
history assessments. After the baseline evaluation was completed, participants are 
assigned to the clinical and field cohort. The non-clinical field cohort is followed over 
time by the researchers and provided recommendations for care as well as annual 
newsletters and questionnaires. This cohort may engage in recommended screening 
locally, but are monitored to observe their healthcare actions. The clinical cohort travels 
to the NIH Clinical Center annually for a 1-2 day visit that includes a range of MRIs, 
blood tests, and interviews.  
Participants are allowed to bring one support person during their visit to the 
Clinical Center, and these support people range from siblings to friends to parents to 
spouses. Participants are not required to bring a support person, and often the friend or 
family member who travels with them varies from year to year. Support persons who 
consent to enroll in the study agree to complete the same psychosocial and medical 
history assessments as the LFS patients. Participants, their support people (if considered a 
family member), and/or a family member who is also enrolled in the study are invited to 
complete a family interview. 
The participants first completed an individual Colored EcoGenetic Relationship 
Map (CEGRM) interview with a genetic counselor, a healthcare professional with 
specialized training in medical genetics and counseling. The CEGRM is a novel 
counseling tool, a simple method of obtaining detailed social exchange information 





social exchange domains (information, tangible, emotional, and spiritual/religious 
support) with color-coded symbols applied to the genetic pedigree, to increase the 
understanding of communication and support within cancer-prone families (Kenen & 
Peters, 2001; Peters et al., 2016). After completing the CEGRM, couples met together 
with a Marriage and Family Therapist for the family interview.  
Interviews lasted approximately one hour and were audio recorded with the 
permission of the participants. Transcripts of the interviews were requested from the 
research team to be analyzed for the current study. Participant names and other personal 
identifying information were removed from this dataset and replaced with pseudonyms 
prior to analysis, and all identifying information has been removed from the transcripts. 
The transcripts were stored on a secure NIH computer that is password protected, as was 




A total of 64 family interviews were conducted between 2012 and 2017 during 
annual coordinated care visit to the NIH Clinical Center. Of these 64 interviews, 26 
included couple pairs (52 individuals). Although sexual orientation and marital status 
were not part of the exclusion criteria for this study, all couples were heterosexual and 
married. Of those 26 couples, 21 included a female partner with LFS. Participants’ ages 
ranged from 22-61 years. 17 of the 25 couples included a partner with an LFS-cancer 






Of 18 couples that reported their level of education, over 60% had a college 
degree and many have a graduate degree. Out of the 18 couples that reported their income 
level, 50% have an annual income of over $100,000, well above the national median 
household income in 2016 of $57,617 (Guzman, 2017). For the 21 couples that reported 
marriage duration, the average length of marriage was 15 years and the range was 2-32 
years. These participants possessed a high-level of familiarity with healthcare systems, 
since the LFS Screening study requires an intense amount of paperwork to enroll and to 
continue to participate annually. After visits to the National Institutes of Health Clinical 
Center, frequent follow up is required, either at home or at the Center, to assess if a 
finding from the MRI could be a possible cancer. In addition, participants must have the 
ability to take several days off work each year to come to the Clinical Center for the 
screening, as well as to schedule doctors’ appointments every four months for blood 
draws. Over half of the sample reported a religious affiliation, including: Catholic, 
Protestant, Jewish, LDS/Mormon, and Methodist. 
 Most of the couples have had at least one child. Of those, only four couples had 
not tested any of their children for the familial TP53 mutation at the time of the 
interviews. Out of the total 47 children of participants, 79% had undergone genetic 
testing for the TP53 mutation and 34% tested positive. Three couples had a child who had 
died due to cancer. See Table 10 for information on couples’ children.  
 
Design: Grounded Theory and Interpretive Description 
The data analysis used the tenets of grounded theory (GT) (Charmaz, 2006; 





method in which data collection and analysis occur simultaneously. ID uses GT as its 
foundation, and has its methodological roots in nursing research, which contextualizes 




 Multiple members of the LFS research team at the NCI collaborated to build the 
interview guide, including a family therapist, genetic counselor, social work consultant, 
and oncology medical staff. The interview guide included a semi-structured protocol, 
modified for the constellation of family members attending the annual visit. The goal of 
the family interview protocol was to focus on intra-family communication issues, 
reproductive decision-making, couple relationships, cancer prevention behaviors, and 
choices regarding genetic testing for adults and children.  
 
Data Analysis  
 Transcripts were analyzed using the inductive analysis steps of thematic, axial, 
and open coding, informed by grounded theory methodology. The coding team was 
comprised of four researchers trained in qualitative methods with experience working 
with medical transcript data. During the initial readings of the interviews, three coders 
conducted open blinded coding on three transcripts individually, identified significant 
content, and noted personal reactions and reflections. Researchers used Dedoose software 
to conduct open thematic coding toward the development of a codebook, and initial 





parenting”. At this point, the team’s first qualitative codebook was developed to outline 
and define each theme.  
Two researchers then blinded six transcripts and coded them independently using 
the first codebook to check for inter-coder differences regarding code length and code 
definitions. Discrepancies were resolved through discussion, and selective coding for 
specific themes began. After half of the transcripts were coded by one person, three codes 
were determined to be too broad (family of origin, parenting, and coping), and the first 
author used thematic coding again to create child codes that fell underneath the three 
larger parent codes. These additional child codes were added to the codebook, and 
transcripts were recoded using this second, refined version of the codebook. The 
codebook was modified and finalized, and two researchers independently coded all 
transcripts. In the final analysis phase, the coding team met to discuss interpretations and 
synthesize findings into recurring themes.   
 Linguistic analysis was employed to tag specific phrases and words that reflected 
aspects of participants’ identity. Included in the codebook was a theme regarding 
pronoun use, and plural versus singular identifiers were coded on a scale from 0 “I” to 10 




This study employed the following methods to maximize rigor and trustworthiness of the 
findings:  
Group process data analysis. A team-based approach to coding and synthesizing 





each other’s findings and established consistency across individual findings. Second, a 
seasoned qualitative researcher and medical provider with expertise in hereditary cancer 
genetics provided mentorship and additional feedback regarding the thematic findings of 
the study. These strategies facilitated the validation of the data and findings through 
cross-verification from multiple sources.   
Team debriefings. The Li-Fraumeni Syndrome Screening clinical research team 
met weekly to discuss upcoming meetings with families that were coming to the clinic 
and to review most recent visits to the clinical center. The researcher who served as 
interviewer on this project participated in these weekly debriefing sessions as well as 
one-on-one debriefing with the genetic counselor that conducted the individual interviews. 
The purpose of these meetings was to discuss any concerns regarding the mental health of 
the participants, follow up on questions, and cross check information gathered from 
multiple sources. In addition, peer debriefings with another qualitative researcher who 
observed family interviews provided a preliminary direction for the analysis process.  
Prolonged exposure and time in the field. Over the course of three years, the 
primary interviewer conducted over 60 family interviews with multiple configurations of 
family members, such as sibling pairs, couples, parent-child groups, etc. During this 
extended period of time, the interviewer became intimately familiar with these families 
and developed familiarity with some of the common challenges and strategies employed 
by families in the face of LFS. The semi-structured nature of the interview allowed the 
interviewer to probe regarding specific issues or clarify family coping processes. This 
technique and the time invested allowed the researcher to develop relationships and 
rapport with family members and aid in the co-construction of meaning between 







Couples across the study described living with a sense of ambiguous danger due 
to the persistent threat that disease could manifest itself suddenly and pose great threat to 
the individual’s well-being and survival, yet they did not have clues as to onset, course, 
or outcomes. As a result, couples remained in a constant state of apprehension. Here Bert 
illustrates what it is like to know his wife’s family history with cancer:  
Bert:  We’re both worried. After you’ve seen it [cancer] happen, and you’ve seen 
it happen to her, her father, her sister. You know where you finish the race, you 
just don’t know when you’re finishing the race. 
From this description, Bert demonstrated how he shares his fear with his wife and her 
family regarding the uncertain nature of the cancer timeline and how cancer’s 
inevitability makes them feel worried that his wife will get cancer and die early.  
 
Ambiguous Danger 
Like Bert and his wife, couples participating in the screening study discussed 
coming to the NIH in hopes that screening would detect cancer at an early stage so that 
they have a higher chance of survival. Yet, the annual intense screening also came at an 
emotional cost. Some spouses described the cycle of stress regarding annual cancer 
screening and the fear of finding an abnormal result or learning about another 
preventative surgery that might help reduce the risk of future cancer. The spouses were 
very attuned to the anticipation of results that could come out of a screening visit, and 
partners without LFS were perceptive of their partners’ anxiety leading up to the visit. 





game is never over.” This is a statement that expresses the lifelong burden of worry and 
anticipation specific to the cancer screening that they participate in every year. Tim and 
his wife Jackie must wait for days after the screening test results come back to learn 
whether or not a new cancer has developed. For these couples, annual screenings add to 
the chronic nature of LFS, and are combined with an ongoing sense of ambiguity related 
to the potential stressor of cancer.  
Thematic coding of the 26 transcripts revealed two prominent typologies of 
coping with the screening and disease burden associated with LFS. First, nineteen 
couples coped in connection, in which both partners identified LFS as a shared challenge. 
Partners in this category used language to indicated mutuality and shared identity as their 
approach to living their lives with LFS. Second, nine couples coped independently and 
regarded the stress of LFS as affecting them individually. Partners in this category 
frequently used bi-directional protective buffering to shield their partner from distress. 
Withholding these emotional reactions and experience often increased isolation and 
disconnection within the relationship.  
 
Coping in Connection 
The majority of couples engaged in cohesive coping styles that reinforced a sense 
of togetherness through uncertainty and demonstrated the value of the relationship. Three 
specific behaviors served as indicators of mutuality. First, in the shared interview, both 
partners revealed concerns about the threat of cancer to their lives and family, indicating 
their engagement in open dialogue. Joe and Veronica found out that Veronica had LFS 






Veronica: It put us into a position that we didn’t have a choice but to be strong 
and hold on together. We’re dealing with something serious and we don’t have 
time to worry about little, stupid things. We reached a different level in our 
relationship.  
Joe: It put things in perspective. My thing was, “Stay focused.” Do what we need 
to do. Get married. Live the rest of our lives. 
Second, these couples viewed LFS as a “We-stress” and used plural pronouns to 
address themselves when talking about LFS. Third, these couples provided examples of 
how they were attuned to each other’s needs and alternated sharing the burden of LFS-
related stress.  
“We” versus “I”. Couples’ deliberate and specific use of “we” served as a proxy 
for the sense of joint ownership over managing and coping with LFS. The frequent use of 
“we” by non-LFS spouses indicated a high level of involvement in care. The use of “we” 
in the following example captures the intensity with which the non-LFS partner takes 
responsibility for and part in the health and care of the LFS-partner: 
Tim: Well, we’ve been very blessed with a clean bill of health now repeatedly. 
And I think a part of me, knowing that we’ve been granted sort of a reprieve, 
we’ve been given another clean bill, and not that we might not be still given one, 
but we’re going to have – and that's fine. We’ll deal with whatever has to happen, 
and the timing of that, and how it affects whatever. We’ll just make a plan, and 
we’ll do it. 
Tim uses “we” to describe his wife’s past and present health status, as well as 
their future plans. This demonstrates his perspective on a joint front in the face of 






Balance/taking turns. Partners also demonstrated a shared commitment to a joint 
approach to coping by alternating emotional caregiving and taking roles. They described 
a process in which one would serve as the emotionally “strong”/capable/ supportive 
partner while the other expressed a need to emotionally grieve/process and withdraw 
momentarily from family responsibility. Based on timing and life events, partners 
switched roles of who leaned on whom for strength. For example, the news that Veronica 
was positive for the TP53 mutation was difficult for her to handle. To support her initial 
adaptation and relieve her of the burden, her husband Joe made phone calls to share the 
news with family members: 
Veronica: Our parents knew I was getting tested; they knew there was a chance. 
Joe: I probably made the phone calls. 
Veronica: Yeah. I don’t remember. 
Joe: You probably didn’t do it. I probably made the phone calls.   
Interviewer: And told everyone? 
Joe: Yeah. I don’t think it was – you weren’t in a good state of mind. 
Veronica: No. 
Here Joe exhibited that he was attuned to Veronica’s mood and could complete 
the necessary task at hand in a way that helped relieve her burden. This demonstrated 
how couples must adjust their daily lives and roles to compensate for adjustment to the 
illness. The lack of clear recollection of who took on what task also points to Joe and 
Veronica not keeping score of who did what when for whom. Instead they seamlessly 
switch roles of responsibility for certain LFS-related duties. For several of these couples, 





distress that the other partner felt. Jared looked out for Liz and encouraged her to take the 
steps that she needs to do to stay healthy: 
Liz: He’s always my protector…you really shouldn’t be getting the x-ray 
Jared: I keep telling her that there is going to be a tomorrow…that’s my job.  
Liz: So, I think sometimes it’s more of that struggle around, “Gosh, like, it’s 
really hard,” and I just don’t want to go through that. Or I’ll feel, like, upset 
about, like, gosh, not knowing, or finding out that something’s there. You know, 
ignorance is kind of blissful. But he does a really good job just encouraging me 
and telling me that it has to be done. And he’s right. I agree. 
Liz described the struggle of constantly having to seek information that may turn 
out to be bad news, but also gratitude toward Jared for boosting and motivating her when 
she does not feel able to manage the stress of potential cancer findings. Jared took on the 
role of health behavior monitor for Liz, and his pragmatism balanced her desire to remain 
ignorant of any potential health issues.3 Another aspect of the health protector role was to 
maintain vigilance toward the prevention or cancer-risk reducing behaviors that their 
partners should be engaging in, including x-ray exposure, sun exposure, exercise, and 
healthy eating habits.  
 Lisbeth described a support process that many couples experienced when visiting 
the clinical center. Partners with LFS described the comfort of having their partner with 
them while they were undergoing stressful medical tests.  
Interviewer: And how has it been for you coming like and being the support 
person during this process. 
                                                 






Steve: It’s been good she doesn’t require a lot of support (*laughter*). I just like 
to spend time with her and being with her during this situation. 
Lisbeth: I always like having him with me because I think too that part of this 
study there is always a scan and it’s a long scan and so on top of scanning 
anxiety in general, so it’s just nice to have him along. I’m really tired and he finds 
his way around. (*laughter*) 
This passage demonstrates how the shared comfort that each partner feels in the presence 
of the other can aid in relieving anxiety they have regarding screening.  
Coping Independently 
Couples who coped independently viewed LFS as an individual stressor and were 
less internally consistent in their story. They coped with events in ways that relied on 
individual strengths and vulnerabilities, and focused on their own individual plot or 
perspective. Three specific themes indicated emotional distance between partners, 
including use of “I” language, protective buffering, and disconnection in their 
experiences. Some partners had a gap between their beliefs about what they perceived as 
a challenging life experience, and this gap in beliefs caused distance between the partners. 
For example, the partner with LFS often perceived that their spouse was worse off 
because it is easier to be the person with cancer than watch a loved one go through it. On 
the flip side, the non-LFS partner possessed a heavy burden of fear regarding losing their 
spouse or a child to cancer that they did not often share with the LFS carrier spouse. 
These communication patterns expressed that they did not share the fear or burden with 






 “I” versus “We”. Compared with connected coping, independently oriented 
couples coped in a simultaneous, parallel, and distinct manner. Most often the person 
with LFS used “I” in the context of describing their experience with cancer, 
demonstrating their independent identity in coping with the diagnosis, treatment, and 
recovery. Several couples did not share a narrative of coping, nor did they seek support 
from each other during times of high stress. When asked about a team approach to 
tackling stress or health problems, stated that they found their own roles in the family, but 
that it was not focused on support or empathy and focused on individual responsibilities 
instead.  
Bill: We didn't really cope, because she pretty much just takes care of herself. It's 
not my decision what she does with her body or medical because pretty much 
everything I say probably she's going to say is stupid or blame me, like scapegoat 
type stuff. So I stay out of it. I just took care of the kids and everything else and let 
her try and get healthy. 
In the above example, Bill described feeling like his primary role is in supporting 
aspects of daily life rather than her health care and emotional well-being. The members 
of the couple each found areas in which they could balance their family life by taking on 
other necessary roles beyond the healthcare responsibilities. Bill framed the healthcare 
aspects of LFS as his wife’s challenge to deal with, and not their shared challenge. His 
partner Harriet is a nurse, and her response confirms Bill’s statement in that she describes 
herself as a “controlling” person, and someone who has a hard time accepting help or 
listening to other people (including doctors). This couple had an internally consistent 
narrative regarding each of the partners’ roles. Bill’s language demonstrates a sense of 





Instead, Bill focused his attention on taking care of the kids in order to help Harriet 
devote her attention to getting healthy. This couple openly articulated that they coped 
separately during Harriet’s breast cancer and stated that if it were not for their children, 
they may not have stayed together for so long. How this lack of connection is related to 
the cancer experiences is unclear; however, the language of independent coping is related 
to the disconnection that the couple felt. 
Another couple, Fred and Rebecca discussed the death of their son from an LFS-
related brain tumor: 
Fred: I kind of dealt with it on my own terms, the good days and the bad days.  
Rebecca: I don’t know if I could have handled it, I’m still having a rough time. 
 This couple was very much in sync with each other, and still felt that their 
relationship was strong, even through their son’s multiple cancers. However, on an 
emotional level, the death of their son was too raw an event to cope together. The couples 
that coped independently from each other found a rhythm and pattern of distinct coping 
that did not rely on their spouse. For some, coping alone was easier than having 
conversations with their partner that forced them to face painful emotions of grief, fear, 
and anxiety. Lucy and Phil described their team process before and after screening: 
Lucy: I withdraw before and after the test. “Don’t give me one more thing to do. 
Don’t mess with me until this is over.” Because I tend to cognitively slow down. 
The things that I have to do just take longer, so I just want to put everything off 
until this is handled. 
Phil: I have to deal, process wise, what’s the contingency plan.  
 This woman with LFS described the struggle of anticipating bad news but 





making responsibilities. Many couples agreed that the process of experiencing cancer risk 
or being diagnosed with LFS tested their relationship but made them stronger as a family.  
  
Protective buffering. Partners often engaged in protective buffering behaviors to 
shield their spouse from stress related to cancer worries or prevention behaviors. This 
process of protective buffering was bi-directional, meaning that both partners used this 
tactic. Not only were the non-LFS partners (who can be considered equivalent to the 
caregivers in other studies) engaging in protective buffering; also, the people with LFS 
themselves were also frequently hiding their worries and fears, or avoiding talking about 
the disease out of consideration for their “healthy” partner.  
 
LFS partner protective buffering behaviors. LFS partners used multiple 
methods of behavior and communication to shield and isolate their partner from the 
effects of LFS. Many of the women with LFS expressed guilt and frequently said “he has 
it the worst” because their husbands might 1) serve as the caregiver for them and possibly 
their children and 2) outlive multiple family members. In some cases, LFS partners 
delayed making specific health decisions out of consideration for their partner’s 
circumstances. For example, Jessica and Andrew were in agreement that Jessica should 
get genetic testing to see if she had LFS. Andrew believed that they were on the same 
page and wanted it to happen right away, but he thought that Jessica was dragging her 
feet because she did not want to know the results. During the family interview, Jessica 






Jessica: I pulled back and I stopped talking about it because he was under a lot of 
stress. And he never asked me to. I probably could’ve moved forward with the 
study and said, “Okay, I’m ready to test.” But I was nervous, because I knew the 
next 6 months he was under a lot of stress at work, and I thought, “This might not 
be the right time.” 
Andrew reacted with surprise when Jessica told him that she had delayed her 
genetic testing because of his work stress. This was not the only couple to reveal 
protective buffering behaviors for the first time during the family interview. In this case, 
Jessica knew that there was a potential for additional stress to their lives if the genetic test 
revealed that she had the TP53 mutation. Most partners believed that the person at risk 
had the right to choose whether or not to complete genetic testing, and the timing of 
genetic testing became a topic of shared interest between partners because of the various 
implications that the results might have for their joint lives. 
After Jessica completed testing and found out that she had the TP53 mutation, the 
idea of having LFS was constantly at the forefront of her mind. She would sometimes 
share her thoughts and feelings with her husband Andrew, but she also wanted to give 
him space if his thoughts about LFS were not as frequent as hers. In this quote, she talked 
about how she held back from discussing her concerns with him: 
Jessica: When you first get your diagnosis, it’s on your mind 24/7. And you feel 
this weight and burden all the time. I would watch him watching a football game, 
and it’s on my mind, and I want to talk about it, but I would see, “Oh, he’s having 
a moment that’s LFS free. He’s getting to escape it for a minute, I don’t want to 
take that from him.” I’d be hesitant to interrupt, so sometimes where I’d just wait 





Jessica was simultaneously protecting her partner and giving him a reprieve from the 
reality of LFS even though she is in need of support. This type of break that Jessica 
provided Andrew was not a result of a request from Andrew, but was intended as an 
unspoken expression of her caring about him that meant sacrificing her own needs.   
Many couples had invested years of their relationship to cancer treatment, 
recovery from surgery, or cancer screening. Some of the LFS partners felt guilt for the 
time their partners spent caring for them or at hospital visits and tried to relieve their 
spouses from those health-specific responsibilities. Michelle has LFS, and together the 
couple has two children, both of whom have LFS. In the following example, Michelle 
discussed how involved Sam has been in her care:  
Michelle: Every one of [my chemo treatments], he’d be sitting there in a hard 
chair at the end, four hours later. I’m like “That’s really pathetic, honey. You 
don’t have to come.” “Yes I do. I want to be there.”  
Sam: But these appointments, I don’t- 
Michelle: These ones you don’t. I usually tell him no. Like I’ll deal with it. I don’t 
like him having to deal with it…I mean, it sucks. So, I don’t like him having to 
come to all of it. You know? I try and schedule the kids’ stuff. 
 Sam’s consistent company during Michelle’s chemotherapy treatments 
demonstrated his commitment to her and his involvement in her cancer treatment, even 
with her protests that he did not have to be with her. Since then, Michelle has taken over 
the scheduling of doctors’ appointments for herself and their two children, because she is 
trying to shield Sam from the experience. Sam agreed that it has been hard to participate 





Regarding the strain that Michelle feels around screening, Sam said, “I can see 
it’s stressing her, so I’m happy to take over a lot of it,” demonstrating that he’s willing to 
be a part of her cancer care and prevention.  
 
Non-LFS partner protective buffering behaviors. For some couples the non-
LFS partner felt the need to spare the other undue emotional pain to avoid increasing the 
fear or stress that their partner was experiencing. Further, non-LFS partners protected 
themselves from experiencing additional worry by minimizing open dialogue with their 
LFS spouses. For some, this strategy created barriers to communication and increased 
discord. One woman’s description of the interaction pattern outlined the harmful 
consequences of protective buffering within a couple that was dealing with the wife’s 
breast cancer. Her husband, Gilbert was holding back his emotional turmoil in an effort to 
shield his wife, but it ended up increasing isolation from each other.  
Gilbert: Some of the huge things, I always felt if I told her I was worried it would 
cause her to worry more. I thought, she had enough on her plate. I didn’t want to 
add to it. I couldn’t let myself do that. So I went into my box and just hid from her.  
Cordelia: A lot of his struggles that he was thinking and feeling, again because he 
didn’t want to burden me with them, he kind of hid them pretty well. So I wasn’t 
really aware of a lot of the things he was feeling…I thought to myself, “Well if I 
could have someone that I could cry with, that would make me feel so much better. 
So Gilbert, why can’t you do this?” I feel like that caused a lot of tension between 
us. So the distance kind of became even more.  
The couple discussed seeking psychotherapy, in which Gilbert learned how to tell 





he can “trust in her that when I talked about my fears it wasn’t gonna make her fears 
worse.” Cordelia still has some reservations about this new pattern of interaction because 
“I have LFS, the chance of me getting another cancer is kind of high. Is this gonna 
happen all over again?”  
Statements from the next couple, Adam and Eve, refer to hiding 
worries/news/cancer-related thoughts and concerns from one’s spouse or partner as a 
means to shield them from stress and pain.  
Eve: When you don’t want to talk about it and I want to is the only time it’s hard 
Adam: I probably don’t want to be sad (*laughter*) 
Eve: He is more positive, more of an optimist and I’m more of a realist and so 
you don’t like it when I’m realistic about things because he is more like, “You are 
never going to get cancer” (*laughter*) Or at least you say stuff like. “You don’t 
have to worry about it.” You don’t think so? 
Adam: Well she calls it optimism, and I think that she is just really negative 
sometimes.  
In this conversation, Eve called Adam the optimist and herself the realist in the 
relationship. This type of terminology was employed frequently by couples in the 
independent coping style category. Often these couples had discrepant perceptions of risk 
or were less cohesive in how they manage their worry about cancer. These patterns 
solidified over time and couples reported these patterns were hard to change. The 
different risk perceptions that couples held made it more challenging to discuss topics 
that involved cancer, because one person wanted to talk more about it as a way to prepare 
or gather information, and the other person wanted to minimize the risk. The protective 





compassion and sympathy for their partner’s position, but made (not always accurate) 
assumptions about what their partner needed. 
 
Male partner unique experiences. Gender differences played a role in the 
findings. Many male partners of females with LFS described wanting to act but feeling 
helpless when there was no way for them to support or provide tangible assistance to 
their partners. For example, Gilbert described how he was feeling during his wife’s breast 
cancer, “I felt guilty asking for help, didn’t even talk to anybody about it, because 
nothing was wrong with me.” The experience of being interviewed about these issues 
often provoked strong emotional reactions, especially for these men, who focused their 
attention heavily on their spouse as the person suffering and in need of support.  
 
Discussion 
This qualitative study highlights the ongoing and understudied challenges faced 
by couples dealing with LFS. In the review of 26 interview transcripts, the overall 
conclusion was that spouses of individuals with LFS were considerably engaged and 
knowledgeable in the care and decision making-processes with their partner. Additionally, 
couples were mostly cohesive in their relationships regarding health care, family planning, 
and parenting goals. Through focused coding, we developed themes and identified 
specific processes that were only relevant to the couples’ relationship and coping styles. 
The 26 couples all identified ways in which LFS has affected their lives and their 
relationship. Many couples reported that the process of experiencing cancer risk or being 
diagnosed with LFS was a test of their relationship and made them stronger as a family. 





effects of protective buffering. The partners mirrored the negative emotions previously 
described by people with LFS in other studies, in which there exists an ongoing elevated 
degree of cancer worry that affects their daily functioning (Lammens, 2010). Participants 
frequently discussed their anxiety regarding potential cancer diagnoses, using language 
that resembled a perception of “looming vulnerability” in which the danger of cancer was 
dynamic and multidimensional (Riskind, 2005).  
 
Protective Buffering  
Literature on cancer patients and their caregivers suggests that spouses often hide 
their concern and emotional distress from the partner with cancer. This is an attempt to 
cover up their own distress to help the person with the illness, but it can be associated 
with lower relationship satisfaction in patients (Hagedoorn, Kiujer, et al. 2000; Langer, 
2010; Langer, Brown, & Syrjala, 2009). The research has shown that it is commonly the 
spouse in the caregiving role who is more often engaging in protective buffering 
behaviors. In the present study, we found the opposite. In this study, protective buffering 
occurred more strikingly on the part of the individual with LFS. These partners often 
wanted to shield their families from their own stress about getting cancer or wanted their 
spouses to be free from having to constantly support them. Similar to the findings from 
Lammens (2011) study of partners of people with LFS and Von Hippel-Lindau (VHL) 
disease, this study found that the non-LFS partner experienced a moderate amount of 
LFS-related stress. This was rarely discussed between the partners at home, but during 
the interviews many of the male partners of women with LFS expressed grief and sadness 
about past cancer hardships and the possibility of future cancers. Many of the women in 





the spouse that will most likely outlive them and potentially their children if the offspring 
also develop cancer. Men, though, used protective buffering to hide their feelings of 
inadequacy and frustration for not being able to take action and do something to fix the 
situation.  
 
Resilience in Couples Coping with LFS  
The family resilience framework outlines processes regarding how families can 
dynamically adapt and cope with adversity (Walsh, 2012), and the findings of this paper 
support the hypothesis that families living with LFS can cultivate resilience in multiple 
ways, the first of which is to focus on “living with” LFS, rather than focusing on “getting 
past” a particular event. In addition, by addressing ambiguous information such as cancer 
risk through open communication and consistent messages, couples made meaning of 
their situation and developed a shared sense of purpose. Additionally, couples coped with 
the stress of screening by staying connected and using open emotional expression such as 
sharing painful feelings, empathizing, and using humor.  
Strength and resilience among these couples derives from their ability to develop 
long-term dyadic strategies for managing LFS and its ongoing logistical hardships and 
emotional stresses. The sharing of this burden helped couples cope with the disease. 
Members of the couples in this sample elaborated on what it meant to be a supportive 
spouse and provided some concrete examples of how the partners balance the burden 
between the two of them. The flexibility of roles in the ongoing, life-long experience of 
living with LFS is the main strength of these families. There are times when one partner 





person can sometimes internally shut off their own distressed thoughts and emotions out 
of protection and love for their partner.  
The couples’ flexibility in roles and identities in relation to health was mirrored in 
their language and the pronouns that they used to describe their experiences. The use of 
“We” versus “I” language in their process of coping from a relational perspective has 
been explored in previous cancer literature (Kayser, Watson, & Andrade, 2007). When 
couples coping with cancer viewed the cancer as a dyadic stressor or a “we-stress”, they 
were of the philosophy that they were in it together, and they talked more openly about 
the cancer. In the current study, the greater use of “we” by non-LFS spouses often 
indicated a higher level of involvement in care.  
This study did not explore the broader sense of “we-ness” for these couples that 
existed in the context of their extended family or other family members who have LFS. 
Future research can expand this definition of “we” by looking at the larger family system 
and identifying when the non-LFS partner may feel like an “outsider” because he or she 
does not have LFS, and how this influences the couple’s relationship.  
 
Implications for Practice 
Living with LFS is a challenging, ongoing, and shifting process for families, and 
mental health practitioners in psychosocial oncology must be aware of the evolving and 
transforming coping styles that couples employ. To contribute to family well-being, 
clinicians should support partners’ mutual disclosure of distress as one means to facilitate 
shared coping over time. For example, when couples are engaging in protective buffering 
as a means of coping, clinicians can identify these behavioral patterns, draw the couple’s 





these behaviors. It may be helpful for the clinician and couple to understand how 
protective buffering is related to the emotional distress of one or both partners and what 
types of emotion regulation strategies may help them “live with” the distress. This 
practice can prevent couple conflict that might arise when an individual’s protective 
buffering efforts backfire due to incorrect assumptions he or she has made about the 
partner’s needs.  
Additionally, facilitated conversation between couples was deemed “healing”, 
“helpful”, “insightful”, and “revealing” by participants and provided further evidence for 
a systemic approach to handling this unique syndrome and the intense cancer screening 
that people choose to engage in to catch cancer early. Communication and relationship 
training or coaching can be integrated into systems of care, especially when families first 
find out about LFS or when they are diagnosed with cancer. Clinicians can pay attention 
and utilize language that mirrors the pronouns that patients use when referring to 
themselves or their families, and employ more “we” or “you both” to include both 
partners linguistically. The skills and management strategies offered by medical family 
therapists, a less well-recognized but invaluable set of resources, can supplement the 
services available through genetic counselors, nurse practitioners, and appropriately-
trained physicians.   
 
Study Strengths and Limitations 
 Findings from some prior studies have provided descriptions of the perspective of 
individuals with LFS, but rarely have the voices of their partners, who are also living 
through the experience, been revealed. The present dataset represents the richest and 





family interview was the timing; for many participants, the family interview was the last 
activity on their schedule, and they were processing a lot of the information that they had 
received from other clinicians on the team. They had begun to think about next steps and 
beginning to face going home to either think about prophylactic surgery or returning to 
normal life until they heard the results of their screening. This primed the couples to have 
thoughts about the effects of LFS on their individual and shared lives at the forefront of 
their minds when the qualitative interviewer asked the prompting questions.  
The procedures used in obtaining the sample for this study clearly had effects on 
the characteristics of the participants who were included. For couples to participate in the 
family interview, the spouse of an individual with LFS must have gone through rigorous 
consent and assessment procedures, leading to a self-selected sample. Spouses that 
attended clinic may have been more highly involved in LFS related care or more 
supportive than spouses who did not come to clinic. In addition, a disproportionate 
number of couples included a female partner with LFS; in only four couples did the male 
partner have LFS. Additionally, the sample was almost entirely White, well-educated, 
and had a high level of socio-economic status. These both reflect limitations within the 
larger LFS Screening Study. There are more female participants enrolled, and female 
participants are more likely to attend their annual clinic visits with family members than 
are male participants. Although the exact prevalence of LFS across racial and ethnic 
groups in the United States is unknown, it is assumed to be equal across ancestral groups 
and not predominantly found in White families. Therefore, future research must engage a 
more diverse group of participants to better characterize the experiences of couples who 
identify with other ethnic or racial groups and are more representative of the 





the resources available to them based on their socioeconomic status, whether they have 
children, how many of the children or other family members have LFS, and how many 
cancer diagnoses they have experienced.  
Another factor that may have influenced the data is that there were three different 
interviewers who worked with couples. Five interviews were conducted by the first 
interviewer, one was conducted by a second interviewer, and the first author conducted 
the following 20 interviews. Different interviewers may have slightly different styles of 
interacting with participants, and with a semi-structured interview script there is freedom 
to ask follow-up questions, of which many might have varied across interviewers. Thus, 
interviewers’ own prior knowledge and assumptions regarding LFS and effects of cancer 
on families may have influenced the line of questioning and the topics that members of 
the couples discussed. The assumptions and potential biases of interviewers and coders 
were addressed through regular clinical and research supervision, collaboration in an 
interdisciplinary team, and guidance of a seasoned qualitative mentor. These methods 
were utilized to maintain objectivity and maximize credibility.  
 
Conclusion 
 Partners often made health care decisions together, with shared goals for ongoing 
health and wellbeing. Yet, with inherited, highly penetrant cancer syndromes this is not 
always the case, since high disease burden, limited screening utility, and ongoing distress 
changed the styles in which couples cope with each aspect of the disease. The findings 
from this study strengthen the argument for additional mental health supports for partners 
of individuals with LFS, and for specific attention to couple relationship dynamics. 





issues that may be interfering with a couples’ ability to cope well together. Subsequent 
appropriate referrals for couples therapy can be made for families that are struggling and 
need additional skills and support. Additional research is needed to establish the best 
assessments for family mental health and coping strengths for this population, as well as 
targeted mental health and family systems interventions, including psychoeducation, 








Table 9. Demographic Characteristics of the Sample 
Sample Characteristics Female (n = 26) Male (n = 26) 
Average age (years) 40 43 
Age range 22-57 23-72 
TP53-mutation-positive 21 4 
Highest education achieved  
(missing data from 8 couples) 
High school diploma 0 1 
Vocational/trade school 1 3 
Some college 1 2 
Bachelor’s degree 9 4 
Some graduate school 1 3 
Masters or doctoral degree 6 5 
Total household annual income  
(missing data from 8 couples) 
$10,000 to $19,999 1 0 
$30,000 to $39,999 0 2 
$40,000 to $49,999 1 1 
$50,000 to $69,999 4 2 
$70,000 to $99,999 3 4 
$100,000 or above 9 9 
Race/Ethnicity 
White 26 26 
Hispanic/Latino 1 1 
Religion  
(missing data from 7 couples) 
Catholic 3 3 
Protestant 7 4 
Jewish 2 2 
LDS/Mormon 3 3 
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CHAPTER 5: STUDY 3 
Embedded Social Networks of Couples Coping with Li-Fraumeni Syndrome 
 
Introduction  
The evolution of cancer genetics has shifted medical practice and research from 
an individual-focused stance to a more family-focused perspective. Cancer in a family 
member affects multiple people close to them psychologically, emotionally, and 
concretely (H. Badr & Krebs, 2013). Although not connected genetically, couples are the 
core dyadic relationship in family systems, and partners of people with cancer are often 
the main support person and caregiver for the one with cancer (Hagedoorn, 2011). 
Although couple relationship research points to romantic partners as each other’s primary 
secure attachment and support person, couples often reach out to others (extended family, 
family of origin, friends, social groups, co-workers) for additional support. These 
extended networks have multiple roles in the couples’ lives, at times providing hands-on, 
tangible support, and at other times providing emotional connection and empathy. These 
networks can be especially important sources of resources as members of a couple strive 
to cope with cancer. 
Li-Fraumeni Syndrome (LFS) is a hereditary syndrome with a high lifetime risk 
of cancer. LFS is mostly caused by germline TP53 mutations and follows and autosomal 
dominant pattern of inheritance (Malkin et al., 1990). Individuals with LFS have a 90% 
lifetime risk of developing cancer and a 50% chance of a second, independent primary 
cancer. The most prevalent LFS tumors are early-onset breast cancer, sarcomas, leukemia, 
adrenal carcinomas, and brain cancer (Mai et al., 2016). Onset of cancer risk is in 





compared with adult-onset inherited cancer syndromes. Couples in which one partner has 
LFS must confront the likelihood of future cancer diagnoses and potential early cancer 
mortality. The only preventive option for LFS patients is prophylactic mastectomy to 
reduce the risk of breast cancer.  To detect expression of the disease at an early stage, 
regular surveillance is recommended.  
Hereditary cancer syndromes, and specifically LFS, are family matters that not 
only pose a considerable threat to the well-being of high-risk family members but also to 
the partners (Lammens et al., 2011). Partners are confronted not just with the cancer 
susceptibility of their spouse but also with the possibility of their children or future 
children may also be at increased risk of cancer (Metcalfe et al., 2002; Mireskandari et al., 
2006). This can lead to life-changing decisions (i.e., family planning) and in the cases 
where cancer does occur, a significant amount of caregiving responsibility being placed 
on other family members. The worry regarding future cancers may have an effect on the 
psychosocial distress of the both partners, especially because the timing of a diagnosis is 
so difficult to predict, and families must develop methods for coping and constant health 
preparation.  
 
Social Support, Integration, Social Networks and Health 
 Intimate relationships and communities play important roles in shaping health 
outcomes in the general population (Berkman, 2000). Berkman and colleagues proposed 
that social networks shape individual health and health behaviors primarily through (1) 
social support (e.g., sharing resources such as information, funds, and emotional support) 
that foster individuals’ positive health behaviors; (2) social influence on individuals’ 





norms); (3) social participation and engagement (e.g., the individual’s choices to engage 
in healthy or unhealthy activities and connecting with friends); (4) person-to-person 
contact (e.g., exposure to disease); and (5) access to material resources and goods (e.g., 
healthcare, housing). However, despite evidence for the important influences of social 
networks on individuals’ health, there have been limited social network analyses in health 
research, especially for cancer cases.  
A few studies have established the power of emotional support in intimate 
relationships, finding that lack of emotional support is associated with worse mortality 
and health outcomes for people who have experienced cancer (Sarma et al., 2018), heart 
attacks, and stroke (Fiorillo & Sabatini, 2011). Similarly, smaller social networks and 
social isolation have also been associated with higher mortality risks in several health 
conditions (Ikeda & Kawachi, 2011). Some researchers have concluded that when 
individuals are socially isolated, they are less able to buffer the impact of health stressors 
and are at greater risk of negative health outcomes (Smith & Christakis, 2008). 
The specific mechanisms that underlie the relationship between social network 
size and health have been explored in several studies of healthy and ill participants. One 
study found that individuals with larger support networks considered potential stressors 
to be less threatening, which led to a reduced level of stress symptoms and a better 
subjective health condition (Fiorillo & Sabatini, 2011). These findings indicated that 
individuals with larger trust and support networks considered potential stressors to be less 
threatening, which leads to a reduced level of stress symptoms and a better subjective 
health condition. This has important implications for the perception of cancer risk for 
families coping with LFS, in that individuals with larger support networks may be less 





 In the field of hereditary cancers, social network members have been found to 
play an important role in providing social resources and promoting health behaviors. In 
particular, one study of families with Lynch Syndrome found that older adults (over age 
60) were more likely to be nominated as providing instrumental support, emotional 
support, help in a crisis situation, and dependability when needed (Ashida et al., 2011). 
Older family members were also more likely than younger family members to be 
described as encouragers of colon cancer screening.  
Social support is believed to contribute to reducing the perception of new 
incidents as stressful and the avoidance of stressful events, as well as improving the 
ability to cope with events and their consequences. For example, one study of sisters in 
hereditary breast and ovarian cancer families found that social integration, or the size of a 
person’s emotional support network, was negatively associated with anxiety (Koehly et 
al., 2008). The impact of social support appeared to have both a psychological and 
practical function. Psychologically, the presence of a strong social support network can 
change the way that people appraise a stressor/health issue by making a health problem 
feel more manageable when a person is surrounded by emotional supports that build up 
their self efficacy and self-esteem. Practically, structural and tangible support can buffer 
the impact of a health issue on a person’s life by spreading the burden of care across 
multiple people (Åslund, Larm, Starrin, & Nilsson, 2014; Friedman & King, 1994; 
Roohafza et al., 2014). Looking beyond the ill person, social support has also been shown 
to buffer negative impacts of psychological distress among caregivers of people with 
cancer (Pinquart & Sorensen, 2007).  
 Resource transfer through personal networks may be most important in 





that families with LFS engage in intensive cancer screening to diagnose cancers early, 
when they might be easier to treat. Current cancer risk management guidelines for 
individuals with LFS from the National Comprehensive Cancer Network (NCCN) 
include yearly physical examinations with blood tests, dermatologic exams, and brain 
magnetic resonance imaging (MRI) of body and brain. Colonoscopies are also 
recommended every 2-5 years starting at age 25. Additional recommendations are based 
on the family history of type and age at onset of cancers. Women also have additional 
breast cancer screening, which includes annual breast MRIs starting at age 20. These 
exams require frequent visits to the doctor, and when a cancer is diagnosed or a person is 
undergoing treatment, they require a large amount emotional and tangible support.  
 
Couple Coping Using Dual Ego-Centric Social Networks 
Couples do not exist in isolation, but rather they are embedded in social networks. 
The members of a couple may share common network members, and over time they may 
increasingly invest in each other’s extended friend and family networks (Felmlee, 2001).  
Although individuals’ friendship networks become smaller over the life course, when 
couples move in together, their shared friendships and joint contacts grow and become 
more strongly related (Kalmijn, 2003). These shared networks can provide resources to 
the couple or can drain resources away when members of the network need assistance 
from the couple (Bryant & Conger, 1999). 
Couples engage in dynamic coping processes when faced with an initial 
threatening event such as learning about Li-Fraumeni Syndrome status through genetic 
testing. This is a stressful process that includes experiencing cognitive, physiological, and 





using their available resources. When faced with a shared health threat (i.e., cancer risk), 
family members may cooperate using a reciprocal exchange of support from each other 
or may use commonly shared support resources. Research is needed to explore how 
families employ interactive support processes to cope with a shared threat. 
Prior studies of social support in couple relationships have not actually collected 
social network data, and instead rely on global assessments of network characteristics, 
such as a static social support metric that asks individual how much support they are 
receiving in general from categories of people (not specific individuals). These 
assessments are generally not customized to couples and do not allow for the 
classification of overlapping networks between partners. Also, studies that have explored 
the intersection of partners’ social networks have relied on reports from only one member 
of the couple, which likely are biased and do not adequately capture the perspectives of 
both partners (Cornwell & Waite, 2012).   
To test existing theories of how social networks affect a couple’s functioning 
requires assessing and examining the properties of the partners’ “dual ego-centric social 
networks”, which are the combined network of relationships that surround a couple 
(Kennedy, Jackson, Green, Bradbury, & Karney, 2015). A couple’s network includes 
members who either have shared ties with both partners of the dyad or ties that are 
primarily linked to one partner and not the other. Collecting data about such ties from 
both partners can minimize the amount of missing or inaccurate network information. In 
addition, an assessment of duo ego-centric couple networks is developed using data 
gathered from both individuals, but the aggregated result may reveal features that lie 





Previous literature on social support in LFS families is scarce and has focused on 
describing the individual-level support networks of people with LFS (Peters et al., 2016). 
However, an assessment that provides a full view of the interdependent nature of coping 
with cancer or the risk of cancer requires methods that can capture and characterize the 
connections among those multiple individuals who are coping together. Thus, the present 
paper used social network analysis of the dual ego-centric networks of individuals with 
LFS and their spouses. The social network approach provides a framework for 
quantifying and visualizing these interpersonal relationship patterns and their effect on 
the couple’s behavior.  
Social Network Analysis 
 The history of social network analysis is rooted in social theory, empirical 
research, and formal mathematics and statistics. The social network perspective defines 
relationships by the interactions and linkages among units. Using a social network 
framework, a social environment can be expressed as patterns or regularities in 
relationships among interacting units (Kennedy et al., 2015). These regular patterns in 
relationships are called structure. Some of the underlying assumptions of the social 
network perspective relevant to the present study are: 1) actors and their actions are 
viewed as interdependent rather than independent, and 2) relational ties between actors 
are channels for the flow of resources (material or nonmaterial) (Wasserman & Faust, 
1994). Social network analysis employs statistical analyses and visual diagrams to map 
relationships, resource exchanges, and interactions; i.e., patterns of social connections.  
 Social network analysis may be used for hypothesis development and 
phenomenological description, as well as hypothesis testing. The processes of model 





qualitative or count data and creating visual representations of a network (which includes 
multiple people and the ties between them). From there, researchers make observations 
about the relational counts or visualizations (ie. identifying patterns regarding size and 
configurations of social networks) and move on to model specification and testing using 
quantitative methods. Network models may also be used to test theories about relational 
processes or communication patterns. Such theories posit specific outcomes such as 
health behaviors or health outcomes, which may then be evaluated against observed 
network data regarding communicated health risks.  
In this study, we explored two specific aspects of LFS couples’ social networks: 
shared supports and reciprocal support. Shared supports are defined as a ratio of how 
many people both partners nominated as providing support, over the number of total 
people that the couple nominated as providing support. Reciprocal support is defined as 
the level of exchanges of support between partners, and the four levels ranging from no 
reciprocity to full reciprocity (mutuality) are illustrated in Figure 11. These two aspects 
of LFS couples’ social networks were analyzed in conjunction with cancer occurrences 
and three psychosocial symptoms: depression, anxiety, and somatization. Specifically, we 
explored how couples communally coped with cancer using reciprocal support and their 
shared social networks.  
 
Objectives 
This study used social network methodologies to quantify social support across 
married spouses, one of which is at high risk of cancer, and its relation to each partner’s 
psychological distress in the context of cancer risk. These methods captured the degree of 





resource constructs. After exploratory consultation between three psychosocial 
researchers on the results of couples’ “dual ego-centric networks,” four main hypotheses 
were developed. Specifically, we investigated whether individual social integration, 
partners’ shared supports, or reciprocal spousal support enhance psychological adaptation 
in couples living with LFS.  
 Below are the specific hypotheses that we tested: 
1) The number of cancers reported by the partner with LFS will be associated 
with higher psychological distress symptoms for both partners. 
2) The number of cancers reported by the partner with LFS will be associated 
with larger dual ego-centric support networks. 
3) The percent of shared support that couples report will predict individual 
psychological distress symptoms, with more shared support predicting fewer 
symptoms.  
4) The typology of the dyad (mutual, asymmetric, or null, see Fig. 11) will 
predict differences in psychological distress symptoms between partners, with 
mutually supportive couples reporting smaller differences in BSI scores as 




The present sample included 20 heterosexual couples from families with a known 
deleterious TP53p53 mutation. The twenty partners with LFS were selected from a larger 
pool of 146 individual participants with LFS in an IRB-approved National Cancer 





methods. All of the 40 participants were non-Hispanic Caucasian, and their ages ranged 
from 27 to 71, with a mean age of 41. Sample characteristics are presented in Table 11. 
The sample was well educated; 75% of participants had at least a college degree. The 
sample was also wealthy, with almost 60% of participants reporting over $70,000 as their 
annual household income. All of the couples have at least one child, with the median 
number of children being 2. Fifteen of the LFS partners reported at least one cancer in the 
past (the highest was five cancers), and two of the non-LFS partners had a cancer 
previously. None of the participants had an active cancer at the time of data collection 
(one of the requirements to enroll in the study). This group of 20 LFS participants and 
their partners was representative of the larger screening cohort. 
Procedures 
The Li-Fraumeni Screening Study is an ongoing cohort study of families with 
LFS that were recruited between 2010 and 2017. Couples for this study were selected if 
one partner had undergone genetic testing and received a diagnosis of LFS, and their 
spouse also enrolled in the study. Participants of the study come to the Warren G. 
Magnusen Clinical Center of the National Institutes of Health once annually to 
participant in rigorous cancer screening that includes full-body, brain, and breast MRI. 
Participants are allowed to bring one support person to the screening, and if the spouse 
chose to enroll in the study they were considered for this analysis. A clinician obtained 
informed consent and conducted a medical history and physical examination. During this 
visit, participants completed questions regarding their psychological distress as well as 





Figure 9. Illustrative Colored Eco-Genetic Relationships Map (CEGRM) 
 
The CEGRM (see Figure 8) is a visual research tool to assess social interactions 
and support exchanges between family members and friends of participants (Kenen & 
Peters, 2001). An investigator administered a 20 to 30-minute semi-structured interview 
using a genetic pedigree4 as a template; a copy of the interview protocol can be found in 
Appendix F. Participants were asked to list the first names of family members, friends, 
and groups with whom they feel close and who were not on the pedigree. In the next step, 
participants operationalized social support resources by placing stickers onto the pedigree 
next to the relevant individuals whom they felt provided those support resources. The 
types of social supports provided by family and friends to participants included 
exchanges such as LFS information, tangible aid, spiritual support, and emotional support. 
The finished CEGRMs were scanned into digital images and social exchange data were 
                                                 





coded into databases for subsequent social network analyses. All digital images and data 
files were stored on secure servers at the National Institutes of Health. Data files 
containing CEGRM sticker counts and demographic information were all de-identified 
using participant ID numbers, and these numbers also served to match spousal pairs. 
Audio files and investigators’ hand-written comments on the CEGRM scripts were used 
to clarify unclear sticker placement.  
The first (baseline) CEGRM interviews that participants completed were selected 
for analysis because it was the first time that participants completed this activity, and 
those interviews cover their social networks up to that point; therefore, they have the 
richest relational data. Subsequent CEGRMs are focused on an annual update of the 
information collected from the baseline interview. There were four couples in which 
baseline CEGRMs from the two partners were completed one or two years apart. This 
often arises from a situation in which the non-LFS spouse was either not enrolled in the 
study or not present at the LFS spouse’s first screening visit. Often, non-LFS spouses 
(who are not undergoing the intense LFS full body screening) will enroll as participants 
at a later point in the study and will complete their consent forms, baseline paper work, 
and baseline CEGRM at the LFS-partner’s second or third visit.  
 
Measures 
Demographic data included age, race/ethnicity, education, income, number of children, 
and cancer history. Demographic information was collected at baseline, before beginning 
the screening study, through a paper-pencil Individual Information Questionnaire (IIQ). 
There were four couples missing IIQ data due to non-LFS partner enrolling later in the 





Psychological distress was measured using the Brief Symptom Inventory (BSI-18), 
which was administered at each visit to the Clinical Center immediately preceding any 
evaluations. The BSI-18 is a psychometrically validated self-report instrument that is 
used to measure psychological distress within the past 7 days in three domains: 
depression, anxiety, and somatization (Derogatis, 2001). Normative T-scores derived 
from general population norms were computed for each BSI-18 subscale. For a copy of 
the BSI-18 with instructions and questions, please see Appendix A. For the visualizations, 
BSI global and subscale scores were calculated into quartiles, with lighter colors 
representing lower BSI scores (yellow, orange) and darker color representing higher BSI 
scores (red, purple). The cut-off scores can be found in Table 12. Additionally, we 
calculated the difference in scores between partners for each BSI subscale. Because this 
study did not directly measure qualities of the couple relationship, discrepancies in 
distress scores between partners were utilized as a dyad-level variable that provides 
information about the relationship. Previous studies have shown that smaller differences 
in psychological distress between partners were related to higher marital satisfaction and 
more similarity in health behaviors (Lewis et al., 2006; Manne et al., 2004). 
 
Data Analysis 
Descriptive statistics were used to describe participants’ psychosocial features and 
their social support networks’ structural characteristics. There were no missing BSI or 
CEGRM data, but four couples had incomplete demographic information. Visualizations 
of the social networks were obtained using R software (RCoreTeam, 2014), and the 





dyadic network data, were also conducted in R packages sna (Butts, 2016) and lme4 
(Bates, Maechler, Bolker, & Walker, 2015). 
The first step of the analysis was to create visual representations or “Dual Ego-
Centric Networks” of the CEGRM and BSI data for dyad pairs. The term “Ego” here 
refers to the participant who was completing the CEGRM, and the combination of data 
from related spouses including is called a “Dual Ego-Centric Network.” The grey circles 
to which the arrows are pointing to comprise the “Alters”, which refers to the people that 
the “Egos” nominated as a person within their social network. The two circles with 
colored centers represent the two members of the couple. Colored circles encircled by a 
bold line represent the partner with LFS. The colors in the center of these circles indicate 
the BSI global and subscale scores of the participant (see Table 12). The arrows pointing 
outward indicate a friend or relation that the participant nominated as providing a specific 
type of support. Grey arrows mean that this friend or relation was not nominated for that 
type of support. Thickness of the arrow line indicates degree of relation, with thicker 
lines indicating first-degree relation and thinner lines indicating second degree or 
friendship. Please see Appendix G for the full list of visualizations by family.  
Figure 10. Example of Dual Ego-Centered Networks 
        





Visualizations of dual ego-centered networks can provide insight for developing 
hypotheses and interpreting results (Kennedy et al., 2015). Three psychosocial 
researchers met to review the visualizations and describe observed patterns of social 
support (see Appendix H for comparisons of Dual Ego-Centered Networks). All of the 
researchers had experience working with family-level data, and two were experts in 
social network analysis. Observations of the visualizations were recorded and formed into 
hypotheses to be tested statistically.  
Social integration and communal coping characteristics were derived from the 
CEGRM process described above. We considered three structural types of social 
exchanges. The first, reciprocity, is a family-level variable that indicates whether or not 
spouses selected each other as providing a given type of support. In this study we 
categorized each couple according to three types of dyadic reciprocity: full, asymmetric, 
or null (see Figure 11). Full reciprocity, also called Mutuality, indicates that both spouses 
selected each other as people who provide a specific type of support. Asymmetrical 
reciprocity indicates that only one spouse nominated their partner as providing a type of 
support. Null reciprocity indicates that neither spouse selected the other as providing one 





Figure 11. Four Types of Dyadic Reciprocity 
 
The second type of social exchange considered in this study was social integration, an 
ego/individual-level variable that measured the size of a participant’s social support 
networks (the number of people providing each type of support). Lastly, this study 
measured shared supports between partners, which is a dyad-level variable that indicates 
the number of persons providing support to both partners. This variable was count based, 
and was also transformed to a percentage that represented how many people were 
nominated by both partners as providing the same type of support (numerator) over the 
total number of people nominated by each partner for that type of support (denominator). 
Shared support denominators were conditional on all the people that were nominated by 
either partner. 
Once the social network variables were calculated, we employed Welch’s t-tests 
to examine group differences on BSI global and subscale scores, and individual ego-
centric social network sizes for the four types of support. Correlations were employed to 
establish any associations between number of cancers the LFS partners reported and the 





and at the individual level, we used generalized linear mixed models clustered on the 
dyad to account for dependence between partners. For models in which the outcome 
variable was at the dyad level, we used regressions appropriate for the distribution of the 
outcome variable (Bates et al., 2015).  
Regression analyses addressed three main hypotheses. First, we expected that 
mutual dyadic support for each of four support types (emotional support, health 
information exchange, tangible support, and spiritual support) would predict smaller 
differences between partners in overall BSI scores as well as on each BSI subscale 
(anxiety, depression, and somatization). We tested this hypothesis using a series of 
Poisson regressions (to approximate the half-normal distribution) in which couple 
mutuality predicted the absolute value of the difference in partners’ scores on the general 
BSI and subscales.  
Second, we hypothesized that individuals embedded in couples who exchanged 
mutual support would have lower scores on the general BSI as well as on the subscales. 
We used a series of generalized linear mixed models clustered on the dyad to test whether 
mutual support at the dyad level predicted individual BSI scores. Third, we hypothesized 
that the amount of overlap in supports (that is, the proportion of people who were named 
by both partners as providing a particular type of support out of the total set of 
individuals who provided that type of support to either partner) would predict lower 








On average, study participants did not appear to be psychologically distressed 
when compared with general population norms (Table 13). Only two participants, one 
female with LFS and one male without LFS (not related to one another), had clinically 
significant levels of distress based on BSI norms (Global BSI score ≥ 63). Using two-
tailed independent t-tests, there were no significant differences between the BSI scores 
across genders (i.e., men with LFS vs without LFS) or within LFS groups (women with 
LFS vs men with LFS) on the BSI global and subscale scores.  
 
LFS Cancers and Psychological Distress 
We found trends suggesting that the number of cancers that the partner with LFS 
reported was negatively correlated with their depression score (r (18) = -.40, p = .07), but 
not with their partner’s depression score (r (18) = .06, p = .82). Similarly, there was a 
trend pointing for the number of cancers a person with LFS had to be negatively 
correlated with their anxiety score (r (18) = -.42, p = .07) but this trend was not found for 
their partner’s anxiety score (r (18) = -.26, p = .27). Unexpectedly, these trends provide 
some evidence that partners with LFS who have had more cancers tend to have less 
depressive and anxiety symptoms.  
Correlational analysis revealed no significant relationship between the LFS 
partner’s number of cancers and either their own somatization symptoms (r (18) = .24, p 
= .32) or the non-LFS partner’s somatization symptoms (r (18) = -.21, p = .37). 
Correlational analysis also revealed no significant relationship between the LFS partner’s 





non-LFS partner’s global distress symptoms (r (18) = -.27, p = .37). These results only 
did not support our hypothesis that the number of cancers reported by the partner with 
LFS will be associated with higher BSI scores for both partners. Future analysis will aim 
to increase the sample size, which may strengthen the correlations, but if the negative 
correlations are maintained, this would counter our hypothesis. 
 
Social Network Size 
 Participants discussed LFS with more members of their support network than the 
number from whom they received tangible assistance or emotional support (Table 14). 
There were four couples in which both partners nominated zero people for spiritual 
exchanges and four couples in which only one partner nominated people as providing 
spiritual exchanges.  
 Using independent t-tests, we assessed for group mean differences (men with LFS 
vs. men without LFS, women with LFS vs. women without LFS, men vs. women with 
LFS, men vs. women without LFS) in conditional social network size for the four types 
of support. Although it appears that there may be some patterns related to how males 
cope with risk (LFS males’ support networks appear larger than non-LFS males), we did 
not find any significant difference between. In addition, there were no other significant 






Figure 12. Social Integration by Group 
 
 
Shared Social Networks 
On average, couples had health information exchanges with 20 people, and 19% 
of those people were shared supports between the two partners (see Table 15). This 
indicated that out of the total number of people who were nominated by either partner as 
providing health information to either partner, around 19% were the same person for both 
partners. Sixty-five percent of couples also both nominated each other as providing health 
information.  
Tangible assistance was provided to couples by an average of 16 people, of which 
17% (about 3 people) were nominated as providing that support to both partners. Only 7 
out of the 20 couples indicated mutual tangible assistance, lower than any other category 





Members of couples were very emotionally supportive with each other, with 17 of 
the 20 couples providing reciprocal emotional support, but couples only had an overlap of 
8% in their emotional support networks. These results indicate that partners received 
extensive emotional support from each other, but that they each relied on unique friends 
and family to provide additional emotional support. 
When analyzing spiritual support, the four couples who indicated that they had no 
people with whom they had spiritual exchanges were removed from the group. Of the 16 
remaining couples, 10 couples provided full reciprocal spiritual support, and had 11% 
overlap in their shared social network.  
 
LFS Cancers and Dual Ego-Centric Social Network Size 
 We tested the correlation between the number of cancers that the partner with 
LFS had and the size of the couple’s dual ego-centric support networks. Correlational 
analysis indicated trends that showed the number of LFS cancers was negatively 
associated with the size of the couple’s emotional support network (r (18) = -.40, p = .08) 
and tangible support network (r (18) = -.41, p = .07), but not the couple’s informational 
exchange network (r (18) = -.77, p = .45) or their spiritual network (r (18) = -.07, p = .76).  
These results do not support the hypothesis that the number of cancers reported by 
the partner with LFS will be associated with larger dual ego-centric support networks. 
The trends in the findings suggest that the opposite may be true, that couples who have 
experienced more LFS cancers have fewer people that they rely on for emotional and 







Shared Support and Psychological Distress 
 Linear models were run to determine whether there was a significant relationship 
between percent shared supports and the BSI scores of participants. None of these models 
revealed significant results, indicating that the amount of shared support between partners 
was not related to psychological distress of individuals in our sample. These results do 
not support the hypothesis that more shared supports would be associated with less 
psychological distress. Possibly due to power issues, we did not find a relationship 
between percent shared support and individuals’ psychological distress. 
 
Reciprocity and Difference in Psychological Distress 
Poisson regression models were employed to test whether couple mutuality in 
support was related to the difference in BSI scores between partners (see Table 17). 
Asymmetric and null ties pooled together as the reference group and mutuality was the 
predictor. The results showed that if couples reported mutuality on tangible, emotional 
and spiritual support, their differences on BSI global, somatization, and depression scores 
were significantly smaller (see Table 17). When couples reported mutuality on health 
information exchange and emotional support, their difference on anxiety symptoms was 
significantly smaller. Thus, these results generally support the hypothesis that mutuality 
would be associated with smaller difference in psychological distress between partners.  
 
Discussion 
This social network analysis represents a novel method for understanding the 
interplay between the social support networks that surround couples and the 





provided crucial care to families that were at high-risk of cancer, but previously they 
often have been difficult to assess in studies. Mapping these social support networks is 
important for understanding how families cope with the possibility of multiple cancers.  
These findings are consistent with research that has indicated that a minority of 
individuals with LFS and their partners experienced heightened levels of psychological 
distress (Lammens. 2011; Peters, 2016). Our correlational trends suggested that partners 
with LFS who have had more cancers tended to have less depressive and anxiety 
symptoms. This may indicate that with each cancer people with LFS were adjusting 
better and developing less psychological distress. This is in line with resilience theory 
that has been supported in the population in the other studies in this dissertation. It is also 
possible that this effect is not linear; for example, there may be a large increase in 
psychological distress symptoms after the first cancer diagnosis, and subsequently 
smaller decreases in distress for each subsequent diagnosis. The LFS screening study is 
collecting longitudinal psychological distress data, CEGRMs, and medical data, and in 
the future a longitudinal analysis of the process of psychosocial adjustment may be 
possible. In addition, trends in the data suggest that couples who have experienced more 
LFS cancers have fewer people that they rely on for emotional and tangible support. This 
may be explained by the “pruning down” of a network during and after a cancer 
experience. Many families that have survived cancer described how they “found out who 
their real friends were” due to a loss of friends, either from support fatigue or the family 
not asking for help.  
The findings of this study indicate that there are different patterns of support 
within couples as well as around couples. We found that the amount of reciprocal support 





frequently mutually nominated each other as providing emotional support, followed by 
health information exchange, spiritual exchange, and lastly tangible assistance. When 
support was asymmetric, the LFS partners more often nominated the non-LFS spouse as 
providing tangible, informational, and emotional support, and this pattern was stronger 
for tangible support. These findings may point to the caregiving role that the non-LFS 
spouse would take on if their partner had cancer.  
Interestingly, we found that although couples are mutually very emotionally 
supportive, they do not have many shared emotional supports outside the relationship, 
indicating that partners seek out each other, but seek other people when they need 
emotional support. This is an encouraging sign that individually partners have a broad 
network of support outside of the relationship. Couples do not rely wholly on one or two 
shared persons for their various support needs. Mutuality in the four types of support had 
strong associations with smaller differences in psychological distress between partners. 
This points to a level of connection and congruency of emotional function in couples that 
are mutually supportive.   
 
Strengths and Limitations 
This study is the first of its kind to investigate the social context of couples living 
with LFS. Utilizing social network analysis, qualitative, and quantitative data, we were 
able to identify the specific sharing of resources between married partners as well as how 
often they support each other. Our findings included descriptions and visual 
representations of the couples’ shared support networks. The analysis described the rich 
quantitative social network data collected through a qualitative, semi-structured interview. 





perceptions of the network to be combined into a description of the social context that 
utilizes data from multiple network participants. Building on the findings from the 
previous two studies, this social network analysis captured both individual and dyad level 
use of support as a coping style, as well as information about the patterns of support 
within the couple relationship. The CEGRM has been used to measure the social 
networks of individuals and families from other hereditary disease populations, and the 
findings of this study can be compared to those studies using similar tools.  
Several limitations of this study should be noted. First, due to the cross-sectional 
nature of this study, it was not possible to draw conclusions regarding causality, but only 
statistical associations. Second, although we attempted to capture the experiences of as 
many people with LFS and their partners as possible, the sample size available for this 
study was relatively small. The small sample size limited our ability to detect significant 
between-group differences in BSI scores or social network size or to fit more complex 
models due to a lack of power. Third, the structure of the CEGRM interview may have 
biased some of the results. For example, a pedigree from the partner with LFS was used 
for the placement of stickers nominating support people. This pedigree does not include 
the family of origin for the person without LFS; therefore, if a partner without LFS had 
significant non-family support people in their life, they would have had to add this 
information to the CEGRM manually. This extra step may have dissuaded some 
participants from adding all of their support people. Our analysis did not, however, detect 
any group differences in the size of each support network. Finally, the structure of the 
CEGRM interview was to first nominate people with whom participants have discussed 
LFS or cancer. Using this as the starting place for the interview primed the participants to 





 We believe our preliminary results presented herein warrant additional research in 
several areas. Future research can look at the size of couples’ shared support networks as 
potential moderators for the mediation model outlined in Paper 1, regarding cancer worry 
and its impact on their mood and daily functioning. Future studies will also incorporate 
family interview data and social network data to flesh out more specific descriptions of 
dyadic coping styles and how those typologies relate to patterns of social support. In 
addition, it is important to explore how reciprocity patterns of the type found between 
partners also can be identified as operating with support people outside of the couple 
dyad. In this study, although our multi-informant network visualizations included 
information about the degree of relation for support people, we did not use these data in 
our analysis. In the future we would like to utilize these data that captures the degree of 
closeness between participants and relatives (degree of relation) or friends to analyze how 
mutuality predicts which friends or family members individuals go to beyond their 
partner. This type of study would also help shine light on individuals’ choices to seek 
support from others who have a better understanding of the syndrome (related by blood 
or who also have LFS) versus friends and relatives who are not as familiar with the 
unique needs of this population.  
As the LFS study continues, multiple cancers are diagnosed each year of the study, 
and, as we collect outcome data on their cancer survival outcomes, we can incorporate 
the social network data as a predictor of health outcomes. Using this study as a model, we 
can collect longitudinal information about social networks to explore how different types 
of couples (couples with children, children who have or have not had cancer, couples 
who have or have not had cancer, etc.) are coping with Li-Fraumeni Syndrome by using 





changes in social networks, especially in relation to life events associated with LFS, such 
as a new cancer. 
Lastly, this sample is not nationally representative with regard to race, education, 
or income; future research must integrate perspectives of a more diverse population. 
Specifically, these 20 couples all have strong medical support as part of their 
participation in the LFS screening study. They can meet regularly with experts in the 
field of heritable cancer syndrome and do not have to pay for intensive cancer screening 
procedures (e.g., MRIs). This is compared with a cohort of people who must navigate a 
health care system outside of the National Institutes of Health. The psychosocial 
experiences of families with LFS who are not part of the LFS study screening cohort are 
likely to be very different from the experience of this study’s sample.  
Clinical Implications 
Mutual support in these LFS couple dyads has been shown to have positive 
associations with psychological distress. Research on survivors of cancer continues to 
elucidate informational and emotional needs during their long-term survivorship (Vivar 
& McQueen, 2005) and people with LFS may have similar needs across the life course. It 
may be helpful for clinical teams to utilize relationship assessments and interventions that 
focused on the health and functioning of newly diagnosed partners, with survivors 
providing informational and emotional support. To our knowledge there is no specific 
intimate partner support intervention for families living with LFS. This type of 
intervention could profitably focus on quality of life for both the person with LFS and 
their spouse.  
We recommend that all health professionals seeing patients and families with LFS 





and emotional supports. Early identification of areas of concern could guide ongoing 
support and help anticipate future interventions that might be needed. Genetic counseling 
training could also incorporate training in systems-based counseling and research to 
address the social factors involved in living with LFS.  
Conclusion 
 This study represents an important early step in examining a dyadic framework 
for understanding coping with hereditary disease. Coordinated support resources within 
couples may be indicative of either adaptive processes, as in shared emotional supports, 
or maladaptive when considering the exchange of hereditary risk information. Although 
we anticipated higher numbers of cancers to be associated with more psychological 
distress, we found trends that suggested the opposite to be true. These trends indicate that 
partners with LFS who have had more cancers tended to have less depressive and anxiety 
symptoms over time, which points to the resilience and strength of this population. The 
couples in this study were emotionally supportive of each other and had a large range in 
shared social network size.  
Families are complex social systems that can facilitate or impede the coping 
process; the data presented herein suggest there may be real value in elucidating the 
social context in which support processes occur. These results have important 
implications to health-care providers as they facilitate adaptation for at-risk sisters and 
their families. The insight gained from prospective, follow-up studies hold genuine 
promise for improving clinical management of the complex psychological and behavioral 
issues occurring not only in families where sisters are at risk for developing 








Table 11. Descriptive Statistics of Analytic Sample  
Characteristic Descriptive Statistics (N=40) 
Age, years M (range) 41 (27-71) 
# women with TP53 mutation 14 
Education level (N = 30)  
High school degree 1 
Vocational/trade school 4 
Some college 1 
College degree 11 
Some graduate 5 
Masters or doctoral degree 8 
LFS partner with cancer 75% 
Non-LFS partner with cancer 10% 














Table 12. Cutoff Scores for BSI Quartiles 
 Yellow Orange Red  Purple 
BSI Total 34-39 40-44 45-51 52-66 
Anxiety 36-42 43-46 47-54 55-66 
Depression 40 40-41 42-48 49-68 
Somatization 39 40-42 43-48 49-61 







Table 13. BSI Scores by Group 
Psychological 
Distress*  
M (SD)  
LFS Male LFS Female Non-LFS Male Non-LFS Female 
Anxiety 53.17(9.47) 47.21 (8.21) 48.29 (7.95) 48.33 (7.00) 
Somatization 43.83 (4.21) 46.00 (7.79) 45.93 (8.34) 47.67 (8.48) 
Depression 49.83 (7.96) 43.57 (7.15) 46.29 (7.10) 48.33 (8.36) 
BSI Global 50.50 (6.28) 45.07 (7.35) 45.64 (10.15) 47.67 (8.45) 
Note: M = mean; SD = standard deviation. 
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Table 15. Couple-level Social Support 
Support Type Couple 





Shared supports  
 
% 
Health information exchange 20.15 (8.35) 13 (65) 18.55% 
Tangible assistance 15.60 (8.67) 7 (35) 16.67% 
Emotional support 14.90 (9.95) 17 (85) 8.43% 
Spiritual support (16 couples) 13.01 (9.58) 10 (63) 10.99% 






















Health Information exchange 
Mutual 13 5.69 7.38 6.23 5.92 
Non-LFS nominated 4 11.00 12.50 7.00 6.25 
LFS nominated 2 6.00 1.00 3.00 3.50 
Null 1 8.00 6.00 2.00 8.00 
Tangible Assistance 
Mutual 7 6.43 6.14 4.43 4.29 
Non-LFS nominated 10 7.90 8.70 7.40 7.20 
LFS nominated 1 4.00 1.00 4.00 1.00 
Null 2 5.00 11.5 4.00 7.00 
Emotional Support  
Mutual 17 6.29 7.18 4.88 4.64 
Non-LFS nominated 2 11.50 13.00 16.00 15.00 
LFS nominated 0 - - - - 
Null 1 8.00 6.00 2.00 8.00 
Spiritual Support 
Mutual 10 6.70 6.40 4.90 4.20 
Non-LFS nominated 1 11.00 21.00 2.00 5.00 
LFS nominated 2 3.00 9.50 2.00 4.50 
Null 7 7.71 7.14 8.86 8.71 
Note: “Non-LFS nominated” indicates that the partner with LFS nominated their spouse 





































































CHAPTER 6: CONCLUDING DISCUSSION 
Using data from the LFS screening study at the NIH, the three studies comprising 
this dissertation illuminate the psychosocial functioning and coping styles of couples in 
which one partner has LFS. Each study investigated different facets of dyadic coping of 
high cancer risk, including individual-level coping styles, cohesive versus independent 
coping, and couple coping utilizing social networks. Below, I briefly summarize the main 
contributions of each of the studies, their limitations and suggestions for future research, 
and the overarching implications for policy and practice.  
 
Contributions 
The three studies that comprise this dissertation expand the scope of research on 
LFS beyond the individual that has the syndrome to the rest of the family that is affected. 
Each study builds on levels of closeness to the individual, with the first study analyzing 
individual-level variables that were collected from both partners. The second study 
included both members of the couple to create collaborative and shared narratives about 
how they coped together with LFS. The third study developed a social context of friends 
and families that support and surround the couple. Taken together, these three studies 
provide a complex and comprehensive review of couple functioning.  
The first study explored the psychosocial functioning of couples that are faced 
with increased risk of cancer(s) for one partner. One of the major findings of this study 
was that people with LFS frequently worry about their chances of getting cancer, some 
even having thoughts about cancer multiple times per day. This finding was significantly 





daily function as a function of how cancer worry affected their mood. People who more 
frequently worried about cancer also reported that their mood and daily functioning were 
affected by these thoughts. We expected that some of the coping strategies that these 
individual and their partners employ to deal with LFS would moderate this process, and 
that more adaptive coping styles would be associated with less cancer worry affecting 
daily functioning. The results of the study did not show that individual coping styles of 
either the person with LFS nor their partner moderated this cancer worry process.  
The second study explored the ways that couples coped together in the face of 
intense surveillance and significant cancer worry. Utilizing a modified grounded theory 
approach, analysis of the semi-structured interviews revealed several prominent themes.  
First, couples shared a sense of ambiguous danger related to the threat of cancer and 
when to expect a diagnosis. To cope with this ambiguity, couples developed several 
strategies for communicating and adapting. Many couples described resilient processes 
such as role flexibility, connectedness, and utilization of social and economic resources. 
Communication processes varied by couple, with some people engaging in protective 
buffering behaviors or individual problem-solving in an effort to spare their partner any 
unnecessary pain or stress. Other couples openly shared their fears and engaged in 
empathy and collaborative problem solving.   
Many participants and collaborators pointed out the utility of psychosocial 
interviews as a major contribution to the LFS screening study at the NIH. The screening 
at NIH is a unique experience for the families, and many of the couples used this time 
during the family interview to discuss worrisome symptoms leading up to the visit to 
Bethesda because heightened the potential that a new cancer would be found. The family 





of a stressful experience. Many of the couples comfortably gave feedback about the 
process of screening at NIH to the interviewer, who was then able to relay the feedback 
to the research team, who then made appropriate adjustments (example: how to discuss 
mastectomies with women). At the conclusion of the interviews, many couples said they 
had never discussed LFS in the context of their family to this depth, or in such an open 
manner, and that they appreciated the opportunity to be enlightened regarding their 
partners’ perceptions and experiences.  
The third study employed a novel approach to exploring couples’ social support 
structures. Utilizing a social network framework, visual representations of familial and 
friend supports were created via a semi-structured interview and quantitative analyses 
were performed. One of the most important findings of the study was that the sample of 
couples was highly mutually supportive, emotionally, but less so when it came to 
providing tangible support, which was found to be slightly unequal (non-LFS partner 
provided more tangible support). In addition, the number of cancers that the person with 
LFS had was negatively associated with distress, meaning people who had experienced 
more cancers were less distressed. Couples who had experienced more cancer also 
reported smaller emotional and tangible support networks, possibly pointing to how after 
having cancer people may lose peripheral friends but bonds with close friends may be 
strengthened. Lastly, the differences in BSI scores were smaller when the partners 
reported mutual support, indicating a cohesion and collective mentality about distress and 
support. The integration of two participant perspectives in this manner provided insight 






The three papers each had their various strengths and weaknesses, but viewed as a 
whole, they provide a more complete picture of the functioning of couples with LFS. The 
first and second studies utilized distinct methods for measuring partner coping styles, and 
the results of the Brief COPE and the qualitative typologies of dyadic coping integrate the 
perspectives of both partners when the data collection is done both individually and with 
the two partners together. The third paper captures individual psychological distress at a 
different time and provides more detail about how members of couples utilize their 
support networks to cope with the demands of a complex health situation.  
Limitations and Suggestions for Future Research 
LFS is rare syndrome and although this study represents the largest study of 
couples living with LFS to date, the relatively small sample size decreased our statistical 
power, which limited our ability to apply more complex analytic tools in hopes of 
detecting an effect when there was one. Therefore, without sufficient statistical power, 
the quantitative studies may be subject to Type 1 and Type 2 errors. We attempted to 
address this limitation by simplifying our analysis with fewer variables, rather than 
utilizing more complex predictive modeling. Future research on families that are affected 
by LFS can build upon this dataset and increase the sample size to improve the power of 
the study. 
An important limitation of this study is that the findings are not likely to be 
generalizable to a broader US population from which the respondents were not 
systematically drawn, in this case, to all married individuals with LFS and their partners. 
Recruitment methods were unique to this study, and they yielded a particular group of 
couples that produced these particular results. These families had a long history of 





commonly had multiple affected family members and had made extensive use of genetic 
testing and LFS cancer screening. Thus, the population described here is heterogeneous 
in terms of age, relationship length, longevity of knowledge of mutation status, and 
cancer experiences, while being relatively homogeneous with regard to race, 
socioeconomic status, sexuality, level of education, etc. Therefore, these findings provide 
little insight regarding how families who differ on these characteristics might experience 
their lives when affected by LFS. Further qualitative and quantitative studies should 
focus on these other subgroups within the LFS population to increase our understanding 
of what kind of variation might exist that we could not capture Additionally, since our 
studies were biased towards female mutation carriers and their male partners, a larger 
sample of men with LFS and their female partners or a sample of non-heterosexual 
couples may further enrich and clarify the findings of the current study.  
 A possible deficiency of this study is the discrepancy between the qualitative and 
quantitative studies with regards to negative experiences. Studies 1 and 3 found 
participants’ levels of distress were relatively low; however, Study 2 uncovered a range 
of negative emotions related to the LFS experience and the cancer screening experience. 
These negative experiences were not captured in the quantitative studies, suggesting that 
the measures that were used may not be appropriate for this population. Future studies of 
couples in LFS can employ measures that are more focused on family relationships and 
dyadic coping.   
Implications for Policy and Practice 
Promoting resilience is a critical element of psychosocial care for people with 
LFS and their families. There has been little analysis to date on the nature of the families' 





unique features of family relationships and interactions in the context of LFS. Specific 
features of the families' experience with cancer were examined in this dissertation with 
the goal of developing approaches to care that recognize and incorporate the 
interconnectedness of family responses and the considerable needs of family members for 
emotional and practical support (Yates, 1999).  
Although the absolute risk of cancer is not affected by the couples’ resilience, 
their state of mind or outlook can certainly modulate the experience of risk. This is a 
valuable accomplishment on the behalf of the couples, and holds an important message 
that they can pass along to their children or other family members about how they choose 
to live with LFS. The resilience of these families should be not be underestimated and 
clinicians working with this population should focus on principles of strength instead of 
deficit for clinical and community-based practice. Taking a relational view of human 
resilience means including family members in the process of screening and 
communication of results. Clinicians can also evaluate families for their community, 
cultural, and spiritual resources, and connect them to in-person or online support groups, 
the LFS Family Association, or the LFS bi-annual symposium for families and 
researchers. It is important to acknowledge that every family has a different pathway and 
style for coping. There is huge variation in LFS families related to their specific health 
challenges, pile-up of symptoms, and immediate versus long-term stressors. Clinicians 
must consider the unique situations and family beliefs of their patients, and can point out 
developmental phases or generational patterns that adds context to the coping of the 
family.  
The implications of this research can help promote and encourage open 





care and genetic education are crucial resources that are not distributed equally across the 
United States in general, and for families with LFS in particular. This sample represents a 
highly motivated group of participants who values modern healthcare and constant 
medical monitoring. However, there are many people with LFS who may not have access 
to information about LFS or the cancer risk management options available to them, or 
who hold different opinions about how to manage their cancer risk, which helps define 
additional needs that are not currently being met.  
Amidst a deluge of information about genetic testing, cancer risk, risk-reduction 
strategies and cancer screening, couples felt overwhelmed, but were able to form 
cohesive beliefs about the best ways to balance risk-management and maintaining their 
family goals. Individuals with LFS also emphasized that the presence of the spouse 
helped relieve anxiety and distress during the screening procedures. This is in line with 
couples’ research that has shown that the physical presence and empathetic stance of a 
partner can reduce the levels of reported pain that the other person feels (Goldstein, 
Shamay-Tsoory, Yellinek, & Weissman-Fogel; Younger, Aron, Parke, Chatterjee, & 
Mackey, 2010). In addition, a support person can manage, share and distribute the 
healthcare responsibilities to mitigate the very real burdens of day-to-day living that is 
felt by the family. This research underscores the need for a systemic and relational view 
of the health care for families who are affected by LFS. Although some families are more 
vulnerable or face more hardships than others, all families have the potential for positive 
growth as they face health challenges. Services focused on coping skills, adaptation, and 
competence that build off underlying resilience can empower families, bring hope, and 







Appendix A: Brief Symptom Inventory  
Derogatis, L. R. (2001). BSI 18, Brief Symptom Inventory 18: Administration, scoring 
and procedures manual. Minneapolis, MN: NCS Pearson, Inc. 
 
Below is a list of problems people sometimes have. Read each one carefully and circle 
the number that best describes how much that problem has distressed or bothered you 
during the past 7 days, including today.  
 
Circle only one number for each row. 
 
During the past 7 days, how 










A. Faintness or dizziness 1 2 3 4 5 
B. Feeling no interest in things 1 2 3 4 5 
C. Nervousness or shakiness 
inside 1 2 3 4 5 
D. Pains in the heart or chest 1 2 3 4 5 
E. Feeling lonely 1 2 3 4 5 
F. Feeling tense or keyed up 1 2 3 4 5 
G. Nausea or upset stomach 1 2 3 4 5 
H. Feeling blue 1 2 3 4 5 
I. Suddenly scared for no 
reason 1 2 3 4 5 
J. Trouble getting your breath 1 2 3 4 5 





L. Spells of terror or panic 1 2 3 4 5 
M. Numbness or tingling in 
parts of your body 1 2 3 4 5 
N. Feelings of hopelessness 
about the future 1 2 3 4 5 
O. Feeling so restless that you 
couldn’t sit still 1 2 3 4 5 
P. Feeling weak in parts of your 
body 1 2 3 4 5 
Q. Thoughts of ending your life 1 2 3 4 5 







Appendix B: Cancer Worry Scale 
Custers, J. A., van den Berg, S. W., van Laarhoven, H. W., Bleiker, E. M., Gielissen, M. 
F., & Prins, J. B. (2014). The Cancer Worry Scale: Detecting fear of recurrence in 
breast cancer survivors. Cancer Nursing, 37(1), E44-50.  
 
During the past month, how often have you thought about your own chances of getting 
cancer (or another cancer)? 
 
Not at all or rarely .............................. 1 
Weekly ............................................... 2 
Daily ................................................... 3 
Several times a day ............................ 4 
 
 
During the past month, how often have thoughts about your chances of getting cancer (or 
another cancer) affected your mood? 
 
Not at all or rarely .............................. 1 
Weekly ............................................... 2 
Daily ................................................... 3 
Several times a day ............................ 4 
 
 
During the past month, how often have thoughts about cancer affected your ability to 
perform your daily activities? 
 
Not at all or rarely .............................. 1 
Weekly ............................................... 2 
Daily ................................................... 3 






Appendix C: The Brief COPE Scale 
Carver, C. S. (1997). You want to measure coping but your protocol's too long: Consider 
the Brief COPE. International Journal of Behavioral Medicine, 4(1), 92-100.  
 
The following questions ask about ways you've been coping with the stress in your life 
since you found out that you or a family member had cancer, or may be at increased risk 
of having cancer. There are many ways to try to deal with problems. These items ask 
what you've been doing to cope with this one. Each item says something about a 
particular way of coping. We want to know to what extent you've been doing what the 
item says. Don't answer on the basis of whether it seems to be working or not—just 
whether or not you're doing it. Please circle the response that best describes how often 





it at all 
I have 
been doing 
it a  
little bit 
I have been 





doing this  
a lot 
A. I've been turning to work or 
other activities to take my 
mind off things 
1 2 3 4 
B. I've been concentrating my 
efforts on doing something 
about the situation I'm in 
1 2 3 4 
C. I've been saying to myself 
"This isn't real." 
1 2 3 4 
D. I've been using alcohol or 
other drugs to make myself 
feel better 
1 2 3 4 
E. I've been getting emotional 
support from others 
1 2 3 4 
F. I've been giving up trying to 
deal with it 
1 2 3 4 
G. I've been taking action to try 
to make the situation better 
1 2 3 4 
H. I've been refusing to believe 
that it has happened 
1 2 3 4 
I. I've been saying things to let 
my unpleasant feelings escape 
1 2 3 4 
J. I’ve been getting help and 
advice from other people 
1 2 3 4 
K. I've been using alcohol or 
other drugs to help me get 
through it 
1 2 3 4 








it at all 
I have 
been doing 
it a  
little bit 
I have been 





doing this  
a lot 
different light, to make it 
seem more positive 
M. I’ve been criticizing myself 1 2 3 4 
N. I've been trying to come up 
with a strategy about what to 
do 
1 2 3 4 
O. I've been getting comfort and 
understanding from someone 
1 2 3 4 
P. I've been giving up the 
attempt to cope 
1 2 3 4 
Q. I've been looking for 
something good in what is 
happening 
1 2 3 4 
R. I've been making jokes about 
it 
1 2 3 4 
S. I've been doing something to 
think about it less, such as 
going to movies, watching 
TV, reading, daydreaming, 
sleeping, or shopping 
1 2 3 4 
T. I've been accepting the reality 
of the fact that it has 
happened 
1 2 3 4 
U. I've been expressing my 
negative feelings 
1 2 3 4 
V. I've been trying to find 
comfort in my religion or 
spiritual beliefs. 
1 2 3 4 
W. I’ve been trying to get advice 
or help from other people 
about what to do 
1 2 3 4 
X. I've been learning to live with 
it 
1 2 3 4 
Y. I've been thinking hard about 
what steps to take 
1 2 3 4 
Z. I’ve been blaming myself for 
things that happened 
1 2 3 4 
AA. I've been praying or 
meditating 
1 2 3 4 
BB. I've been making fun of 
the situation 






Appendix D: Cohen Stress Scale 
Golden-Kreutz, D. M., Browne, M. W., Frierson, G. M., & Andersen, B. L. (2004). 
Assessing stress in cancer patients: A second-order factor analysis model for the 
Perceived Stress Scale. Assessment, 11(3), 216-223.  
 
The following questions ask you about your feelings and thoughts during the past month. 
In each case, please circle the choice that best describes how often you felt or thought a 
certain way. 
 








A. How often have you been 
upset because of something 
that happened unexpectedly? 
0 1 2 3 4 
B. How often have you felt that 
you were unable to control the 
important things in your life? 
0 1 2 3 4 
C. How often have you felt 
nervous and “stressed”? 
0 1 2 3 4 
D. How often have you felt 
confident about your ability to 
handle your personal 
problems? 
0 1 2 3 4 
E. How often have you felt that 
things were going your way? 
0 1 2 3 4 
F. How often have you found that 
you could not cope with all the 
things that you had to do? 
0 1 2 3 4 
G. How often have you been able 
to control irritations in your 
life? 
0 1 2 3 4 
H. How often have you felt that 
you were on top of things? 
0 1 2 3 4 
I. How often have you been 
angry because of things that 
were outside of your control? 
0 1 2 3 4 
J. How often have you felt 
difficulties were piling up so 
high that you could not 
overcome them? 






Appendix E: Semi-Structured Interview Protocol (Family Interview) 
INTRODUCTION 
Interviewer: Thank you all so much for your willingness to participate in this interview 
study. I’d like to tell you a bit more about the purpose of this study. I am interested in 
learning about the experiences of both individuals and families with increased hereditary 
cancer risk, and specifically about how living with that risk impacts and is impacted by 
your relationships with each other. Through this research, I’m hoping to explore and 
better understand the experiences of individuals and families affected by TP53 mutations. 
Someone on our team has already spoken to each of you about your individual 
experiences related to the mutation in your family; now, I’d like to learn how you talk 
about and collectively understand what’s happening within your family, relative to your 
genetic predisposition to cancer. 
I want to remind you that whatever you say here is completely confidential; I will not use 
your real names or any personal identifying information when reporting our findings. 
Each of you has already chosen individual pseudonyms to be used in place of your first 
names in anything we write from this study. Is there a fictitious last name that we could 
use to refer to all of you as a family? 
I also want to reassure you that, as a mental health professional who works with 
individuals and families facing medical and genetic challenges, I am deeply and 
personally committed to understanding your unique and personal experiences as members 
of families faced with hereditary cancer risk, and how that might impact other important 
aspects of your lives. 
The results generated using the information provided by you and other study participants, 
may help inform the body of knowledge about psychosocial issues affecting mutation 
carriers and families, as well as the manner in which these challenges are understood by 






Do any of you have any questions for us about the purpose of the study or what we hope 
to do with the results?  
OK, let’s get started. Please remember that if you don’t feel comfortable answering any 
of the questions, just let us know and we can skip them. Does that sound OK? 
 
SECTION A: DEMOGRAPHICS AND FAMILY RELATIONSHIPS 
Great. First we’d like to get some basic information about all of you as a group. 
1. How are the [three, four, five, etc.] of you related? 
2. Tell us about how the [three, four, five, etc.] of you chose to participate in the 
study together, or to be here as support persons.  
a. Is there anyone you wish were here who isn’t?  
b. How do you make sense of that absence? 
3. [Get a sense of family structure] 
a. [if siblings are present] Who is the oldest sibling? Youngest? Are there 
other siblings who aren’t here today?5 
b. In families in which there has been a death, follow-up about how that has 
been handled. How have other family members stepped in to fill the role of 
a lost loved one? How has the loss been dealt with? 
c. Who is the closest? Who has a more distant relationship? 
4. Tell me about how you all communicate and interact with each other. How do you 
keep in touch? 
 
SECTION B: FAMILY HISTORY OF CANCER AND TP53 MUTATIONS 
OK. Next, we’d like you to tell us about how you became aware of the TP53 mutation in 
your family. Can you tell us that story? 
Please tell me about who has had cancer in your family and what those experiences have 
been like. 
                                                 
5 Italicized questions are “probes,” which serve as reminders for the interviewer to gather this information; 
these items will not be directly requested unless the interviewees do not talk about them in their answers to 





1. When did the family first become aware that cancer might be hereditary? 
2. How did genetic testing come to happen in your family? 
3. Who was the first to be tested? How did information about genetic testing spread 
from that person to other family members? 
4. What challenges have you faced in talking about cancer risk as a family, or 
addressing cancer-related issues that have surfaced within the family since 
genetic testing? How has the family dealt with those? 
 
SECTION C: GENETIC TESTING 
Next, we’d like to know about how your family communicates about genetic testing 
specifically.  
1. Is there a family belief about whether/when/which people should get tested?  
2. What are the various ways this message has been communicated? Have you found 
some ways more or less effective than others?  
3. How are decisions about genetic testing made by individuals in your family? 
4. To what extent were each of you involved in each others’ genetic testing 
processes? In what ways did you participate? 
5. What has happened in the family when someone gets tested and receives her/his 
results? (How) are those results communicated to other family members? 
6. How has your family responded to members who choose not to get tested? 
 
SECTION D: RISK MANAGEMENT 
The next several questions will focus on how members of the family are involved in each 
others’ risk management decisions and experiences. Is there a traditional way or family 
expectation about how people who carry the mutation should manage their risk? By 
manage, I mean any behaviors that people do in response to their cancer risk, in an 
attempt to monitor for and/or avoid cancer. 
1. Which specific management options have the members of your family considered 
or used? 
2. How do you communicate with each other about risk management? 
a. Positive experiences? 
b. Negative experiences? 





4. What happens when individuals make different choices about how to manage 
their cancer risk? For example, if one family member decides to participate in 
screening and one opts not to? 
5. What happens when family members disagree with each other about how one 
person should manage her/his cancer risk? 
6. Is there a family authority or “leader” when it comes to risk-management? Who, 
and why that person? Is there a person to whom others turn for advice or 
information? Why this person? Has this been an effective way to handle these 
decisions? 
 
SECTION E: THE NEXT GENERATION 
Next we’d like to know about how information regarding the TP53 mutation and cancer 
risk has been or will be communicated to and handled with the next generation – young 
people in your family who aren’t old enough yet to fully understand this issue, maybe 
your kids or grandkids. 
1. Tell us about who in the family fits in this group. 
a. What is the gender distribution – how many boys, how many girls? 
b. How old are the kids in the next generation? 
c. How many are children of known carriers? Children of people who have 
tested negative? Children of family members who haven’t been tested? 
d. Is the next generation pretty much complete, or are new babies still 
coming into the family? 
2. What has happened in your family with regard to testing minors for the mutation? 
a. How are any cases of childhood cancer relevant to this question? 
b. What has happened when different children within the family have 
different mutation statuses? 
c. How have family members reacted to decisions about testing minors? 
3. Thinking specifically about older kids who are capable of understanding the idea 
of being tested, tell me what information about the LFS and/or cancer and cancer 
risk has been shared with members of this next generation? 
a. How have these conversations gone? 
b. Is there a family consensus about whether/when this information should be 
shared? What happens when people disagree? 
4. Have any untested family members under age 18 expressed an interest in being 
tested for the mutation? How has that been handled?  
5. Have issues related to having a TP53 mutation come up as members plan 
pregnancies?  
a. How are these issues handled? 
b. What strategies have family members considered relative to influencing 
the likelihood of passing the mutation along to a child? (e.g., adoption, 





c. Has anyone utilized, or is anyone planning to utilize, these options? What 
was the response from the family? 
d. What happens when people disagree? 
e. Have you learned anything specific from your own experiences, either 
helpful or not helpful, that you would want to pass along to younger family 
members? 
6. What are your hopes for the next generation with regard to TP53 and cancer? 
 
SECTION F: INTERVIEW WRAP-UP 
1. What else do you think is important for me to know about your family that I 
didn’t ask you about? 
2. What has it been like being interviewed together about these issues? 
3. Anything else you’d like to tell me? 
4. Do you have any questions for me? 
 
Thank you so much for your help. If I have more questions for you that come up later, is 
it alright for me to contact you?       YES NO 
 
And, if you think of anything else that you forgot to say or if you think of something else 
you’d like to tell me regarding your experience, please call or e-mail me – I’d love to 
hear from you. 
 
I will be e-mailing my study findings –interpretations and conclusions – to participants to 
get their feedback and reactions. Would you be willing to read those findings and get 
back to me with comments?                           YES NO 
 
OK. And if in the future I decide to collect some follow-up data through a survey, 
interview, or questionnaire, would you be willing to participate?        YES NO 
 
Okay. Everything you’ve shared today has been very helpful, and I truly appreciate your 
taking the time to talk with us today. I will be looking forward to talking with you again 
when the results have been analyzed, to get your feedback on our interpretation of the 
data. 
 







Appendix F: CEGRM Script 
Name:  _________________________________________ CEGRM Case #: _________ 
Date: ______________________ Time: _________ CEGRM number:  1    2     3    4 
Administered by: ____JP    ____LH ____ Other________________________________ 
 
Introduction: 
__ Researcher Roles: 
• Genetic counselor: any questions from prior counseling? 
• Researcher interested in study participants as people, beyond just the 
medical. 
__ Description and purpose: 
• Getting to know you in the context of family and friends. 
• Collaborative effort between us, since you are the expert. 
__ Show paper and legend 




__ Review pedigree and symbols 
__ Update as needed 
__ Explain how we will use pedigree as the basis of the CEGRM by adding symbols 
__ First let’s add symbols and first name of other people in your life with whom you feel 
close.  This may include friends, neighbors, doctors, ministers, church members, co-
workers, parents of kid’s friends, and even pets. 
 
Types of People: 
 __ Friends 
 __ Neighbors 
 __ Doctors 
 __ Minister/Rabbi/Priest, etc. 
 __ Co-Workers 
 __ In-Laws 
 __ Others  
Do you have a confidante?  __ No __ Yes (specify with *)______________________ 
Particular Groups, Teams, Support Groups, Clubs that you relate to mainly as a group? 
 





Let’s use a blue circle to identify anyone in the family and among your friends with 
whom you’ve talked specifically about cancer in the family or the genetic testing that you 






__ SDR, TDR (specify) 
__ Friends 
__ other (specify)  
  
Who did you talk to first about genetic testing? And then…… 
 
Is there a primary person with whom you discuss new cancer or genetic information?  
Why that person? 
 
How does the information get disseminated, i.e., how do these conversations come about? 
 
Are the exchanges mutual?  E.g., they call you when they have something to tell and you 
call them when you have news? 
 
Are the people with whom you discuss general cancer issues the same people with whom 
you discuss cancer in your family and genetic issues?  How are those groups the same or 
different? 
 
Do you feel as though you are able to talk about cancer and genetic issues with friends 
and family members as much as you need to (i.e., do you get the informational support 
that you need?) 
 
Silver Stars = Information Gatherer(s)/Researcher(s) 
We can use a silver star to identify a person who takes on the job of looking for new 
information about cancer or genetic testing.  They might do this by searching online, 
doing a lot of reading, or putting themselves in touch with other people going through 
similar experiences.  Is there someone in your family who fits that description? 
 __ Parent(s) 
 __ Sibling(s) 
 __ Child(ren) 
 __ Spouse/Partner 
 __ Self 





__ SDR, TDR (specify): 
 __ Friends 
 __ other (specify) 
 
What does that person/those people do to gather that kind of information? 
 
What do you think motivates that person/those people to do this? 
 
Green Stars = Information Disseminator(s) 
Are there one or two main people in the family or among close friends who spread 
genetic and cancer information to all the others and who try to get everyone talking about 







__ SDR, TDR (specify) 
__ Friends 
__ other (specify) 
 
How does that person/those people go about the job of dissemination? 
 
What do you think motivates that person/those people to do this? 
 
Red Stars = Information Blocker(s) / Private Person(s) 
This person or people might be sort of like the opposite of the green star person.  In some 
families, there are people who are very private and don’t seem to want to talk about these 
health issues. 
 
Who in the family or among friends (or maybe even yourself) doesn’t want to hear about 













__ other (specify) 
 
How do they show that they don’t want to talk about it? 
 
What do you think is behind this? 
 
Is this person’s reluctance to talk specific to the issues of cancer and genetic testing, or is 
that something that happens with other topics as well? 
 
Green Circles = Tangible Help 
When you need something, like a favor or some help with something, whom do you 
count on? 






__ SDR, TDR (specify) 
__ Friends 
__ other (specify) 
 
What kinds of favors do these individuals do for you? 
 
Are these favor exchanges mutual?  If so, how do you help them? 
 
Do you feel as though you get the right amount of this type of support?  Or do you 
sometimes feel like you could use some more of this type of support? 
 
Yellow Circles = Emotional Exchanges 







__ SDR, TDR (specify) 
__ Friends 






Who is the primary person that you count on for this kind of support?  Why that person? 
 
Do you find that you are able to be both a giver and a receiver of this type of support?  
i.e., in situations or at times when you find yourself needing emotional support, are you 
still able to be an emotional support to others?  Tell me about how that works for you. 
 
Do you feel as though you get the right amount of this type of support?  Or do you 
sometimes feel like you could use some more emotional support? 
 
Red Circles = Spiritual Exchanges 
You have already mentioned/or I noticed that you haven’t mentioned exchanges in 
regards to spiritual or religious resources.  I wonder whether you feel that spirituality is 
an important part of your social world? 
__ yes 
__ no 
__ can’t say 
__ other:  
 
Do you or have you in your life affiliated yourself with a particular religious group? 
 __ In family of origin: _______________ 
 __ In adulthood: ______________ 
 






__ SDR, TDR (specify) 
__ Friend(s) 
__ other (specify) 
 
By what means do you connect?  
__ attend the same church, synagogue, bible study group 
__ pray together or for each other 
__ socialize in church-sponsored events 
__ spend time with yourself/introspective/journal/nature 
__ other:________________________________________________________ 
 
Do you feel as though you get the right amount of this type of support?  Or do you 






Ending/Closing/Changes over Time 
__ Transition: That does it for my part. Thanks for sharing all of this with me.  It 
definitely helps me understand better your experience as you’ve been dealing with all of 
this.  I have a better sense of how your family and friends work together.   
 
__ Summarize: Let me just review what you’ve told me the main events been going on 
in your life recently, e.g., health issues, work, moving, relationships….    
 
__ Stressors: Are there other things that have been stressful or challenging? 
 
__ Other Missing: Is there anything else or anyone else that we missed this year? 
i.e., Is there anything else that you would like to tell me about your experiences with the 
dealing with the cancers or cancer risk in yourself or your family? 
 
__ Impression: As we pause for a moment and look at your family CEGRM, what do 
you see? 
i.e., How would you describe your social world as you’ve shown it to me here? 
 
__ Changes over time:   You’ve told me a bit about how different types of support have 
been exchanged differently among members of your social network over time.  I’d like us 
to take a look at all the CEGRMs we’ve created together, from all of your visits, and see 
if you have any other impressions about how things have changed or what things have 



























































































Appendix H: Social Network Visualizations by Support Type 
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